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DNA is packaged into ‘on’ and ‘off’ states, which are loosely more open and 
accessible and more compact and inaccessible respectively. How the compact 
heterochromatic ‘off’ state is regulated and its role in disease is poorly 
understood. 
 
The ‘off’ heterochromatic state has defined characteristics of increased DNA 
methylation and Histone 3 trimethylation (H3K9me3). DNA methylation loss 
does not change the compact nature of heterochromatin. Loss of H3K9me3 
results in an increase in cancer in mice; however visually compact DNA is 
still present.  
 
Broadly I aimed to identify components that regulate the heterochromatic 
‘off’ state, and investigate their role in the development of colon cancer drug 
resistance. I found that the loss of a component that turns ‘on’ genes 
appeared to regulate silent genes. This corresponded to a decrease in HP1 
that is normally associated with maintaining the heterochromatic ‘off’ 
associated. This suggests that the activator is required to produce the 
components to maintain the compact ‘off’ state.  
 
Additionally I aimed to address whether H3K9me3 effects the compaction of 
the heterochromatic ‘off’ state. I found that loss of H3K9me3 affected the 
level of compaction globally as well as at compact ‘off’ regions of the DNA. 
This correlated with an increase the amount of RNA bound to DNA. Re-
establishing H3K9me3 ablated these effects. Further research is required to 




Since the discovery of DNA packaging into chromatin, and McClintock’s 
(1951) work on position-effect variegation providing evidence of non-
mendelian inheritance, the principal of a genome maintaining ‘on’ and ‘off’ 
states has been widely adopted. However, the underlying mechanisms that 
regulate these dynamic chromatin states and their effect on disease are still 
poorly understood. 
 
DNA methylation and histone trimethylation at H3K9 and H4K20 are the 
core hallmarks of the heterochromatic constitutively ‘off’ state.  Constitutive 
heterochromatin is predominantly comprised of repetitive satellite 
containing pericentromeric regions and telomeres and in mouse 
heterochromatin clusters into large chromocenters. These regions are 
cytologically more compact and generally transcriptionally silent across 
embryonic and differentiated mouse cell types. However, in addition to 
increased genomic instability, mouse tumour cells sustain increased satellite 
expression suggesting constitutive heterochromatin is disrupted. Therefore 
how constitutive heterochromatin is maintained has important implications 
for genome regulation and disease, and remains poorly understood.  
 
While satellite DNA sequences are not evolutionarily conserved, 
pericentromeric and telomeric heterochromatin occurs across species. 
Heterochromatin formation is therefore independent of the underlying DNA 
sequence, supporting the hypothesis that epigenetic components can 
regulate chromatin structure. DNA methylation is generally thought to be 
associated with transcriptional silencing and chromatin compaction. 
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However, Gilbert et al (2007) showed that the complete loss of DNA 
methylation did not affect the compaction at heterochromatin or global 
genome compaction.  
 
The role of H3K9me3 in regulating heterochromatin has also been an area of 
keen interest. H3K9me3 patterns are established by suppressor of variegation 
3-9 homologues and provide the binding site for heterochromatic protein 1 
[HP1] which can in turn recruit Suv39h1. This Suv3-9h-HP1-H3K9 axis 
enables its propagation throughout heterochromatin. Peters et al (2001) 
demonstrated that in mice loss of suv39 homologues 1 and 2 caused a loss of 
H3K9me3 at constitutive heterochromatic domains. These Suv39h null mice 
demonstrated decreased genome stability, and an increased prevalence of 
oncogenesis. However cytological chromocenters are still present in the 
absence of H3K9me3. Therefore the function of H3K9me3 as a causative 
agent in heterochromatin formation is still debated. 
 
Broadly the aim was to investigate the phenotypic role of heterochromatic 
epigenetic components in cancer progression, and address whether 
H3K9me3 effects large scale chromatin structure. To identify 
heterochromatic gene silencing components, an inhibitor screen was 
performed in an artificial silenced reporter system. The reporter fluorophore 
was silenced by the presence of centromeric arrays from yeast/bacterial 
artificial chromosomes and human alpha satellite repeats enriched for 
H3K9me3. To address the function of the de-silencing components identified 
in cancer, the fitness of colon cancer cells [HCT116] was investigated before 
and after the development of resistance to the MEK inhibitor trametinib. The 
most intriguing result was that BET protein inhibition resulted in de-
repression of the reporter construct and trametinib resistant HCT116 cells 
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were more sensitive to BET inhibitors, while subsequent investigation 
showed HP1 protein levels were altered. Analysis of publically available 
datasets of tumour drug resistance, showed elevated BET protein binding at 
HP1 promoters in resistant cell lines suggesting an indirect role in gene 
silencing. 
 
To investigate the consequence of H3K9me3 loss on chromatin structure, 
mouse embryonic stem cells that lacked both Suv39 homologues were used. 
Microccocal nuclease digestion and sucrose sedimentation demonstrated a 
global decompaction of large-scale chromatin fibres whilst re-expression of 
suv39h1 rescued H3K9me3 at chromocenters and global chromatin 
decompaction. Loss of Suv39h also increased chromatin associated RNA 
levels that were also rescued by Suv39h1 re-expression. This suggests that 
H3K9me3 has a role chromatin fibre compaction globally as well as at 
constitutive heterochromatin, potentially mediated by chromatin associated 
RNA. 
 
To conclude, multiple components were identified that are involved in 
transcriptional silencing. Evaluating their function in tumour progression 
demonstrated a possible role of BET proteins in the development of MEKi 
resistance that may be mediated through HP1 proteins. H3K9me3 and its 
binding partner HP1 affect global chromatin compaction. The global 
decompaction after Suv39h loss correlates with an increase in chromatin 
associated RNA, suggesting a possible mechanism for changes in chromatin 
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Chapter 1: Introduction 
 
Since Friedrich Miescher discovered DNA in 1869 (Hoppe-Seyler, 1871) the 
structure and regulation of a cell’s genetic material has remained a 
fundamental research question. For Watson and Crick’s DNA structure to fit 
inside the nucleus of a eukaryotic cell the DNA requires multiple levels of 
packaging. DNA is initially wrapped around and bound to positively 
charged proteins forming fibres, which undergo further levels of folding.  
 
The tight packaging of these fibres enables regulation of underlying DNA 
processes in addition to overcoming the spatial constraints of the 
nucleosome. This regulatory ability of fibre structure has been linked to gene 
expression, genome regulation, and repair pathways. Mechanisms to 
modulate the topology of chromatin fibres are loosely termed epigenetic, 
derived from the Greek term epi- meaning “on top of” genetics. These 
processes enable cells to differentiate into different sub types despite the 
same underlying genetic sequence. 
 
The structure and regulation of condensed chromatin fibres is implicated in 
many biological processes, from faithful sister chromatid separation after 
replication to preventing gene expression at specific loci or in large Mb 
domains. For oncogenesis to occur tumour suppressor mechanisms must be 
disrupted, allowing uncontrolled oncogenic proliferation. DNA mutations, 
gene silencing, and gene activation mediate this process. Epigenetic 
pathways were first implicated in cancer when tumours were found to 
exhibit DNA hypomethylation (Feinberg and Vogelstein, 1983). With the 
addition of whole-genome sequencing, epigenetic components have been 
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demonstrated as the most frequently mutated in cancer (Forbes et al., 2011). 
Metastatic tumour progression after initial treatment is often resistant to 
treatment and lacks common new mutations like initial oncogenesis. This has 
led to the proposal of epigenetic mechanisms in metastasis formation. 
 
Studying epigenetic components that regulate a condensed fibre state 






















1.1 Chromatin constituents 
 
Multiple levels of organisation can define the complexity of chromatin 
structure. Primarily 147 base pairs of the DNA helix are wrapped 1.7 times 
around an octamer of histone proteins forming a core particle. In chromatin 
this structure is stabilised by histone H1 that binds close to the dyad, the 
point at which DNA enters and exits the nucleosome. Nucleosomes are 
positioned regularly along the DNA and when unfolded appear as a 10-nm 
‘beads on a string’ like structure (Alberts, Bray and Lewis, 1994). Under 
physiological conditions nucleosome arrays are further packaged into 30-nm 
diameter fibres. Additional levels of folding have been argued in the order of 
40-60 nm and 117 nm (Pope et al., 2005). Ultimately chromatin fibres are also 
folded by a looping model (Gibcus et al., 2018), which during mitosis results 
in the chromosome cytological bodies first seen by Walter Flemming (1878). 
1.1.1 Core histones 
The base unit of chromatin, the nucleosome comprises eight core histones 
and a linker histone. Linker histones bind to the DNA and associate with 
neighbouring nucleosomes through the long c-terminal tail (Allan et al., 
1986). Core and linker histones, have many post-translational modifications 
[PTMs], including acetylation, methylation, phosphorylation, ubiquitination, 
and less well studied more “exotic” modifications. These modifications 
correlate with transcriptional states and it has been suggested they could 
influence chromatin fibre function. Along with PTMs, core histones of the 
nucleosome can be evicted and replaced with variants to regulate chromatin 
structure in a site-specific manner.  
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The histone octamer that forms a nucleosome when bound to DNA 
comprises of histones H2A, H2B, H3, H4, or their individual variants. H3 
and H4 form a heterotetramer that binds to two H2A/H2B dimers. The 
histone octamer proteins are enriched with lysine and arginine residues 
resulting in a net positive charge whilst the antipodal negative charge of the 
DNA phosphate backbone results in a general propensity for DNA histone 
interactions.   
 
DNA and histones interactions are confined by proximal electrostatic and 
Van de Waal forces on the surface of the histone globular domain, which 
results in the DNA wrapping around the histone octamer. These interaction 
forces also differ depending on the underlying nucleic acid sequence 
revealing a bias for nucleosome positioning (Gonzalez et al., 2016).    
 
Neighbouring nucleosomes are individually distinct due to linker DNA 
being enriched with GC, GG, CG, and CC dinucleotide sequences. The DNA 
length of these linker regions fluctuates from 10-90 bp throughout the 
genome, by cell type, and species (Van Holdebo, 1989). Linker histones H1 
and its variant H5 also contain polar and charged surface amino acid 
residues, which allow binding to linker DNA. The linker histone H1 is 
composed of a globular domain with C-terminal and N-terminal 
unstructured tails. The globular domain of H1 associates with the dyad of 
the nucleosome, while the disordered tails interact with the naked linker 
DNA and nearby nucleosomes. H1 binding stabilises nucleosomes by 
reducing the free energy of the supramolecule. This increases the tolerance 
for nucleosome stacking and compaction to a 30 nm fibre state (Allan et al., 
1980). 
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1.1.2 Histone variants 
Canonical histone genes cluster in the genome and their transcription activity 
is tightly regulated by the cell cycle. Histone variants, by contrast, are 
typically dispersed throughout the genome, and are constitutively expressed. 
Histone variant chromatin incorporation occurs at the expense of their 
canonical counterparts and is normally regulated by histone chaperones. 
Chaperones associated with additional complexes with preferential binding 
affinities to particular post-translational modifications, allows for histone 
variant deposition to be tightly regulated (Luk et al., 2007; Obri et al., 2014). 
Histone variants maintain a large percentage of sequence similarity; yet have 
multiple effects including altering the structural dynamics of chromatin 
(Talbert and Henikoff, 2017). This enables variants to have diverse functions 
in DNA repair, transcriptional, and replication processes.  
 
H2A, H2B, H3 and H1 have known histone variants. Centromeric CENP-A, 
one of eight H3 variants, has greater than 60% similarity but unique N-
terminal tails. Deposited by histone chaperone HJURP, CENP-A 
incorporated nucleosomes in vitro are more stable and form more compact 
fibres than canonical H3 (Panchenko et al., 2011). In vivo, however, CENP-A 
nucleosomes are interspersed, except at structurally similar inactive 
centromeres. CENP-A is thought, therefore, to stabilise the fibre structure 






Other H3 variants of note include structurally similar H3.1/2 and H.3.3. 
Differing via a single amino acid H3.1 and H3.2 have yet to have 
distinguished functions, and are together described as canonical H3. 
Canonical H3 incorporation is mediated by CAF-1 in a replication dependent 
manner, representing the majority of H3 in chromatin. H3.3 DNA sequence 
diverges from H3.1 by five base pairs in humans, resulting in less stable 
nucleosomes, suggesting an altered chromatin incorporation and effect on 
chromatin structure (Tagami et al., 2004; Chen et al., 2013). 
 
H3.3 is deposited independently of the cell cycle by chaperone HIRA, or the 
chromatin re-modellers CHD1, and DAXX (Konev et al., 2007; Drané et al., 
2010). H3.3 is enriched at enhancer and transcribed loci, suggesting it might 
be frequently turned over, although it is also enriched at telomeric and 
pericentromeric regions (Wirbelauer and Bell, 2005). H3.3 enrichment at 
active and inactive regions is dependent on HIRA or DAXX mediated 
incorporation respectively (Goldberg et al., 2010).  
 
H2A variants have a diverse range of functions. H2A.Z is deposited at 
actively transcribed genes and is often found at the same loci as H3.3. 
Incorporation of H2A.Z destabilises nucleosomes synergistically with H3.3 
resulting in nucleosome depleted regions thought to promote transcription 
factor binding (Suto et al., 2000; Jin et al., 2011; Chen et al., 2013).  The local 
chromatin environment also regulates the DNA damage response, through 
the replacement of H2A by H2A.X. Distributed throughout the genome, this 
variant has an alternate C-terminal, which upon DNA damage is 
phosphorylated at ser139 marking the loci for repair (Rogakou et al., 1998). 
The most divergent variant is macro-H2A, which is nearly three times larger 
than canonical H2A. 
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Macro-H2A has 64% similarity to H2A, but also contains a linker to a large 
ancillary C-terminal domain that is located outside the core nucleosome 
particle (Pehrson and Fried, 1992). Found at the inactive X chromosome, 
macro-H2A is correlated to chromatin compaction and transcriptional 






























Figure 1.1 Nucleosome structure and the affect of histone variants. (A) Histone 
octomer containing two copies of H2A-H2B and H3-H4 heterodimers, with their 
disordered tails protruding from the core particle. (B) Depiction of the core nucleosome 
particle with certain histone variants that disrupt the DNA dyad resulting in a more open 
nucleosomal structure. Adapted from Shaytan, Landsman and Panchenko, (2015) 
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1.1.3 Histone modifications 
While the replacement of histones with variants is the most extensive 
nucleosome modification, histone post-translational modifications [PTMs] 
are associated with regulating the local chromatin environment. The majority 
of known post-translations occur on the N-terminal histone tails that 
protrude from the nucleosome core. Many types of histone modification 
have been identified on lysine, arginine, glutamine, serine, and threonine 
residues. The function of these modifications including methylation, 
acetylation, phosphorylation, and ubiquitination is still not fully understood. 
 
Lysine acetylation on H3 and H4 N-terminal tails correlates with 
euchromatin and actively transcribed regions. The positive lysine charge is 
lost upon acetylation, weakening inter-nucleosomal histone and DNA 
interactions. This mechanism is proposed to directly result in an open 
chromatin fibre structure. However in vitro studies of repetitive DNA on 
reconstituted nucleosome arrays showed no significant change to fibre 
structure due to pan acetylation (Neumann et al., 2009), although globular 
domain acetylation at the interface of H3/H4 tetramer and H2A/H2B dimer, 
has been shown to destabilise the histone octamer resulting in more 
accessible chromatin fibres (Ye et al., 2005).  
 
Histone acetylation occurs at multiple lysines on H3 and H4 including H3 –
K9, -K14, -K18, -K56 and H4 –K5, -K8, -K12, -K16, -K91, and is required for 
their correct assembly. This modification is transferred to histones via 
histone acetyltransferase enzymes (HATs) and removed by histone 
deacetylases (HDACs). Bromodomains, a left-handed highly charged pocket 
formed from four α-helices, recognise histone acetylation and occur 
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commonly in transcriptional activators and chromatin re-modellers 
(Filippakopoulos et al., 2012). Maintaining acetylation profiles has an 
important role in gene regulation and genome stability, where HDAC loss 
results in aneuploidy. (Hebbes, Thorne and Crane-Robinson, 1988; Dovey et 
al., 2013). 
 
Methylation also occurs on histone lysines in direct competition with lysine 
acetylation, in addition to arginine residues. Arginines can be methylated 
twice while lysines can take three methylation groups and unlike acetylation, 
methylation does not alter the amino acids charge. Methylation is added to 
histones in a site-specific manner by different methyltransferases (HMTs); 
lysine histone methyltransferases (HKMTs) contain the Su(var)3-9, enhancer-
of-zeste and trithorax (SET) domain while PRMTs are the class of 
methyltransferases specific to arginine residues. 
 
Removal of mono-, di-, and tri- methyl groups is tightly regulated. Lysine-
specific demethylase 1 (LSD1), uses oxidative demethylation to remove 
mono- and di- methyl groups (Shi et al., 2004). LSD1 specificity is achieved 
from the addition of different protein complexes to regulate its binding (Lee 
et al., 2005). All methylation states including trimethylated lysine residues 
are demethylated by the large class of jumonji domain containing proteins 
via Fe(II) and α-ketoglutarate mediated oxidation (Yamane et al., 2006).  
 
Unlike acetylation, histone methylation has been associated with both active 
and repressive chromatin states. Constitutively inactive chromatin, such as 
telomeres and pericentric regions are marked with H3K9me3 which in turn 
recruits heterochromatin protein 1 (HP1) and its own methyl transferase; 
Suppressor of variegation 3-9 homologue 1 or 2  (Suv39h1/2). This positive 
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feedback loop maintains the repressed chromatin state throughout the cell 
cycle (Haldar et al., 2011). In contrast, H3K4me3 is associated with actively 
transcribed regions along with H3K36 and H3K79 methylation (Martin and 
Zhang, 2005).  
 
The role of these methylation modifications on gene regulation does not 
appear to be universal. Confusingly, additional studies have found 
H3K9me3 at actively transcribed genes and H3K36me2 supressing intragenic 
transcription initiation (Carrozza et al., 2005; Vakoc et al., 2005). Despite the 
intricate functions of histone methylation, subsequent loss directly influences 
genome integrity. Double knockout of the Suv39h isoforms 1/2, responsible 
for H3K9me3 modification, results in increased rates of polyploidy, meiotic 
abnormalities, and chromosomal mis-segregation (Peters et al., 2001).  These 
murine models also showed increased incidence of tumour formation and 
decreased viability, demonstrating the importance of methylation for 
genome integrity.   
 
Histone methylation is also known to play roles in cellular responses, such as 
DNA damage, where H3K79me is deposited. DOT1, the HKMT responsible 
for H3K79me, recruits 53BP1 to double strand break sites via its tudor 
domain which in turn binds to methylated lysines. This process is required 
for correct repair pathways to proceed. However whether double strand 
breaks directly affect the local chromatin structure, making it accessible to 
53BP1 and DOT1, or if this signalling causes an increase in chromatin 
accessibility remains unclear (Huyen et al., 2004).   
 
Protein phosphorylation occurs frequently across protein classes and 
functions, and histone phosphorylation is important for cell cycle regulation. 
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Histone phosphorylation has been found at serine, threonine and tyrosine 
residues, for example, H3S10 adjacent to the H3K9 methylation site is 
phosphorylated by Aurora B as cells begin mitosis (Wei et al., 1999). 
Phosphorylation at H3S10 causes HP1 proteins, that would normally bind to 
H3K9me3, to dissociate from the chromatin fibre (Hirota et al., 2005). Without 
phosphorylation and subsequent loss of HP1 proteins, the loading of 
condensin is perturbed adversely affecting mitotic condensation and genome 
integrity (Adams et al., 2001; Giet and Glover, 2001). 
 
Histone modifications can also occur on histone variants such as the 
phosphorylation of H2A.X at ser139; this happens rapidly after DNA 
damage and requires the ATM, ATR, and DNA-PK kinases. This 
phosphorylation of the chromatin fibre occurs in megabase arrays around 
the double strand break site, where 53BP1 and BRCA1 are subsequently 
recruited (Soutoglou and Misteli, 2010). After DNA damage has been 
repaired, H2A.X is dephosphorylated by PP2A and PP4 (Chowdhury et al., 
2005) or removed from the chromatin fibre by the FACT complex (Heo et al., 
2008). H2A.X knockouts have shown increased genomic instability and 
cancer prevalence not recoverable in H2A.X rescue experiments with ser139 
point mutations  (Celeste et al., 2003). While many histone modifications 
correlate with chromatin fibre states, the changes in fibre compaction after 
DNA damage provided a tractable system to test the consequences of 
various histone modifications. DNA damage marks such as phosphorylation 
of H2AX, H3, and H2B in addition to H2A ubiquitination were not causative 
however to the compaction state alterations in the chromatin fibre 
(Fernandez-capetillo, Allis and Nussenzweig, 2004; Kruhlak et al., 2006; Lee 
et al., 2015; Ui, Nagaura and Yasui, 2015).  
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In addition to histone modifications functioning in the DNA damage 
response pathway, recent studies have found that they can also predispose a 
region to chromosome instability. For instance, the frequency of double 
strand breaks and translocations is associated with H3K9me3 depletion 
whereas active marks H3K27ac and H3K4me1 were enriched irrespective of 
underlying transcription levels (Burman et al., 2015). In this study causality 
was demonstrated by tethering histone modifiers to a lac operon, altering the 
density of H3K9me3, H3K27ac, and H3K4me1, which affected break 
frequency. Despite transcription levels not being affected, H3K9me3 
decreased endonuclease accessibility suggesting that a more open chromatin 
environment is prone to greater instability than more compact H3K9me3 
containing regions. 
 
Given the plethora of histone modifications and their enzymatic regulators, 
histone modifications are often transient. The retention of histone 
modifications after DNA replication and nucleosome turnover was assessed 
by capturing nascent chromatin strands (Alabert et al., 2014). In HeLa cells, 
expelled histones were recycled in the subsequent two nascent DNA strands 
resulting in a hemi-modified state. Full recovery of histone modifications 
then occurs within the next cell cycle, except for heterochromatic marks 
H3K9me3 and H3K27me3 which develop more slowly over multiple cycles. 
How more rapidly dividing cells, such as embryonic stem cells, maintain 








As described above, lysine acetylation has been identified as prevalent 
regulatory post-translation modification that removes the residues positive 
charge (Kim et al., 2006; Choudhary et al., 2009). Acetyl- ChIP-seq studies 
have demonstrated a correlation of histone acetylation with actively 
transcribed genes, with aberrant acetylation and gene expression associated 
with tumorigenesis (Zhao et al., 2014). 
 
Bromodomains are a highly conserved motif, first identified in the brahma 
gene, that forms and highly charged molecular pocket facilitating protein-
protein interactions on acetylated lysines (Haynes et al., 1992).  This domain 
is present in 42 proteins in the human genome with some containing 
multiple bromodomains or other histone interacting domains 
(Filippakopoulos, 2012). These proteins display a wide range of functions 
regulating gene expression. These range from scaffolding roles of large 
transcriptional complexes and individual catalytic functions including: 
methyltransferases, HATs, and helicases to function in chromatin 
organisation (Haynes, 1992; Yamane, 2006; Alsarraj et al., 2013; Bao and Shen, 
2014). 
 
The additional domains within bromodomain containing proteins can also 
affect the binding affinity of the bromodomain pocket. For instance, a single 
bromodomain typically binds to the histone peptide with the N-terminus at 
the back of the pocket between the ZA-BC α-helices. This positions the lysine 
residue at the exit vector on the ZA helix (Filippakopoulos, 2012). An 
adjacent PHD domain however, as found in TIF1α, engages the N-terminus 
on H3K4 forcing the bromodomain to bind further down the peptide at 
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H3K23ac (Tsai et al., 2010). By contrast, the adjacent PHD domain in the 
BPTF transcription factor differs by having its orientation reversed. When the 
PHD domain engages with methylated H3K4, the bromodomain orientation 
is therefore inverted limiting interactions with lysine residues on the same 
histone tail, and encourages trans H4K16 interactions within the same 
nucleosome (Ruthenburg et al., 2011; Xi et al., 2011). 
 
While bromodomains are highly conserved across the 42 proteins within the 
human genome and across species, there is a sub family of bromodomain 
extra terminal [BET] proteins. These contain a C-terminal extra terminal 
region that allows for selective targeting of these bromodomains from the 
bromodomain family (Filippakopoulos et al., 2010). The BET protein sub 
family is comprised of four proteins, Brd2, Brd3, Brd4, and BrdT. Each of 
these proteins contain two adjacent bromodomains allowing them to bind 
two acetylated lysine residues such as H4K5 and H4K8 by BrdT (Rousseaux 
et al., 2009). Whether these adjacent domains bind to lysine residues in cis or 
trans histone tails in vivo remains an area of discussion within the field. 
 
More recent reports have demonstrated that BET proteins can also recognise 
non-acetyl lysine modifications including: propionylation, butyrylation, and 
crontonylation (Tan et al., 2011; Sabari et al., 2015; Goudarzi et al., 2016). The 
functional role of such non-canonical lysine binding and its effect on BET 







BET proteins are known to have key regulatory functions. Brd2 and Brd4 are 
both embryonic lethal in mice, and are known to function in cell cycle 
progression by regulating transcription of c-myc and other master growth 
regulatory genes (Houzelstein et al., 2002; Shang et al., 2009; Coudé et al., 
2015). Brd3 is known to interact with transcription factor GATA-1 to regulate 
erythroid specific differentiation genes, whilst BrdT is a testis specific 
transcription factor with similar functions to Brd4. Loss of BrdT results in 
aberrant testis development resulting in sterile mice (Shang et al., 2007; 
Lamonica et al., 2011). 
 
The canonical transcriptional regulatory mechanism of BET proteins revolves 
around the recruitment of the p-TEFb complex (CDK9 and cyclin T) to 
transcriptional start sites, facilitating paused RNA polII phosphorylation and 
transcriptional elongation (Kyoo Jang et al., 2005; Yang et al., 2005; Itzen et al., 
2014). Given the fundamental functions of these proteins for efficient 
transcription and faithful cell cycle progression, their binding profiles vary 
significantly between cell types. The regulatory mechanism behind these 
different binding profiles has yet to be fully understood and is currently an 










Additionally bromodomain protein mutations commonly occur in cancer, 
likely due to their key role in transcription and proliferation. In Paediatric 
cancers, for instance, 21 of the 42 bromodomain containing proteins have 
increased mutation frequencies. How these mutations effect cellular 
phenotypes have yet to be fully explored however. Bromodomain proteins 
are also common sites of translocations and gene fusions in cancer. NUT 
midline carcinoma, for example, is caused by the fusion of Brd3 or Brd4 to 
nuclear protein in the testis (NUTM1). NUT proteins normally function to 
recruit HAT enzymes including CREBBP and P300, acetylating the 
surrounding histones. When fused to a BET protein that in turn recognises 
histone acetylation, this results in unregulated expanding regions of 
hyperacetylation only limited by TAD boundaries resulting in this disease 
(Haack et al., 2009; Alekseyenko et al., 2015). Understanding the function and 
regulation of BET proteins therefore is a key question in both developmental 













1.1.5 Chromatin remodelling complexes 
A diverse range of proteins aside from histones bind chromatin in vivo. 
Chromatin re-modellers alter nucleosome frequency or composition where 
they act at a local level causing small scale disruptions to the chromatin fibre 
and changing the accessibility of the underlying DNA. With such a 
fundamental role chromatin re-modellers are found in many chromatin 
dependent processes, such as replication, cell cycle progression, DNA 
damage repair and transcription. The ATP dependent active domains of 
these re-modellers are split into four classes: SWI/SNF, ISWI, INO80, and 
CHD. 
 
SWI/SNF re-modellers are found in large complexes with other polypeptides 
in two different classes: BAF (BRG1 associated factors) and PBAF 
(Polybromo associated factor). In humans, BAF complexes contain both 
ATPase subunits, BRM and BRG1. PBAF by contrast only contains BRG1, but 
sharing many other bromo associated core factors with BAF complexes 
(Mohrmann and Verrijzer, 2005). SWI/SNF specificity is regulated by varying 
the DNA binding domain and bromodomain composition of subunits, 
allowing loci and tissue specificity via nucleotide sequence and the 
nucleosome acetylation state (Shen et al., 2007; Dechassa et al., 2012). 
SWI/SNF function is important for genome regulation, and components have 
an increased mutation rate in cancer. PBAF component BAF180 is recruited 
to DNA damage sites resulting in silencing of the surrounding region 
(Kakarougkas et al., 2014). SWI/SNF complexes also have important functions 
in sister chromatin cohesion and decatenation. Specifically, loss of SWI/SNF 
components results in an increase in cytological chromosome breaks and 
lagging chromosomes in mitosis respectively (Dykhuizen et al., 2013; 
Brownlee et al., 2014).  
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The ISWI class of re-modellers incorporate SNF2H or SNF2L ATPase’s. They 
are associated with a diverse range of functions, both repressing and 
activating target loci. The ISWI complex NURF is recruited to promoters by 
the GAGA transcription factor, where it alters nucleosome spacing to 
facilitate transcription (Mizuguchi et al., 1997; Xiao et al., 2001). Studies 
investigating the distribution of core ISWI catalytic subunits in Drosophila 
found that ISWI rarely correlated with RNA polymerase II distribution on 
polytene chromosomes, suggesting it has a more general role at 
transcriptionally inactive genomic regions (Deuring et al., 2000). Furthermore 
in yeast, ISWI homologues reposition nucleosomes at promoters, making 
them nuclease-inaccessible and repressing gene expression (Goldmark et al., 
2000). ISWI also functions in the DNA damage response pathway. The ACF 
and CHRAC complex subunit ACF-1 interacts with HP1 proteins and binds 
to DNA double strand breaks similarly to phosphorylated H2A.X facilitating 














INO80 chromatin re-modellers are characterised by having a split ATPase 
domain across two subunits. This ATPase module associates with RuvB-like 
helicase proteins, known to bind replication forks and holiday junctions in 
vitro. (Iwasaki and Takahagi, 1991; Shen et al., 2000). These complexes were 
shown to regulate H2A.Z and phospho-H2A.X histone exchange throughout 
the genome and at DNA damage sites (Papamichos-chronakis et al., 2012; 
Bao and Shen, 2014). Loss of INO80 and redistribution of H2A.Z causes fork 
collapse slowing S-phase progression (Hur et al., 2010) whilst loss of INO80 
at DNA damage foci disrupts the 5’-3’ resection of the DNA strands during 
homologous recombination (Gospodinov et al., 2011). Histone 
acetyltransferase TIP60, a component of the INO80 complex, is required to 
open chromatin for DNA repair and to subsequently remove phospho-
H2A.X to restore the basal chromatin state (Kusch et al., 2004). 
 
In addition to acetyl recruiting poly bromodomain re-modellers such as 
BAF180 (Porter and Dykhuizen, 2017), chromo helicase domain (CHD) 
complexes are characterised by their ability to bind methylated histones. The 
nucleosome remodelling and deacetylase complex NuRD is the only CHD 
complex currently thought to be recruited via transcriptional regulators. The 
active subunit CHD3/4 with HDAC1/2 promotes transcriptional repression 
of the Hox locus through its interaction with hunchback in Drosophila (Kehle 
et al., 1998; Zhang et al., 1998). NuRD’s interaction with the ELKF 
transcription factors is mediated by the addition of small ubiquitin-like 
modifiers (SUMOs), resulting in KAP-1 target transcriptional repression 
(Siatecka, Xue and Bieker, 2007).  In addition to gene regulation, CHD3 – 
NuRD complexes are released from heterochromatin after DNA damage 
resulting in chromatin fibre disruptions (Goodarzi, Kurka and Jeggo, 2011). 
CHD recruitment specificity via its chromodomain to methylated histones, 
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however, remains controversial and chromodomain deletions of CHD1 in 
Drosophila do not affect its distribution and can bind H3K4 peptides 
independently of the methylation state (Morettini et al., 2011).  
 
Chromatin re-modellers play an important role in facilitating the dynamic 
changes in chromatin fibre structure required throughout the cell cycle, 
kinase signalling responses and gene regulation. Understanding their 
mechanical properties in manipulating the chromatin fibre is an area of 
interest within the field; new cryo-electron microscopy approaches are 
providing significant new insight (Aramayo et al., 2018). However, our 
limited knowledge of chromatin fibre structure still limits our understanding 















In addition to manipulating nucleosomes to alter chromatin fibre structure, 
abnormal DNA topology and catenation can affect the overlying chromatin 
structure. The topoisomerase family exhibit the capability to resolve these 
exotic DNA tertiary structures by inducing single or double stranded breaks 
(Charvin, Bensimon and Croquette, 2003). Type 1 topoisomerases (Top1) 
introduce single strand breaks and are subdivided into A/B depending on 
whether they bind to the 5’ or 3’ strand respectively. Top1A enzymes allow 
one DNA strand to pass, bridged by the enzyme, relaxing negative 
supercoiled DNA (Dekker et al., 2002). Top1B in contrast allows the DNA 
strands to rotate independently of each other in a torsion dependent manner, 
releasing either positive or negative supercoils (Koster et al., 2005; Taneja et 
al., 2007). Type 2 topoisomerases (Top2) are also subdivided into A/B on their 
molecular structure but have similar mechanisms of action. Top2 releases 
topological stress by inducing double stranded DNA breaks facilitated by 












Many biological processes induce mechanical stress on chromatin topology 
including, transcription, replication, and anaphase. During transcription 
RNA polymerase over-winds DNA downstream inducing positive 
supercoils, whilst negative supercoils are formed upstream (Liu and Wang, 
1987; Giaever and Wang, 1988). This produces a positive or negative extra 
turn in the DNA molecule every 10 bp of transcription, making 
topoisomerase activity essential for the transcription of long genes, and 
prevents exotic DNA structures such as plectonenes and cruciforms (Cook et 
al., 1992). Mutations in Top1 in autistic patients appear to preferentially affect 
transcripts >200 kb, indicating the important function of topoisomerases 
(King et al., 2013). Transcription-dependent supercoiling from has been 
shown to stall replication forks, but normal Top1 activity functions to resolve 
these conflicts, facilitating replication of active genomic regions (Tuduri et al., 
2009). 
 
Top2 enzymes are proposed to resolve the positive or negative supercoils 
across replication regions. Converging replication forks can amplify this 
topological stress slowing replication in the absence of Top2 (Baxter and 
Diffley, 2008). In addition to this function, Top2 has been implicated in 
chromatin condensation (Adachi, Luke and Laemmli, 1991). In metaphase 
Top2 forms a structural axis the length of the chromosome required for 
chromatid core separation (Giménez-Abián et al., 1995), whilst Top2 loss 
reduces intra-chromatid fidelity resulting in entangled chromosome arms 
(Uemura et al., 1987; Spence et al., 2007). The consequences of a loss of 
chromatid fidelity results in multiple aberrant mitotic phenotypes, prevents 
cell cycle progression and induces cell death (Carpenter and Porter, 2004). 
The exact role of Top2 at mitotic chromosomes remains unclear, along with 
their role within high order chromatin structures.  
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1.1.7 Cohesin and Condensin 
Structural maintenance of chromosome (SMC) proteins, are found in the 
highly conserved condensin and cohesin complexes. These complexes 
function in the modulation of chromosome structure and are required for 
transcription, mitotic condensation, and chromatid separation. SMC proteins 
have large coiled arms of alpha helices spanning 65 nm, with globular heads 
at either end. One of these domains interacts with its SMC partner forming a 
molecular hinge to the complex (Haering et al., 2002). The diametrically free 
head domains of this SMC heterodimer interact with a kleisin-type 
component, in order to close the molecular loop in an ATP-dependent 
manner (Hu et al., 2011). Due to this large ring like structure SMC complexes 
are thought to associate with chromatin topologically rather than a DNA 
sequence mediated interaction (Murayama and Uhlmann, 2014). 
 
Cohesin complexes contain an SMC1/SMC3 heterodimer closed by RAD21,  
with chromosome loading facilitated by STAG (Tóth et al., 1999; Hu et al., 
2011). Mammalian condensin has a SMC2/SMC4 heterodimer, and two 
separate groups of subunits. Condensin I is closed by CAP-H with CAP-D2 
and CAP-G (Hirano, Kobayashi and Hirano, 1997; Schmiesing et al., 2000). 
Condensin II contains CAP-H2, CAP-D2 and CAP-G comparatively (Ono et 







Despite their striking structural similarities, the molecular functions of 
cohesin and condensin are distinct. Cohesin maintains sister chromatid 
cohesion after replication to allow faithful separation upon its cleavage 
during anaphase (Uhlmann, Lottspeich and Nasmyth, 1999). Cohesin is 
initially loaded onto chromatin in an ATP-dependent manner during G1 by 
SMC loader NIPBL (Ciosk et al., 2000). Throughout G1 cohesin levels 
equilibrate via its constant unloading via WAPL and PDS5 (Tedeschi et al., 
2013). During replication, the cohesin ring structure is stabilised by SMC3 
acetylation mediated by Sororin which prevents WAPL-cohesin removal 
(Hou and Zou, 2005; Nishiyama et al., 2010). In conditional WAPL knock out 
cells, cohesin unloading is also prevented resulting in vermicelli like 
chromatin condensation in G1 and abnormal chromosome segregation 
during mitosis (Tedeschi et al., 2013). Regulation of cohesin loading and 
stabilisation therefore has a fundamental architectural role in chromatin 
organisation throughout the cell cycle.   
 
In mitosis, for WAPL to access cohesin complexes and allow sister chromatid 
separation, Aurora B or CDK1 phosphorylates Sororin expelling it from 
cohesin complex, (Dreier, Bekier and Taylor, 2011). This initially occurs along 
the chromosome arms during prophase as the centromere is protected from 
phosphorylation by Shugoshin recruited phosphatases (Meppelink et al., 
2015). During anaphase, cleavage of centromeric cohesin occurs by separase 
(Uhlmann, Lottspeich and Nasmyth, 1999). In order for cohesin complexes to 
be reloaded in the following cell cycle, HDAC8 is required to deacetylate 




Cohesin has also been implicated in modulating large-scale chromatin 
structure. Cohesin chromatin loading correlates with CTCF sites at structural 
chromatin boundaries (Parelho et al., 2008). This has led to the proposal of 
cohesin loops linking chromatin fibres in the same manner as sister 
chromatids but in trans across a chromosome. Recent Hi-C studies in cohesin 
knock out cells results in the loss of all loop domains (Rao et al., 2017). 
Despite such stark changes in large-scale chromatin organisation, 
transcriptional regulation is only modestly affected. This suggests that while 
cohesin complexes help organise chromatin throughout the nucleus they do 
not inherently regulate the accessibility of the underlying genes (Schwarzer 
et al., 2017). 
 
It is maybe not surprising then that mutations in cohesin subunits are not 
lethal, albeit with severe pathology. Patients with cohesin mutations, such as 
Cornelia de Lange Syndrome (CdLS), exhibit cognitive impairment, limb 
defects, and delayed development.  However rather than mitotic defects, 
CdLS cellular defects appear to be transcriptional, suggesting that the minor 
regulatory role of cohesin on transcription is an essential function in 
development outside of mitotic division (Liu et al., 2009). Indeed the loss of a 
single boundary element can result in aberrant enhancer activity and 








Condensin’s primary role is to compact chromosomes in the early stages of 
mitosis and resolve sister chromatid cohesion in cooperation with Top2 
(Coelho, Queiroz-Machado and Sunkel, 2003; Hirota et al., 2004). However, 
condensins also have regulatory roles within interphase. Hi-C data indicates 
that condensin complexes co-localise with transcription factor IIIC complexes 
(TFIIIC) to form strong TAD boundaries during interphase that support 
constitutively active gene cluster transcription (Yuen, Slaughter and Gerton, 
2017). 
 
During mitotic compaction condensin I facilitates lateral chromosome 
compaction, while condensin II is required for longitudinal compaction 
across the length of the chromosome (Green et al., 2012).  
 
Polymer modelling of Capture-C experiments first suggested the formation 
of consecutive chromatin loops 80-120 kb in mitotic chromatin fibres 
(Naumova et al., 2013). This has led to the proposal that condensin modulates 
these large chromatin looping domains (Skoko et al., 2006; Alipour and 
Marko, 2012). Once formed, these loops then undergo axial compression 
mediated by Top2 (Coelho, Queiroz-Machado and Sunkel, 2003). 
Condensin’s role in chromatin condensation is however still questioned, as 
chromatin compaction is not completely abrogated in condensin or Top2 
absence (Hudson et al., 2003; Carpenter and Porter, 2004; Houlard et al., 
2015). This has led to the contrasting view that condensins regulate higher 
order chromosome architecture rather than the underlying chromatin fibre 





Although Condensin I and II have contrasting roles, they function 
cooperatively for correct mitotic cytological compaction. Detailed 
experiments in Xenopus extracts demonstrated that altered ratios of 
condensin I and II resulted in longer and thinner chromosomes (Shintomi 
and Hirano, 2011). Primary condensin II mediated cytological condensation 
is thought to be essential for correct mitotic chromosome formation as 
condensin I is cytoplasmic until the breakdown of the nuclear envelope 
(Gerlich et al., 2006).  
 
Similar to cohesin loading, condensin II loading is stabilised during S-phase. 
After replication, condensin II stabilisation mediates the formation of sister 
axes functioning in faithful resolution of sister chromatids (Ono, Yamashita 
and Hirano, 2013). Once the nuclear envelope is dissolved, condensin I then 
associates along the chromosome in an alternating distribution with 
condensin II (Ono et al., 2004). Recent seminal studies have demonstrated the 
spiral loading dynamics of condensin II complexes to form the axial core of 
metaphase chromosomes (Gibcus et al., 2018).  This spiral core supports the 
formation of condensin I mediated nested loops resulting in the characteristic 
late prometaphase chromosomes. 
 
Recent studies have also suggested that condensin II interacts with holiday 
junction recognition protein (HJURP) and is required for correct centromeric 
deposition of CENP-A and centromere function (Barnhart-Dailey et al., 2017). 
In conjunction with Gibcus's, (2018) work suggesting condensin II loading 
only occurring at the chromosome core, this would provide a mechanism for 
kinetochore attachment to each chromosome’s for proper segregation. 
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1.2 Chromatin Structure 
 
Chromatin structure is both dynamic and diverse making studying its 
structure a challenging goal. In nuclei, human interphase chromatin is not 
discernible by traditional microscopy techniques. Recent work has coupled 
DNA staining with polymerisation of diaminobenzidine (DAB) for electron 
microscopy to study chromatin in structure inside nuclei (Ou et al., 2017). 
The validity of such techniques to broadly study chromatin structure is still 
debated however, as there may be a bias in the dye (DRAQ5) DNA binding 
distribution. DRAQ5 may preferentially bind to more open euchromatic 
regions or be unable to come into contact with DAB molecule when bound to 
heterochromatic DNA.    
 
Unlike humans, mouse chromatin has distinct chromatin structures 
observable by traditional microscopy methods. Observable heterochromatic 
chromocenters form in many species including mice, although the 
underlying structure is still unresolvable. In vitro studies of chromatin via 
electron microscopy while revealing characteristics of fibre structure are 
limited in their applicability to the complexity of in vivo chromatin. For 
instance understanding how current fixation methods might affect fibre 
structure, in electron microscopy methodology remains an important 






1.2.1 Nucleosome arrays and the 30-nM fibre 
The base unit of eukaryotic chromatin contains, a nucleosome core particle of 
a H3:H4 tetramer with two H2A:H2B dimers bound to it. Wrapped twice in 
147 base pairs of DNA, these nucleosome core particles are stabilised by 
histone H1 binding on the dyad and connected by 10-100 bp “linker” DNA 
(Holde, 1989). The exact position of H1 is still debated, with one model 
claiming the globular domain lies on top of the dyad interacting with both 
DNA linker strands (Allan et al., 1980; Hussain et al., 2010). Alternatively the 
globular domain is removed from the dyad and interacts with only one 
linker DNA strand (Pruss et al., 1996; Brown, Izard and Misteli, 2006). More 
recent studies have shown that linker histone isoforms H1 and H5 differ in 
their binding positions due to altered DNA-contacting residues in Drosophila 
and chicken respectively (Zhou et al., 2016). Off dyad binding has also been 
demonstrated in the human linker isoform H1.4 (Song et al., 2014). 
Additionally canonical H1 has recently been shown to bind at the dyad but 
primarily associating with a single DNA linker, suggesting an asymmetrical 











While our knowledge of nucleosome composition is well defined, how 
multiple nucleosomes are folded into a fibre with a width of 30-nm is still 
hotly debated. Multiple models have been advocated; the solenoid model 
with a helical array, the zig-zag model of alternating nucleosome stacking, 
and an irregular model with varying nucleosome spacing and organisation. 
Recent advances in super resolution microscopy in addition to electron 
microscopy techniques and small angle x-ray diffraction have been used over 
the past 50 years to discern fibre structure (Gall, 1966; Sperling and Tardieu, 
1976; Ricci et al., 2015). While investigating in vitro reconstituted chromatin 
has been possible, the structure of chromatin fibres within nuclei has 
remained elusive, only defined as a dense mass. 
 
Despite such debate, chromatin within a living cell is required to be dynamic 
and malleable, unlikely to result from a homogenous 30-nm fibre structure. 
More likely is a heteromorphic fibre of multiple models, with more compact 
or disrupted loci dependent on the genomic region (Grigoryev et al., 2009). 
This is likely due to the underlying transcriptional state with constitutively 
inactive regions having regular nucleosomes and forming a more uniform 
30-nm fibre structure, whereas, global conformation is less regular and 
interspersed with many disruptions (Gilbert and Allan, 2001). Chromatin re-
modellers alter nucleosome positioning allowing transcription factor 
binding, DNA replication, and repair to occur. Therefore one can see how in 
the dynamic nature of a living, dividing cell responding to environmental 
stimuli, fibre disruptions may occur resulting in a heteromorphic fibre 
structure. These disruptions to nucleosome occupancy can be investigated 





Figure 1.2 Overview of the different orders of chromatin organisation. (A) 147 bp 
of the helical DNA structure is wrapped around an octomer of histone proteins to form a 
nucleosome.  Sequential histone deposition results in a ‘beads on a string’ like 10 nm 
fibre, while inter-nucleosome interactions generates a chromatin fibre in the order of 30 
nm. The compaction mechanisms above 30 nm have not been fully resolved, however 
chromatin forms distinct large-scale structures in interphase that are then further 
compacted into metaphase chromosomes. (B) DRAQ5 staining in interphase 
demonstrates the accumulation of chromatin at the nuclear periphery (C) Hi-C 
modelling throughout mitosis suggests large-scale loop structures emanating from a 
spiral axial core on condensin molecules (red). Resources collated from Alberts, (1994); 
Ou, (2017); and Gibcus, (2018) 
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1.2.2 Large-scale chromatin structure 
Beyond the 30-nm fibre, chromatin fibres are organised into large-scale 
chromatin structures. Methods to investigate large-scale structures are 
currently limited, and detailed understanding is lacking, outside the 
probable formation of chromatin loops. Domains thought to correspond to 
‘accessible’ and ‘compact’ regions can be differentiated by their AT:GC 
nucleotide ratio, histone modification profiles and subsequent bound 
proteins. Historically this has been segmented into gene rich euchromatin, 
and gene poor heterochromatin, based on the intensity of intercalating dyes 
in interphase. Interphase euchromatin has a lower intensity of intercalating 
dyes than heterochromatin and therefore is perceived as more open, 
although this could be attributed to DAPI sequence bias. During metaphase 
however chromatin is uniformly dense suggesting that de-compaction post 
mitosis must be targeted. 
 
Recent genome wide studies of transcription and modification states has 
provided greater stratification into five different classifications: 1- 
constitutively active regions, 2- tissue specific active loci, 3- silenced 
developmental and differentiation loci, 4- repressed gene rich regions, and 5- 
constitutive silenced satellite and repetitive elements (Steensel, 2011). 
Regions 1 and 2 contain the actively transcribed regions of the genome 
characterized by their enrichment in histone acetylation. Due to 
transcriptional activity within these loci, they are expected to contain more 
disruptions to the chromatin fibre, resulting in a more flexible open structure 
to facilitate transcription. Transcriptionally repressed genes and repetitive 
elements in the other classes by contrast will have a more ordered compact 
higher order structure.  
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Living cells do however maintain a functional need to access these more 
compact regions for biological processes such as replication and DNA 
damage repair mediated by chromatin re-modellers. The inherent property 
of the compact higher order structure does however reduce the accessibility 
of the underlying DNA when compared to a disrupted fibre. This is 
discernible by these regions being late replicating and responding more 



















1.2.3 Higher order structure methods and TADs 
Chromosome conformation capture (3C) and fluorescence in situ 
hybridization (FISH) based methods are the two most widely adopted 
techniques to study chromatin higher order structure (Bickmore and Van 
Steensel, 2013). FISH involves the hybridization of fluorescent probes with 
specificity to individual loci up to entire chromosomes. Chromosome 
conformation capture by contrast scores the frequency of a DNA fragment 
contacting with another that can be multiplexed by next-generation 
sequencing across the entire genome. This relies on “fixing” the chromatin 
structure with formaldehyde, fragmenting and ligating proximal DNA 
fragments, before the PCR or sequencing output. These techniques have 
complimentary technical methodologies. FISH benefits as a single cell 
technique but with resolution limited by microscopy methods, while 3C 
methods have base pair resolution, but is limited as it is population average 
data and has the potential bias input by the fixation technique. 
 
The prevalence of 3C-based experiments has led to adoption of the 
topological associating domains (TADs) concept. This suggests that the 
human genome is divided into almost ten thousand loops/TADs on average 
185 kbp in size (Rao et al., 2014). These TADs prevent external chromatin 
interactions, correlating with histone modification profiles and replication 
timing (Pope et al., 2014; Huang et al., 2015). The functional relevance of 
TADs to genome regulation is nonetheless still under debate, as TAD profiles 
are not affected by cell type. However translocation frequency in B cells 
correlates with 3C interaction frequencies, demonstrating a functional role to 
interaction frequency (Y. Zhang et al., 2012). 
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Validation of 3C results using FISH has however had varied success. The 
confinement of intra-TAD chromatin interactions and organisation identified 
by 3C methods was confirmed by intra-TAD FISH probes having a 
physically closer association within the nucleus when compared to similar 
probe genomic distances between TADs (Nora et al., 2012). By contrast a 
comprehensive study at the HoxD locus demonstrated varying success of 
cross validation in different developmental stages (Williamson et al., 2014), 
suggesting that the two techniques might report on different levels of 
organisation.  
 
However, these techniques have facilitated a large step in our understanding 
of higher order chromatin structure, despite their limitations. The 
advancement of these methodologies currently in process hopes to resolve 
the current conflicting experimental data. 3C techniques have been combined 
with sequence capture methods to allow deeper sequencing of defined 
genomic regions increasing the techniques resolution. Additionally, the 
Mistelli lab has addressed the throughput limitations of FISH experiments 
(Shachar et al., 2015). Subsequent studies comparing Hi-C datasets to high 
throughput FISH has demonstrated a common independent allele in 
addition to population heterogeneity that was not detected by Hi-C (Finn et 
al., 2017). This suggests that cell population based techniques have limited 
scope to investigate chromatin structure.  
 
The static nature of our current understanding of genomic interactions will 
soon be addressed by the adaption of the CRISPR-Cas9 system. A recent 
study demonstrated the use of modified guide RNAs to achieve live cell 
imaging of non-repetitive loci, demonstrating a significant advantage to aid 
our understanding of chromatin fibre dynamics (Qin et al., 2017).   
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1.3 Nuclear environment 
 
Chromatin in vivo is found within the nucleus of a eukaryotic cell, 
determining the spatial environment for chromatin organisation. The nuclear 
position of a locus has a functional role in chromatin organisation, affecting 
chromatin structure, transcriptional state, and replication timing. The nuclear 
spatial orientation of a locus is unfixed and dynamic. Throughout 
differentiation many loci alter their nuclear position changing their 
functional properties (Peric-hupkes et al., 2010).  
 
Nuclear positioning however is not tightly defined and varies between cells, 
although intra-chromosomal long range interactions are tightly regulated 
(Chambeyron and Bickmore, 2004). Despite undefined specific 3D spatial 
orientations, loci’s radial 2D distribution appears to be conserved throughout 
the genome. In mammalian cells the nuclear periphery generally contains 
gene poor regions and heterochromatic elements, while active genes usually 
have a more central position. In contrast, centromeres are generally located at 
the nuclear periphery, while telomeres are equally distributed throughout 
the nucleus in differentiated cells (Gilchrist et al., 2004; Wiblin et al., 2005).  
 
The nuclear membrane, which separates the nucleus from the cytoplasm, is 
composed of a lipid bilayer with nuclear pore complexes facilitating 
shuttling. Lamin proteins are transported into the nucleus where they 
accumulate around the inner nuclear membrane forming the nuclear 
periphery once they are phosphorylated and post-translationally mature 
(Henekes et al, 1993; Kilic et al, 1999). Genomic regions at the nuclear 
periphery form lamina associated domains (LADs) between 100 kbp and 10 
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Mbp in size. Nuclear membrane components; the lamin B receptor, emerin, 
BAF, LAP2α/β, and SUN proteins facilitate this association. Constitutive and 
facultative LADs are found within the genome. Facultative LADs tend to be 
the silenced developmental and differentiated genomic regions that differ 
between cell types, whereas constitutive LADs are universal. Signalling 
pathways and chromatin modifiers interact with nuclear lamina proteins to 
regulate nuclear periphery heterochromatin histone acetylation, H3K9me3, 
and subsequent HP1α/β association (Oca, Andreassen and Wilson, 2011; 
Solovei et al., 2011). Importantly, Solovei (2011) showed that the lamin B 
receptor alone is required to tether heterochromatin to the nuclear periphery 
and is required for Lamin A and Lamin C mediated tethering.  
 
Heterochromatic domains are also recruited to the periphery of the nucleolus 
in a mechanism requiring nuclear lamins. Absence of Lamin B1 leads to 
dissolution of nucleoli (Martin et al., 2009). LADs and nucleolar associated 
domains (NADs) are often flanked by insulators such as CTCF which tether 
the ends of the domains to the nuclear periphery in a lamin A dependent 











Premature lamin A that has not undergone the required farnesylation, 
directly binds to HP1α in addition to lamina bridging proteins LAP2α and 
BAF causing their accumulation at the nuclear periphery (Mattioli et al., 
2007). The interaction with HP1α is lost when prelamin A is farnesylated. 
HP1α disassociation from prelamin A-LAP2α complex, is thought to be a key 
regulator of chromatin conformation and transcription in myoblast 
differentiation (Lattanzi et al., 2007; Capanni et al., 2008). LAP2α lamin-
chromatin interaction loci are regulated by nucleosomal HMGN5 regulating 
the level of heterochromatin condensation and mobility (Zhang et al., 2013).  
 
A series of mutations have been identified in lamin proteins associated with 
a wide range of phenotypes including muscular dystrophies, neuropathies, 
metabolic disorders, and premature ageing, together classed as 
laminopathies (Peters, John et al., 1998; Bonne et al., 1999). Lamin knockout 
models only show defects postnatally continuing the idea that the nuclear 
periphery functions in terminal differentiation. The rare and fatal 
Hutchinson-Gilford progeria syndrome (HGPS) laminopathy presents a 
premature ageing phenotype at 12 months and has received the most 
attention. HGPS patients have an LMNA mutation, disrupting the nuclear 
periphery organisation, and altered histone modification distributions. In 
more common laminopathies such as skeletal muscular dystrophy only rare 
patient samples found any evidence of abnormal nuclear envelope and 
heterochromatin structure and this effect was heterogeneous throughout the 
tissue sample (Sabatelli et al., 2001; Sewry et al., 2001). This less severe 
disruption to the nuclear periphery likely leads to the less severe phenotype 




1.3.1 Chromosome territories 
Chromosomes are de-compacted from mitosis to interphase, and occupy 
distinct 3D spatial volumes. This was first demonstrated by hybridising large 
numbers of specific probes across a specific chromosome, in fluorescence in 
situ hybridisation (FISH), to visualise a whole chromosome within the 
nucleus (Cremer et al., 1988). The radial distribution of a chromosome is 
determined by its gene density, with gene poor chromosomes more likely to 
be associated with the nuclear periphery (Boyle et al., 2001). Comparison of 
chromosomes 18 and 19, which have similar genomic sizes, maintain 
significantly different nuclear volumes and position. Gene rich chromosome 
19 is found more centrally and has a larger nuclear volume than gene poor 
chromosome 18 in lymphoblastoid and fibroblast cell types (Croft et al., 
1999). Chromosome territories are not fixed, however, and differ in a tissue 
specific manner, with more closely related cells maintaining more similar 
nuclear territories in mice (Parada, Mcqueen and Misteli, 2004). Unlike mice 
where every chromosome is acrocentric, humans have 5 acrocentric 
chromosomes containing the tandem repeats of the ribosomal genes on their 
short arms. These acrocentric chromosomes cluster around the nucleolus to 
allow processing of the ribosomal RNA.  
 
The intra-chromosomal radial distribution within a nuclear territory is also 
affected by gene density. Again gene rich regions are more central than gene 
deserts that are more situated nearer the periphery (Boyle, Rodesch and 
Bickmore, 2011). This nuclear organisation allows transcriptionally silent 
chromatin to be packaged more densely at the periphery while the less dense 
central volume is occupied by transcriptionally active loci. This less crowded 
central volume increases the accessibility of complexes, and metabolic factors 
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required to facilitate transcription allowing for some tissue specific required 
expression (Moen and Johnson, 2003). Given our limited understanding of 
chromatin fibre structure, the more discriminating components behind 
chromatin territories currently remains unascertained. 
 
Figure 1.3 Nuclear radial distribution of HSA18 and HSA19 chromosomes in 
hESC’s (A) hES cells DAPI stained nuclei, with hybridised HSA18 and HSA19 
chromosome paints. Scale bar is 5 µm. (B) The radial distribution of HSA18 or HSA19 
chromosome paints from de-convolved 2D images, binned into pentiles. N=50. Adapted 
from Wiblin, (2005) 
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1.3.2 Nuclear Scaffolds 
Whether chromatin is suspended within the nucleus or attached to a nuclear 
matrix has been widely debated since the 1980s. Electron microscopy 
experiments demonstrated the presence of irregular fibres connected to the 
lamina at the nuclear periphery (Nickerson et al., 1997) . This scaffold is lost 
after RNase but not DNase digestion suggesting an RNA component to its 
structure or regulation. However these structures have never been observed 
in live cells. (Craig et al., 1997) demonstrated that the genomic regions 
associated with the scaffold were enriched for satellite repeats associated 
with cytological gene poor G bands. The nuclear matrix proteome was 
investigated by 2D electrophoresis after removing soluble proteins, lipids, 
cytoskeleton components, and chromatin from samples consecutively (Fey, 
Wan and Penman, 1984). Over 300 proteins have subsequently been 
identified as associating with this scaffold (Mika and Rost, 2005). The main 
classes of proteins identified were lamins, nuclear mitotic apparatus protein, 
and heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNP A1 
and B1 were proposed to regulate the nuclear matrix. This remained 
controversial due to their scarce abundance on the nuclear matrix filaments 
and inconsistent evidence, leading to the adoption of more dynamic models 
for nuclear organisation. Despite this concept of adoption remaining 
peripheral, recent studies have championed non-coding RNAs as pertaining 






The most defined role for a ncRNA on chromatin structure is XIST. Found on 
the X chromosome, this 15-17 kb long non coding RNA is required of X 
chromosome compaction and silencing (Penny et al., 1996). Recent super 
resolution experiments suggest that XIST localises to around 200 foci on 
average 1 Mb apart along the X chromosome (Smeets et al., 2014; Sunwoo, 
Wu and Lee, 2015). The interaction of XIST to the inactive X remains even in 
conditions that strip histones from the chromatin, suggesting a tight 
association with the underlying DNA (Clemson et al., 1996). This tight 
association has made identifying protein interactors difficult, however an 
elegant study coupled RNA antisense purification with SILAC to identify 
functional interactions with SHARP, SAF-A, and LBR (McHugh et al., 2015). 
SHARP, a subunit of the SMRT co-repressor, recruits HDAC3 and is required 
for the deposition of H3K27me3 by PRC2 along the X chromosome (You et 
al., 2013). The XIST interaction with the lamin B receptor (LBR) has recently 
been supported by studies demonstrating a causative role for XIST RNA in X 
chromosome tethering to the nuclear lamina (Chen et al., 2016). 
 
More recent studies identified highly abundant interspersed repetitive 
elements, such as LINE-1 and CoT-1 associating with less dense euchromatic 
regions and fractionate with the nuclear scaffold components. Loss of these 
repetitive elements also causes chromatin condensation (Hall, Lisa et al., 
2014). Additionally long non-coding RNA HOTAIR interacts with polycomb 
component PRC2, targeting H3K27me3 mediated gene silencing at certain 
loci (Rinn, John et al., 2007). These examples demonstrate that the interplay 
between non-coding RNA and their binding partners is likely crucial in their 
function in regulation of chromatin structure and transcription.  
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Recent papers have begun to contest the direct tethering of chromatin 
repressors by RNA, however. In vitro biochemical analysis by Wang et al., 
(2017) suggested that PRC2 has robust DNA binding affinity towards 
methylated GC rich linker DNA, and that RNA acts as a competitive 
inhibitor to this DNA binding sequestering PRC2 away from the chromatin. 
This confirms the in vivo studies demonstrating PRC2 binding to nascent 
RNAs (Kaneko et al., 2013). The nucleosome-depleted regions at active 
promoters would therefore enhance PRC2 binding, suggesting that RNA 
mediated sequestering of PRC2 from actively transcribed genes as a 
fundamental process of constitutive gene expression (Yuan et al., 2005; 
Schones et al., 2008; Helbo et al., 2017). Additionally, the direct tethering of 
PRC2 by HOTAIR has recently been questioned. Portoso et al., (2017) 
demonstrated that HOTAIR recruitment alone was required for gene 
silencing, and that PRC2 recruitment is a consequence of the loss of nascent 
RNA after transcriptional repression. 
 
An example of RNA binding proteins regulating chromatin structure was 
recently demonstrated by the hnRNP protein, SAF-A. This protein was 
identified as being associated with the nuclear matrix (Romig et al., 1992). 
The function of SAF-A remains unclear but has identified roles in DNA 
repair, kinetochore assembly and gene splicing (Ma et al., 2011; Xiao et al., 
2012; Britton et al., 2014). A recent comprehensive study demonstrated that 
SAF-A formed transcriptionally dependent large oligomers that maintain 
euchromatic chromatin structure. Additionally SAF-A loss resulted in the 
accumulation of phospho-H2AX, implicating SAF-A in genome stability 




1.4 Chromatin structure and gene 
regulation 
 
The first evidence for chromatin de-condensation upon gene activation was 
the accessibility of nucleases to digest active and inactive genes (Gottesfeld, 
Murphy and Bonner, 1975; Bloom and Anderson, 1979). This was first 
observed directly when transcriptional activators were tethered to regions 
labelled with GFP in vivo (Tumbar, Sudlow and Belmont, 1999; Tsukamoto et 
al., 2000). Although this was a synthetic setting, FISH experiments also 
demonstrated chromatin de-condensation at the endogenous Hoxb cluster 
(Chambeyron and Bickmore, 2004) after activation. In addition to cytological 
de-condensation, gene activation is now associated with hyperacetylation, 
hypomethylation, DNaseI sensitivity, and loss of linker histones, indicative 
of generating more accessible chromatin fibres. 
 
The basal state and level of de-compaction is dependent of the genomic loci. 
A heterochromatic transgene spanning 90 Mbs de-condensed 30 fold, while a 
375 kb region of the major histocompatibility complex de-condensed less 
than 2 fold from a more open basal state (Tumbar, Sudlow and Belmont, 
1999; Müller et al., 2004). The highest level of cytological de-condensation has 
been observed at highly active genes such as 75S RNA and ribosomal RNA 
genes theoretically de-condensing to the level of the 10 nm fibre (Daneholt et 
al., 1982; González-Melendi et al., 2001). Experiments using sucrose 
sedimentation techniques demonstrated that chicken erythrocyte β-globin 
gene had a more disrupted chromatin fibre upon activation (Kimura et al., 
1983). This was later shown to be due to the loss of a nucleosome at a DNaseI 
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hypersensitive site, creating a disruption, thus fibre de-condensation upon 
gene activation has yet to be directly demonstrated (Caplan et al., 1987). 
However the presence of a polymerase molecule on a chromatin fibre is 
associated with a temporary de-compaction from the 30 nm chromatin fibre 
state (Andersson, Bjorkroth and Daneholt, 1984). Additionally induced gene 
activation on plasmids in yeast sediment more slowly, indicative of a more 
disrupted chromatin fibre (Kim and Clark, 2002). Furthermore, the Bickmore 
lab later demonstrated that gene rich regions correlate with more disrupted 
chromatin fibres. Although this relationship is not directly indicative of 
transcription, it suggests that the de-condensed chromatin state is permissive 
for transcription (Gilbert et al., 2004).  
 
Active genes also maintain lower levels of linker histone H1 (Tazi and Bird, 
1990) which is thought to influence folding of the 30nm fibre, and suggests 
that linker histones can be a repressor of gene transcription (Thomas, 1984). 
Loss of linker histones results in global changes in chromatin structure and 
mitotic defects (Fan et al., 2005; Maresca, Freedman and Heald, 2005). 
Detailed studies demonstrated that the effect of linker histones on 
transcription was gene specific, mediated by the occlusion of transcription 
factors (Laybourn and Kadonaga, 1991; Shen and Gorovsky, 1996; Crane-
Robinson, 1999). While triple knockouts in mice are embryo lethal, 
individual knockouts do not effect growth suggesting that these gene specific 
H1 functions are not essential or that there is significant compensation 





The expression levels of genes are also inversely correlated with DNA 
methylation. Many highly expressed genes involved in cellular homeostasis 
contain un-methylated 5’ CpG islands (Mikkelsen et al., 2007).  These 
ubiquitously transcribed promoters also exhibit decreased linker histone 
levels (Kamakaka and Thomas, 1990). Recent work demonstrated that 
promoters with CpG islands resulted in a nucleosome depleted region 
independent of transcription levels (Valouev et al., 2011; Fenouil et al., 2012). 
The functional role of CpG islands and these depleted regions is a current 
area of debate. It’s generally accepted that the nucleosome depletion 
increases accessibility to DNA binding transcription factors. Unpublished 
work from the Gilbert lab also suggests that these 5’ CpG islands have a 
structural function in facilitating transcription mediated supercoiling. 
Furthermore, the Balasubramanian lab has proposed the existence of the 
exotic DNA structure the G-quadruplex at promoters (Huppert and 
Balasubramanian, 2007) whilst further experiments have demonstrated that 
the stability of G-quadruplexes within promoters positively correlates with 












Recently RNA has been associated with chromatin de-condensation upon 
gene activation. As mentioned earlier, interspersed repetitive elements, Line-
1 and CoT-1 transcripts function within the nuclear scaffold, maintain the 
euchromatic de-condensed state (Hall, Lisa et al., 2014). Complimentarily 
long non-coding RNA transcripts (lncRNA) from enhancers (eRNA) 
throughout the human genome have been implicated in gene activation 
(Andersson et al., 2014; Pefanis et al., 2015). These >200 bp transcripts are 
transcribed by RNA polymerase II (polII), lack open reading frames, and can 
be post-translationally modified (Kung, Colognori and Lee, 2013). However 
unlike other lncRNAs, eRNAs are rarely spliced and are rapidly degraded by 
the exosome. This results in most eRNA transcripts fractionating with 
chromatin bound proteins (de Santa et al., 2010). Recent studies have 
demonstrated that exosome mediated termination of PolII enables nascent 
eRNAs to recruit transcription factors to the local environment (Lemay et al., 
2014; Sigova, 2015). Correspondingly, eRNAs are proposed to promote site 
specific chromatin disruptions to facilitate gene activation (Mousavi et al., 
2013). Furthermore, seminal experiments from Nozawa et al., (2017) 
demonstrated that RNA in conjunction with SAF-A is required for 











1.4.1 Facultative gene silencing 
 
The basal chromatin state is broadly considered to be repressive. However, 
promoting this condensation further may be necessary to prevent aberrant 
transcription. As touched upon earlier, ncRNAs have been associated with 
classical X-inactivation, and recruitment of polycomb complexes (PcG). First 
identified in Drosophila, antipodal PcG and thrithorax complexes transiently 
modulate developmental gene expression in a tissue specific manner 
(Ingham, 1983). PcG proteins form PRC1 or PRC2 complexes depending on 
the presence of subunit RING1A/B or EZH1/2 respectively. PRC2 functions 
as a H3K27 histone methyltransferase (Kuzmichev et al., 2002) but regulation 
of PRC2 targeting remains to be fully elucidated. Along with lncRNA 
HOTAIR, JARID2 and PHF19 have been implicated in directing PRC2 
recruitment (Pasini et al., 2010; Walker et al., 2010). JARID2 functions with 
PRC2 component AEBP2 to facilitate de novo H3K27 methylation, although 
mechanistically this is not precisely defined (Son et al., 2013). PRC2 subunit 
PHF19 via its tudor domain binds to the active histone mark H3K36me3 
allowing repression of currently active genes in mESCs (Brien et al., 2012; Cai 
et al., 2013). 
 
PRC1 core catalytic subunits, RING1A/B are E3 ubiquitinases targeting 
histone H2A lysine 119 (Wang et al., 2004). Canonical targeting of PRC1 acts 
via subunits with CBX domains, which recognise the PRC2 modification 
H3K27me3 (Levine et al., 2002; Fischle et al., 2003). Non-canonical PRC1 
complexes contain RYBP proteins instead of CBX proteins allowing PRC1 
targeting independent of H3K27me3 (Tavares et al., 2012; Gao et al., 2013).  
Recent studies have now implicated non-canonical PRC1 complexes in 
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recruitment of PRC2 (Blackledge et al., 2014). The complex regulation PcG 
demonstrates the need for tight regulation of gene repression for correct 
development and disease prevention. 
 
Polycomb dependent compaction was demonstrated cytologically by FISH 
(Eskeland et al., 2010), but this was independent of RING1B catalytic activity. 
Binding of PRC1 prevents transcription factor binding resulting in the 
inability to form a preinitiation complex (PIC) required for transcription 
(McCall and Bender, 1996; Lehmann et al., 2012). Polycomb binding also 
precludes SWI/SNF nucleosome remodelling maintaining a condensed 
repressive state (Shao et al., 1999). Maintaining this condensed state requires 
an evolutionarily conserved highly charged domain on PRC1 thought to 
function in its recruitment (Grau et al., 2011). Meticulous super resolution 
microscopy from Boettiger et al., (2016)  demonstrated that PRC1 mediated 
large scale chromatin compaction occurs beyond transcriptional inactivation 
and across subdomains, showing it has a potentially larger role in genome 
organisation.  
 
Polycomb mediated condensed chromatin fibres, as previously mentioned, 
are enriched for linker histones. Recent work has focused on the role of linker 
histone subtypes in maintaining this repressed chromatin structure. Unlike 
total linker histone, which is distributed genome-wide; linker histone 
variants form distinct topological domains. Linkers H1.2-H1.5 associate with 
HP1 domains at the nuclear periphery and are depleted from 
transcriptionally active regions. H1.1 by contrast is found at PcG domains, 
and weakly enriched at transcribed regions (Izzo et al., 2013). This suggests 
that linker histone H1.1 functions complementary to polycomb in transient 
gene repression. 
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1.5 Constitutive heterochromatin 
 
Position-effect variegation (PEV) was first defined by changes in the colour 
pattern in Drosophila eyes (Muller, H, 1930). This change in colouration is 
caused by the translocation of an eye pigment gene to the heterochromatic 
regions surrounding the centromere. The propagation of heterochromatic 
chromatin structure across the pigment gene occurs heterogeneously 
correlating with the patchy pigment distribution across the eye. Molecular 
studies show this clear phenotype directly relates to transcriptional 
repression, and chromatin compaction, over the translocated ‘white’ pigment 
gene. This enabled genetic screening to identify factors that supress or 
enhance the variegation of gene expression across the eye. Suppressors of 
variegation; Su(var)3-7, Su(var)2-5 (also named HP1), and Suv(var)3-9 all 
demonstrated a dose dependent effect on PEV demonstrating their key 
function in heterochromatin propagation (Reuter et al., 1990; Eissenberg et al., 
1992; Tschiersch et al., 1994). Additionally translocation screens identified 
multiple other loci across the chromosome that exhibited position-effect 
variegation including telomeres (Doheny, Mottus and Grigliatti, 2008; Riddle 
et al., 2008). The heritable state of surrounding chromatin has since been 
demonstrated across multiple eukaryotes (Ottaviani, Gilson and Magdinier, 
2008). However, as PEV sites are defined by the underlying chromatin 
structure, they were demonstrated to diverge between cell types (Hofmann, 
Brünner and Korge, 2009). This body of work was the foundation of our 
current understanding that chromatin structure is a major mechanisms for 
gene activation and repression. 
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The relationship between chromatin structure, nuclear organisation and 
transcription has led to much debate as to the causative agent behind 
genome regulation. This has been muddied by correlations with histone 
modifications and replication timing. Heterochromatin is strongly associated 
with the nuclear periphery and the idea of nuclear organisation associating 
with chromatin regulation was first put forward by Carl Rabl, (1885) 
observing peripheral centromere clustering in salamander nuclei.  
 
A causative function of nuclear organisation was first put forward in 
drosophila (Dernburg et al., 1996). Heterochromatic repeats were inserted near 
to the brown eye colour gene and using FISH they demonstrated that its 
nuclear distribution was not altered in embryonic cells. However, upon 
reaching the larval stage, the brown gene is tethered with other 
heterochromatic regions to the periphery supressing its expression 
(Dernburg et al., 1996). Mammalian studies in primary B-lymphocytes have 
also shown inactive genes localising to the periphery in cycling but not 
quiescent cells. In these phenotypically similar cells without nuclear 
peripheral localisation, the heterochromatin foci were not heritable 
suggesting that nuclear organisation is required to maintain chromatin 









More recent studies furthered this work by showing that the early B cell 
factor (EBF1) locus relocates from the periphery to a more central position at 
the same stage of differentiation as its expression (Lin et al., 2012). This effect 
can occur at single genes or at regions with multiple genes (Peric-hupkes et 
al., 2010). An eloquent study recently showed that forcing a loop between the 
β-globin locus and its long-range control region without canonical 
transcription factor GATA-1 was sufficient to induce transcription (Deng et 
al., 2012). Additionally, forcing this loop to γ-globin resulted in its up 
regulation at the expense of β-globin, demonstrating a clear link between 
genome organisation and transcription (Deng et al., 2014).  
 
Adversely, the Bickmore lab recently demonstrated that de-condensation of 
peripheral chromatin without transcription was enough to drive gene 
relocation away from the nuclear periphery. This did not, however, affect 
replication timing unless transcription was induced (Therizols et al., 2014).   
Lack of coupling between nuclear organisation and replication, however 
conflicts with other studies demonstrating TAD establishment in early G1 
correlated with replication timing determination (Dileep et al., 2015). The 
Misteli lab identifying multiple replication components affecting nuclear 
positioning supported this theory (Shachar et al., 2015). They also 
demonstrated knockdown of chromatin structure and SWI/SNF remodelling 
components caused highly expressed genes to be relocated to the periphery 
while maintaining high expression levels (Shachar et al., 2015).  Thus the 
causative nature of silencing at the nuclear periphery is not universal, and 





Heterochromatic histone modifications are also proposed to regulate the 
chromatin fibre. Heterochromatin is acetylated in yeast and Drosophila at 
H4K12 (Turner, Birley and Lavender, 1992; Braunstein et al., 1996). However, 
acetylation in humans is excluded from the heterochromatic inactive X 
chromosome (Jeppesen and Turner, 1993).  This hypoacetylated state, was 
demonstrated to regulate chromatin compaction and gene silencing by the 
Belmont lab. Targeting a VP16-lac repressor to a genomic region with an 
array of lac operator sequences, caused localised hyperacetylation, 
transcription, and chromatin unfolding (Tumbar, Sudlow and Belmont, 
1999). Correspondingly, artificial recruitment of suppressor of variegation 3-
9 homologue 1 (Suv39h1) or polycomb protein EZH2 was sufficient to 
reposition subTAD domains to polycomb bodies or pericentric 
heterochromatin respectively. With the recruitment of Suv39h1 repositioning 
occurred from an active and inactive domain. However Suv39h1 mediated 
repositioning requires the chromodomain not the methyltransferase activity 
of the enzyme and appears independent of transcriptional state (Wijchers et 
al., 2016).  
 
Intriguingly, dense heterochromatin is not continually refractory to gene 
transcription and contains multiple unique gene transcripts in Drosophila 
(Coulthard et al., 2010). The requirement of constitutive heterochromatic 
domains for correct transcription of these genes was eloquently 
demonstrated by translocation studies from the Hilliker lab (Eberl, Daniel, 
Duyf, Brenda and Hilliker, Arthur, 1993). Key regulators of PEV, Su(var)3-7 
and HP1, have subsequently been linked to correct expression of 




The interplay between nuclear positioning, chromatin structure, histone 
modifications, and replication has been extensively studied in relation to 
gene regulation. The complexity of this system is demonstrated the amount 
of conflicting studies in different systems. Pioneering work by Larson et al., 
(2017) recently demonstrated that the formation of heterochromatin via 
suppressor HP1α occurs in phase separated droplets. Loss of this phase 
separation environment results in a decrease in HP1α foci size a frequency in 
cells. This suggests that the liquid environment around chromatin may itself 
contribute to chromatin structure regulation, demonstrating the unknown 















Figure 1.4 Subdiffraction resolution imaging with SIM. (A) Cross section of mouse 
muscle myoblast C2C12 cell nucleus stained with DAPI and imaged by conventional 
epifluorescence microscopy. (D) The same cross-section imaged by 3D SIM 
reconstruction. Bright aggregates are constitutive heterochromatic chromocenters. 
Increase in DAPI intensity at the nuclear periphery is indicative of the 
heterochromatinisation of the adjacent chromatin. Scale bars are 5 µm. Adapted from 
Schermelleh et al., (2008) 
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1.5.1 Centromeres 
The principal cytological constriction of human metaphase chromosomes, 
the centromere, was first observed by Walther Flemming (1882). However, 
due to stark heterogeneity across species, Cyril Darlington (1936) argued a 
centromere must be defined by its function. Centromeres function as loading 
platforms for spindle microtubules, in order to control chromosome 
movement throughout mitosis. Although most eukaryotes contain a 
monocentric restriction, some species have diffuse centromeres along whole 
chromosomes termed holocentricity (Guerra et al., 2010).  
 
The location of monocentric centromeres is characterized by the deposition 
of histone variant CENP-A or its homologue, in most eukaryotes (Earnshaw 
and Rothfield, 1985). Artificial targeting of CENP-A is sufficient for 
kinetochore assembly, indicating its role to nucleate centromere formation 
(Mendiburoa et al., 2011). This allows centromere location to be independent 
of underlying DNA sequences and can heterogeneously drift between cells 
(Yao et al., 2013; Purgato et al., 2015). The amount of CENP-A required for 
centromere formation is also variable, with a single CENP-A required in 
some budding yeasts to kilobase regions of CENP-A deposition (Pluta et al., 
1995; Furuyama and Biggins, 2007; Bodor et al., 2014). Regional centromeres 
are composed of a central core where CENP-A is deposited, and an outer 






The underlying centromeric DNA sequences also demonstrate evolutionary 
variability, thought to be a by-product of meiotic drive in female meiosis 
(Malik and Henikoff, 2009). Most centromeres form over complex arrays of 
highly reiterative DNA sequences. These repetitive arrays are AT-rich 
domains interspersed with retrotransposon clusters, while the central core 
typically has homogenous ordered repeats, the pericentromere is less 
ordered and often has multiple repeat sequences (Fishel et al., 1988; Schueler 
et al., 2001). 
 
These repetitive elements have increased frequency of meiotic recombination 
due to their sequence similarity. This may decrease genome stability when 
their chromatin environment is accessible, and therefore requires a more 
compact chromatin state (Vader et al., 2011), alternatively a regular 
chromatin structure may be required to form a stable kinetochore. These 
compact chromatin fibres were first described as satellite bands isolated from 
bulk DNA in density gradients (John and Miklos, 1979). One of the most 
abundant, the α-satellite, is conserved across primates spanning 5% of the 
genome. α -satellite in primates comprises a core 171 bp repeat that 
hybridises to all human canonical centromeres (Fittler and Zachau, 1979). 
Within the central core of the centromere, sixteen α-satellite monomers are 
arranged sequentially head to tail forming a 2.7 kb higher order repeat unit 
propagated throughout. By contrast, the human pericentromere contains 
disordered adjacent monomers (Aldrup-MacDonald and Sullivan, 2014). 
Nucleosome positioning is strictly defined across α -satellites, first 
demonstrated in African green monkeys (Zhang, Fittler and Horz, 1983). 
Mice by contrast have only two centromeric repeats, major and minor 
satellites. The centric minor satellite has a shorter 120 bp repeat and the 
major pericentric repeat is 234 bp (Wong and Rattner, 1988).  
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Figure 1.5 Centromere structure and organisation. (A) Typical acrocentric mouse 
chromosome, with pericentric major satellite and centric minor satellite (red) repeats. 
(B) Centromere identity components. The CENP-A core contains H3K36me, H3K4me2, 
and acetylation, whereas pericentric regions contain H3K9me3. (C) Major satellite 
organisation (red) in mouse 3T3 cells mitosis or interphase by DNA fluorescence in situ 
hybridisation (FISH). Scale is 10 µm. Adapted from Probst and Almouzni, (2011); Lyn 
Chan and Wong, (2012) 
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1.5.2 Centromere large-scale structure 
The role of CENP-A in large scale chromatin fibre structure at centromeres, is 
limited by its low frequency of deposition (~400) within the core centromeric 
region contributing to just ~4% of nucleosomes (Bodor et al., 2014). High-
resolution microscopy of stretched chromatin fibres demonstrated that these 
were ordered into blocks of CENP-A or H3 containing nucleosomes from 
Drosophila to humans (Blower, Sullivan and Karpen, 2002; Ribeiro et al., 
2010). Electron microscopy experiments demonstrated that CENP-A 
nucleosomes are exclusively found at the surface of the cytological 
constriction. The CENP-A nucleosomes are not prevalent enough though to 
cover the entire surface of the restriction, occupying two thirds of the length, 
and one third of both the width and height of the surface (Marshall, Marshall 
and Choo, 2008). How the chromatin fibre is compacted to allow these 
CENP-A domains to lie on the surface of the fibre remains to be elucidated. 
Many models including; looping, solenoidal, planar sinusoids, and layered 
boustrophedon have been hypothesised. The repetitive nature of satellite 
sequences makes the use of capture-C methods problematic (Naumova et al., 
2013). Additionally, limitations of current microscopy techniques mean that 









Flanking the core centromere, the pericentromere contains canonical 
heterochromatic marks and is responsible for sister chromosome cohesion 
with high levels of cohesion (Glynn et al., 2004). This process is mediated by 
the stabilisation of cohesion complexes throughout S phase (Yeh et al., 2008). 
The heterochromatic nature of the pericentric regions directly mediates this 
process via H3K9me3. In S. pombe, HP1 homologues Swi6 and Chp2 which 
bind H3K9me3 provides a platform for cohesin recruitment (Bernard et al., 
2001; Nonaka et al., 2002). Pericentric cohesin is protected from turnover by 
Swi6 recruiting shugoshin proteins (Yamagishi et al., 2008). These recruit 
phosphatase PP2A preventing cohesin subunit phosphorylation and 
subsequent separase cleavage (Kitajima et al., 2006). The role of H3K9me3 
and HP1 in regulating mammalian cohesin remains controversial. While HP1 
in humans recruits shugoshin proteins, they are not essential for cohesin 
protection and do not drive cohesin recruitment (Koch et al., 2008; Serrano, 
Rodríguez-Corsino and Losada, 2009). However, Suv4-20 methyltransferase, 
tethered by HP1 isoforms significantly contributes to loading cohesin (Yang 
et al., 2008; Shimura et al., 2011; Hahn et al., 2013). Loss of pericentric cohesin 
loading completely abrogates the cytological constriction known as 
heterochromatin repulsion (Whelan et al., 2012). This occurs in the human 
disease Roberts syndrome, causing increased aneuploidy and abnormal 
nuclear morphology due to loss of genome integrity during mitosis (Jabs et 
al., 1991). Despite the function of heterochromatin and cohesins during 
mitosis, the loss of Suv39 methyltransferases in mice does not lead to loss of 
their cytological constriction and remarkably are viable with few minor 






Despite the highly ordered nature of repetitive elements within the 
centromere, they are not essential. Centromeres can form sporadically over 
non-repetitive DNA, classed as neocentromeres. These were first found to 
occur naturally in humans by Voullaire et al., (1993) and can be stably passed 
generation to generation (Tyler-Smith et al., 1999). In Drosophila irradiation 
exposure was sufficient to produce acentric mini-chromosomes containing a 
neocentromere (Murphy and Karpen, 1995). These mini-chromosomes 
demonstrated the ability to recruit centromere specific protein ZW10, and 
formed a neocentromere from the sub-telomeric region of chromosome X 
(Williams et al., 1998). This sub-telomeric sequence does not display the 
cytological restriction of a centromere when not attached to the X 
chromosome outside of this mini-chromosome environment, further 
demonstrating the epigenetic activation step required for centromere 
formation.  
 
Dicentric chromosomes occur when a centromere naturally translocates 
within a chromosome resulting in inactivation of the original centromere 
locus. The dicentric (X;15) translocation in Drosophila first demonstrated the 
loss of centromeric proteins such as CENP-C from the inactive centromere 
(Page et al., 1995). Additionally heterochromatic proteins HP1β and Suv39h1 
are found pericentrically at all canonically active but not inactive 
centromeres (Aagaard et al., 2000; Saffery et al., 2000). The loss of these 
heterochromatic proteins elevates chromosome loss suggesting impaired 
kinetochore function (Taddei et al., 1999; Rea et al., 2000). Furthermore, inner 
centromere protein (INCENP) directly associates with HP1 (Ainsztein et al., 
1998) and binds to the spindle mid-zone as part of the chromosome 
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passenger complex for chromosome arrangement throughout mitosis 
(Mackay et al., 1998). Despite INCENP’s direct interaction with HP1, 
Ainszstein demonstrated this was not required for centromere targeting of 
INCENP, instead functioning in its transfer from chromosomes to the 
anaphase spindle. Recently the role of pericentric heterochromatin has come 
under debate as neocentromeres can occur without surrounding 
heterochromatic marks H3K9me3 and HP1, albeit with centromere cohesion 
defects (Alonso et al., 2010). This demonstrates a functional but not essential 
role of heterochromatin for centromere formation.  
 
1.5.4 Evolutionary New Centromeres 
The ability to form non-repetitive centromeres appears across all forms of 
life. Some species, such as orangutan, horse and chicken, have both repetitive 
and non-repetitive centromeres within their genomes (Piras et al., 2010; 
Shang et al., 2010; Locke et al., 2011). By comparing recently diverged 
evolutionary species these centromeres have been termed evolutionary new 
centromeres (ENCs) (Kasai et al., 2003; Rocchi et al., 2012). This centromere 
repositioning occurs without transposition of the surrounding genetic 
landscape (Montefalcone et al., 1999). Intriguingly however a typical ENC 
acquires the molecular properties and satellite repeat sequences of ‘old’ 
centromeres. Macaques, in contrast to orangutans, have nine ENCs within 
their genome, each of which contains α-satellite duplications (Ventura et al., 
2007). Therefore, despite not being required for centromere formation, there 
is evolutionary pressure for their presence. Furthering this idea, the satellite 
arrays at old centromere positions decay once ENCs are formed (Kalitsis and 
Choo, 2012). 
 62 
1.5.5 Mammalian Artificial Chromosomes 
In order for a chromatin fibre to be a stable constituent of a genome, it 
requires the ability to undergo mitosis. In order to be correctly segregated in 
mitosis, a functioning centromere is required. Generation of S. cerevisae 
artificial chromosomes (YACs) was therefore relatively simple as the single 
CENP-A requires a specific underlying DNA sequence (Clarke, 1998). 
Human artificial chromosome production proved more intricate as the 
underlying factors of centromere formation remain unresolved. Pioneering 
work by Harington et al., (1997) combined α-satellite arrays with telomeric 
and genomic DNA in human HT1080 cells to generate a 6-10Mb 
chromosome, further demonstrating the role of repetitive higher order units 
in centromere structure. Although the mechanism behind artificial 
centromere formation is yet to be fully elucidated, recent studies propose 
that α-satellite has a propensity for epigenetic marks that favour CENP-A 










1.5.6 Regional Centromere Determinants 
For genomic sequences such asα-satellite to be a determining factor in 
centromere location, they must directly or indirectly recruit CENP-A and the 
constitutive centromere associated network (CCAN). In S. cerevisiae the 
single CENP-A nucleosome location is determined by the presence of the 
centromere DNA element III (CDEIII) recognised by Cbf3 (Lechner and 
Carbon, 1991).  
 
Regional centromere sequences across species are conversely highly varied, 
unlike the components of CCAN. CCAN component CENP-C for instance 
has high homology with S. cerevisiae Mif2 protein (Meluh and Koshland, 
1995). Ectopic recruitment of core CCAN components CENP-C, HJURP, and 
CENP-I individually is sufficient for CENP-A deposition and kinetochore 
assembly at centromeres (Hori et al., 2013). This demonstrates that the 
targeting of core CCAN is the main determinant for centromere location. In 
contrast to the conservation of CCAN, the only conserved centromeric 
sequence from humans to mice is the 17 bp CENP-B box sequence (Muro et 
al., 1992). The CENP-B box is present in the higher order repeats of the core 
minor satellite region in M. musculus and humanα-satellite. CENP-B, which 
binds to this sequence, directly stabilizes CENP-A nucleosomes and their 
interaction with CCAN component CENP-C (Fachinetti et al., 2015). While 
CENP-B increases the fidelity of centromere location, loss of the CENP-B box 
in mice is not lethal (Hudson et al., 1998) Additionally other primate and 
rodent species have divergent sequences or lack the sequence entirely (Haaf 
et al., 1995; Kipling et al., 1995). As expected, CENP-B is not recruited to 
neocentromeres, and intriguingly Y chromosome centromeres lack the 
CENP-B box repetitive sequence and subsequent CENP-B binding 
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(Earnshaw, Ratrie and Stetten, 1989; Voullaire et al., 1993). Repetitive 
elements from the Y chromosome however are not able to form HACs which 
require the CENP-B box (Grimes, Rhoades and Willard, 2002; Ohzeki et al., 
2002). This further demonstrates a functional if not essential role for the 
CENP-B box centromeric sequence. 
 
In addition to the underlying genomic sequence at centromeres, specific 
epigenetic states are thought to be permissive to centromere formation.  H3 
variant CENP-A as mentioned is required for recruitment of kinetochore 
components. The effect of CENP-A deposition on a nucleosome’s physical 
property at the centromere remains unclear. Whether CENP-A is found in an 
octamer or a tetramer hemisome in vivo is the crux of this debate (Dunleavy, 
Zhang and Karpen, 2013). Perceptive hydrogen-deuterium exchange 
experiments demonstrated that CENP-A--H4 tetramers are more compact 
due to a rotated interface between the two CENP-A molecules (Sekulic et al., 
2010). Additional studies have demonstrated the ability of CENP-A 
hemisomes to preferentially wrap DNA in a right handed manner 
(Furuyama and Henikoff, 2009). Contrary to this, crystal structures of 
octameric CENP-A nucleosomes do not perform this axis rotation and form 
more condensed arrays (Panchenko et al., 2011; Tachiwana et al., 2011). These 
views were unified recently by Falk et al., (2015), who demonstrated that 
both forms are present in solution with the octameric form preferring CENP-
C binding.  
 
The local chromatin environment is proposed to regulate histone variant 
CENP-A deposition throughout the core centromere. Unlike normal 
nucleosome incorporation, CENP-A is uncoupled from replication and 
remains in a hemi state throughout mitosis (Shelby, Monier and Sullivan, 
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2000; Jansen et al., 2007). Histone variant H3.3 incorporates where CENP-A is 
lost acting as a marker for new assembly of CENP-A nucleosomes in G1 
(Dunleavy, Almouzni and Karpen, 2011). Incorporation of CENP-A is 
facilitated through chaperone complexes containing HJURP and MIS18 
proteins. While not all MIS18 components are evolutionarily conserved, 
MIS18 complexes have been shown to interact with CENP-C across species 
(Moree et al., 2011; Dambacher et al., 2012). CENP-C has also been 
demonstrated to directly interact with CENP-A chaperone HJURP 
demonstrating its ability facilitate CENP-A—CENP-C interactions 
(Tachiwana et al., 2015).  
 
In addition to CENP-C and H3.3 presence at centromeres, surrounding 
chromatin signatures influence CENP-A deposition. For instance MIS16 and 
MIS18 have been proposed to prime the centromere for CENP-A deposition 
via DNA methylation and histone deacetylation (Hayashi et al., 2004; Kim et 
al., 2012). Pericentric regions as mentioned above canonically contain 
heterochromatic marks such as H3K9me3 and DNA methylation (Lehnertz et 
al., 2003). Adversely, the CENP-A core region contains transcriptionally 
permissive marks, H3K4me2 and H3K36me2 (Sullivan and Karpen, 2004). 
This chromatin state has been demonstrated to directly influence CENP-A 
deposition by HJURP (Bergmann et al., 2011). Eloquent studies on human 
artificial chromosomes demonstrated that the heterochromatinization of the 
inner centromere core abdicated centromere function and CENP-A 
deposition (Nakano et al., 2008; Ohzeki et al., 2012).  
 
The requirement of this permissive chromatin state at centromeres has led to 
a hypothesis for transcription at the core centromere. Transcription 
machinery including FACT (facilitates chromatin transcription complexes), 
 66 
RSF1, and helicase CHD1 have all been implicated in CENP-A deposition 
(Perpelescu et al., 2009; Dudek et al., 2010). Absence of FACT mediated 
transcription results in aberrant CENP-A deposition and centromere 
function, demonstrating a direct link between transcription and centromere 
function (Chen et al., 2015). 
 
The presence of RNA transcripts from these repetitive elements appears to be 
required. In S. pombe the RNA interference complex DICER cleaves 
pericentric transcripts, producing small interfering RNA (siRNA). These 
short transcripts and HP1 are required for correct CENP-A deposition (Folco 
et al., 2008). The function of transcription at human centromeres has also 
been inferred by the presence of polymerase II and transcription during 
mitosis, while the Gilbert lab (unpublished) shows transcription during 
interphase at human neocentromeres (Chan et al., 2012). Investigations using 
HACs has also shown the presence of α -satellite transcripts from its 
centromere (Bergmann et al., 2011). Disrupting this transcription at the 
centromere results in kinetochore defects and aberrant CENP-A profiles 
(Quénet and Dalal, 2014; Liu et al., 2015).  
 
Together this body of work demonstrates that interplay of genomic 
sequences, local chromatin states, transcription and CCAN formation occurs. 
Exactly how these contribute to the spatial restriction of the centromere and 
its propagation remains elusive. This remains an area of current major 
scientific interest as the field looks to understand why some abnormal 
CENP-A deposition induces neocentromere formation, while other sites 
remain inert. Understanding this process will provide intriguing 
evolutionary insights in addition to understanding the relationship between 
epigenetic states and chromatin fibre structure. 
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1.5.7 Telomeres 
Telomeres are heterochromatic regions that cap linear chromosomes. They 
were first identified as a distinctive feature of nuclear structure in drosophila 
by Herman Muller, who noted their requirement for faithful genome 
maintenance (Muller, H, 1938). These chromosome caps function to 
distinguish the chromosome ends from breaks. This allows cells to undergo 
mitosis without activating cell cycle checkpoint responses to chromosome 
breaks (Sandell and Zakian, 1993). The requirement of telomeres for cell cycle 
progression has promoted their evolutionary conservation (Meyne, Ratliff 
and Moyzis, 1989). 
 
Vertebrates have large kb arrays of repeating telomeric associated sequences 
(TAS) to cap their chromosomes. Although mostly double stranded, the 
definitive end is a 3’ single stranded overhang ranging from 50-400 
nucleotides (Wright et al., 1997). These exposed nucleotides are proposed to 
form a high order loop like structure, folding into the duplex region of the 
telomere, protecting chromosome ends from DNA repair mechanisms 










Loss or shortening of these capping sequences is associated with senescence, 
faithful chromatid separation, genome stability and oncogenesis (Lundblad 
and Blackburn, 1993; Greider, 1998; Blackburn, 2001). These phenotypes 
occur as DNA replication is not conservative and, therefore, completion to 
the chromosome end is not essential. Organisms must harbour mechanisms 
to restore lost telomeric sequences after every mitotic division to prevent loss 
of telomeric repeats. This is achieved by telomerase which uses RNA 
telomeric transcripts as a template for DNA restoration (Collins and Miller, 
2002). 
 
The stabilisation of the T loop structure and the accessibility of telomerase 
mediated repair is regulated by telosome or shelterin complexes (De Lange, 
2005). Subunits TRF1/2 negatively regulate telomerase activity and in 
combination with POT1 facilitate T-loop formation (Stansel, De Lange and 
Griffith, 2001; Hockemeyer et al., 2006). Although telomere structures are 
required to avoid activating the DNA damage response pathway, shelterin 
recruits many DNA damage proteins involved in signalling, nucleotide 
excision, helicases, homologous repair (HR) and non-homologous end 
joining (NHEJ). These interactions all have a functional role in telomere 
maintenance. Loss of ATM-TRF2 interaction in ataxia-telangiectasia patients, 
for instance, results in aberrant telomere length (Hande et al., 2001; Karlseder 
et al., 2004). This is mediated by excision of the 3’ overhang followed by HR 
or NHEJ that also prevent chromosome end to end fusions (Zhu et al., 2003; 





Werner and Bloom syndrome patients with helicase mutations first 
implicated the role of chromatin structure on telomere maintenance.  WRN 
and BLM helicases have since been shown to interact with TRF2 causing the 
de-condensation of telomeric regions (Opresko et al., 2002).   
 
Mammalian chromatin condensation at telomeres was demonstrated by 
reduced nuclease accessibility in rats (Makarov et al., 1993). Subsequent 
studies have demonstrated enrichment for: constitutive heterochromatic 
HMT’s Suv39h1/2 and Suv420h1/2, their methylation marks H3K9me3 and 
H4K20me3, DNA methylation and HP1 (García-Cao et al., 2003; Gonzalo et 
al., 2006; Benetti et al., 2007). The formation of constitutive heterochromatin 
reduces the accessibility of telomerase enzymes, therefore, regulating 
telomere length. This is demonstrated by loss of Suv39h1/2 or DNMT’s 
causing telomere elongation, and HP1 overexpression instigating telomere 
erosion (García-Cao et al., 2003; Sharma et al., 2003; Gonzalo et al., 2006). 
Similarly to centromeric regions, transcription of telomeric repetitive 
elements has recently been implicated in its regulation. Telomeric RNAs 
(telRNA) are transcribed by PolII from the 5’ strand and therefore does not 
occur at the 3’ overhang. telRNA’s remain chromatin bound at telomeric 
regions by interacting with TRF1 and demonstrate the ability to inhibit 
telomerase activity (Schoeftner and Blasco, 2008). The role of these telRNA’s 
on chromatin structure has yet to be properly investigated, but provides 







1.6 Thesis Aims 
The advancement of sequencing technologies has resulted in a more refined 
understanding of genome organisation and the association of proteins and 
their modifications. However these studies have largely focused on 
euchromatin due to the repetitive nature of centromeric regions. The 
relationship between histone modifications and global chromatin structure is 
based on correlative rather than causative evidence, and a direct role 
continues to be debated. As such, whether both compaction and de-
compaction are active processes also remains unresolved. Identifying factors 
that affect heterochromatin formation, consequently, remains an important 
research question today. 
 
Additionally, epigenetic regulation has been suggested as important 
therapeutic cancer targets (Feinberg, Ohlsson and Henikoff, 2006).  However 
drug development has largely focused on inhibiting oncogenes, rather than 
the re-expression of tumour suppressors, due to clarified mechanisms of 
action, and reduced potential off target effects. Heterochromatic 
abnormalities and mutations in repressive epigenetic factors are however 
associated in disease phenotypes, suggesting their therapeutic potential 
(Ehrlich et al., 2002; Suzuki et al., 2004; Birgisdottir et al., 2006). 
 
Thus this thesis aims to: 
 
• Investigate any causality behind epigenetic regulation of chromatin 
structure correlations. 
 
• Identify components of heterochromatin regulation 
 
• Investigate the epigenetic regulation of acquired kinase signalling 
inhibitor resistance. 
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Chapter 2: Methods 
 
2.1 General reagents, stock solutions and 
buffers 
 
2.1.1 Sources of reagents 
 
All solutions were prepared with deionised water and stored at room 
temperature unless stated otherwise. 
 
Chemicals were purchased from Sigma Aldrich, Fischer Chemicals, GE 
healthcare, and VWR. Enzymes and antibodies were procured from New 
England Biolabs, Roche, Life Technologies, and Promega. Invitrogen 











2.1.2 Stock solutions and buffers 
 
20 × TBE 1L:  108 g Tris-base, 27.5 g boric acid, 40 ml 0.5 
M EDTA 
 
20 × TPE 1L: 218 g Tris-base, 31 ml orthophosphoric 
acid (85%), 40 ml 0.5 M EDTA 
 
20 × TEEP 0.2L: 40 ml 1 M Tris (pH 8), 8 ml 0.5 M EDTA, 40 
ml 100 mM EGTA, 0.05% (w/v) NP40, 250 
μM PMSF 
 
5 × DNA loading buffer: 50% glycerol, 5 mM EDTA pH 8, 0.3% 
orange G (w/v) 
 
4 × SDS buffer: 40% glycerol v/v, 8% SDS v/v, 0.25 M Tris-
HCl pH 6.8, 5 mM β-mercaptoethanol 
 
Buffer 1:    0.5 M Tris pH 8, 0.15 M NaCl 
 
Cell lysis buffer:   85 mM KCl, 0.5% NP-40, 5 mM HEPES 
 
ChIP dilution buffer: 0.01% SDS, 1.1% Triton X-100, 1.2 mM 





Chloroform-IAA: Chloroform and iso-amyl alcohol were 
mixed at a 24:1 ratio 
 
Colloidal Coumassie Stain:  0.25% (w/v) brilliant blue R-250, 45% 
methanol, and 10% glacial acetic acid. 
  
Colloidal Coumassie Destain: 30% methanol, 10% glacial acetic acid 
 
Chromatin elution buffer: 1% SDS, 0.1 M NaHCO3 
 
CSK buffer: 100 mM NaCl, 0.1% Triton X-100, 300 mM 
sucrose, 1 mM MgCl2, 1 mM EGTA, 10 mM 
PIPES and 100 μM PMSF. 
 
Destaining solution: 30% methanol, 7% glacial acetic acid, 63% 
ddH2O (v/v) 
 
Denaturation buffer: 1.5 M NaCl, 0.5 M NaOH 
 
Genomic lysis buffer: 150 mM NaCl, 1% (w/v) SDS, and 10 mM 
EDTA 
 
Hybridisation buffer: 6 × SSC, 10 mM EDTA, 5 × Denhardt’s 




In vitro click reaction mix: 3 μl 2 M triethylammonium acetate buffer, 
30 μl DMSO, 6 μl 5 mM ascorbic acid, 3 
μl 10 M CuTBTA, 1.2 μl 10 mM biotin 
azide 
 
LiCl buffer 0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 
mM EDTA, 10 mM Tris-HCl pH 8. 
 
Luria-Bertani (LB) agar (1L): 10 g tryptone, 5 g yeast extract, 10 g NaCl, 
15 g agar, pH 7.0 by sodium hydroxide. 
Prepared by the MRC HGU Technical 
Services. 
 
Luria-Bertani (LB) broth (1L): 10 g tryptone, 5 g yeast extract, 10 g NaCl, 
pH 7.0 by sodium hydroxide. Prepared by 
the MRC HGU Technical Services. 
 
MD Anderson lysis buffer: 1% Triton X-100, 50 mM HEPES, 150 mM 
NaCl, 1.5 mM MgCl2, 1 mM EGTA, 199 
mM NaF, 10mM sodium pyrophosphate, 1 
mM Na3VO4, 10% glycerol, phosphatase 






Nuclear Buffer A (NB A): 85 mM KCl, 5.5% sucrose, 10 mM Tris pH 
7.6, 0.5 mM spermidine, 0.2 mM EDTA, 250  
μM PMSF 
 
Nuclear Buffer B (NB.B): Nuclear buffer A supplemented with 0.2% 
NP-40 for differentiated cells, and 0.05% 
NP-40 for ESCs 
 
Nuclear Buffer Release 2: 85 mM KCl, 5.5% sucrose, 10 mM Tris-HCl 
pH 7.6, 1 mM CaCl2, 1 mM MgCl2, 250 μM 
PMSF. 
 
Nupage transfer solution: 1 × Nupage transfer buffer, 10 or 20% 
methanol, 1% nupage antioxidant 
 
Neutralisation buffer: 1.5 M NaCl, 0.5 M Tris-HCl pH 7.5 
 
Optimal live cell click reaction: 0.5 mM CuSO4, 0.25 mM THPTA, 250 mM 
sodium ascorbate 
 
Phosphate buffer saline (PBS):  Dublecco’s recipe (without calcium and 
magneisum), 10 mM Phosphate, 137 mM 
NaCl, 27 mM KCl. Prepared by MRC HGU 
Technical Services 
 
Penecillin/Streptomycin: 10,000 U/ml penicillin and 650 μ g/ml 




Propidium iodide solution: PBS, 1 μg/ml propidium iodide, 4 μg/ml 
RNase A. 
 
Proteinase K: 20 mg/ml (w/v) proteinase K, 1.5 mM 
calcium acetate, 50% glycerol, 50 mM Tris-
HCl pH 7. 
 
RIPA: 1% NP-40, 0.5% sodium deoxycholate 
(v/v), 0.1% SDS in water. Protein inhibitor 
cocktail added before use. 
 
Saline sodium citrate (SSC): 0.5L 20 × stock prepared by MRC HGU 
Technical Services: 3 M NaCl, 0.3 M tri-
sodium citrate, pH 7. 
 
TEEP ΔNaCl: 20 × TEEP stock used to make 10 mM Tris-
HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 250 
μM PMSF, supplemented with 1 mM, 20  
mM or 80 mM NaCl. 
 
TBE: 90 mM Tris-borate, 2 mM EDTA prepared 
from 20 × stock 
 




Tris EDTA (TE): 10 mM Tris-HCl, 0.1 mM EDTA. 50 ml 
stock was prepared by MRC HGU 
Technical Services. 
 
TPE: 0.8 M Tris-phosphate, 0.02 M EDTA 
prepared from 20 × stock.  
 
TSE-I buffer 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 
20 mM Tris-HCl pH 8, 150 mM NaCl 
 
TSE-II buffer 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 

















2.2 Bacterial Culture 
2.2.1 Media 
E. coli strains were grown at 37°C in a Luria-Bertani (LB) broth suspension by 
a shaking incubator (250 rpm) overnight. To select for plasmid containing 
bacteria, ampicillin or kanamycin was added as required. Ampicillin 
resistant E. coli colonies were grown on ampicillin containing L-agar plates 
poured by MRC HGU Technical Services.  
2.2.2 Bacterial strains 
DH5α competent cells (Invitrogen) were used for cloning experiments, and 
stored at -80°C. 
2.2.3 Bacterial glycerol stocks 
50% glycerol stocks were made for long-term bacterial storage. 500 μl of E. 
coli suspended in LB broth was added to 500 μl of glycerol and stored at -
80°C. 
2.2.4 Bacterial transformation 
50 μl of DH5α competent cells (Invitrogen) and thawed on ice for 15 
minutes then 50 ng of plasmid or ligation was added. Competent cells were 
heat-shocked at 42 °C for 30 seconds before being rested on ice for 2 minutes 
to reduce the temperature. 400 μl of SOC media was then added to the 
bacterial culture and incubated at 37 °C for 30 minutes. Cultures were 
diluted and spread on L-agar plates with antibiotics, as required. 
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2.3 DNA methods 
 
2.3.1 Phenol/chloroform DNA purification 
To purify mammalian genomic DNA, cells were trypsinised and suspended 
in genomic lysis buffer (GLB). RNase A/T1 mix (Cat No EN0551) was added 
to the GLB lysed solution to a final concentration of 5 μg/ml of RNase A and 
12.5 U/ml of RNase T1.  Samples were incubated at 37 °C for 30 minutes. 
Proteinase K at 150 μg/ml was added to the solution and further incubated 
at 55 °C for 2-16 hours. Phenol chloroform-IAA at a ratio of 25:24:1 was 
added in equal volume to the solution before inversion to mix. Samples were 
centrifuged at 12,000 g for 30 minutes at room temperature to separate the 
different phases. The aqueous phase was transferred to a new tube and re-
extracted with chloroform-IAA, in order to remove residual phenol.  
 
DNA was precipitated from samples by the addition of sodium acetate (pH 
5.5) to 300 mM with 2.5 volumes of ethanol.  1 μl of glycogen 20 μg/ml 
(Sigma cat no G1508) was added as a carrier and incubated at -20°C for 1-16 
hours. The DNA was collected by centrifugation at 12,000 g for 30 minutes at 
RT. The supernatant was removed and the pellet was washed with 1ml 70% 
ethanol to remove residual salt. The DNA was re-centrifuged at 12,000 g 10 
minutes at RT. The supernatant was again removed and the pellet dried at 
room temperature. DNA was resuspended in TE and quantified by 260 nm 
absorbance on a Nanodrop 1000 UV-VIS spectrometer (Thermo Scientfic). 
The 260/280 ratio was used to determine sample purity with 1.85-2.15 
considered free of contaminants. 
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2.3.2 Gel electrophoresis of nucleic acids 
Small DNA fragments (<2 kb) were resolved by horizontal electrophoresis in 
a 1% agarose (Invitrogen cat no. 16500-500) 1 × TBE gel with 0.5 μg/ml 
ethidium bromide (VWR cat no. 443922U). 5 × DNA loading buffer (50% 
glycerol, 5 mM EDTA, 0.3% Orange G) was added to each sample to 1 × 
before gel loading. Unless stated otherwise, 500 ng of 1 kb plus DNA ladder 
(Invitrogen cat no. 10787018) was used as a reference and gels were 
visualised on a UV transilluminator.  
 
DNA fragments >2 kb were resolved by horizontal electrophoresis in a 0.7% 
agarose 1 × TPE gel with 0.5 μg/ml ethidium bromide. Samples were 
prepared in 1 × DNA loading buffer before loading. 500 ng of 1 kb ladder 
(NEB cat no. #N0552) and 0.4 μg of 2.5 kb molecular ruler (Biorad cat no. 
#1708205) were used as DNA size markers. Gels were run at low voltage <35 










2.3.3 Plasmid purification 
Single E. coli colonies from plasmid antibiotic containing agar plates were 
swabbed and incubated in 5 ml L-broth >6 hours 37 °C in a shaking incubator 
(250 rpm). Either a Qiaprep Miniprep Kit (Qiagen cat no. 27104) or E.Z.N.A 
Plasmid Mini Kit (Omega cat no. D6942-01) were used to purify >20 μg 
plasmid DNA from 5 ml E. coli cultures as per manufacturers’ instructions 
and eluted into 30 μl TE buffer, and concentration measured on a Nanodrop 
1000 UV-VIS spectrometer (Thermo Scientific). For 20-200 μg of plasmid 
DNA, a 5 ml E. coli culture was added to 200 ml L-broth overnight at 37 °C in 
a shaking incubator (250 rpm). Plasmid from 50 ml of culture was isolated 
using E.Z.N.A Plasmid Maxi Kit (Omega cat no. D6922) following the 
manufacturer’s instructions and eluted into 50 μl TE. For larger plasmid 
amounts the E.Z.N.A Plasmid Maxi Kit was used in series, as per 
manufacturer’s instructions. 
 
2.3.4 Restriction digestion and ligation of DNA 
Plasmid DNA was digested with the required restriction endonucleases 
(New England Bioloabs) following manufacturer’s guidelines. 10-20 units of 
restriction enzyme was typically used per 1 μg of plasmid DNA at 37 °C for 
2-12 hours. T4 DNA ligase (Cat No M0202S) was used to join DNA 
fragments. A 3:1 vector to insert ratio was used for ligation reactions, with 10 
U T4 ligase per 200 ng of plasmid. Ligation reactions were incubated at room 
temperature of 4 hours. 
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2.3.5 Restriction digested DNA isolation 
DNA fragments from restriction digestions were resolved by agarose gel 
electrophoresis with sybr safe (Invitrogen cat no. S33102). 1 μl of a 1:10 
dilution of sybr safe stock was added to each sample before loading into each 
lane. Gels were viewed under blue light and a single edged razor blade was 
used to excise the desired DNA fragment. Gel fragments where transferred 
to 1.5 ml tubes and the DNA extracted with QIAquick Gel Extraction Kits 

















2.3.6 Cross linked chromatin immunoprecipitation 
Approximately 5x107 cells per ChIP were crosslinked with 1% formaldehyde 
(Sigma cat no. #F87750) in FCS free media for 10 minutes at room 
temperature. To stop crosslinking, formaldehyde was removed and cells 
were washed three times with ice-cold PBS containing 125 mM glycine for 5 
minutes. Cells were removed from tissue culture flasks or 10 cm petri dishes 
using a cell scraper and centrifuged at 500 g for 4 minutes at 4°C. The 
supernatant was removed and the pellet resuspended in RIPA buffer and 
sonicated in 1 ml sequential batches. Fragmentation by sonication was 
performed on a Soniprep 150 for 15 cycles 20 s on and 40 s off at amplitude of 
8 μm on ice. 
 
Samples were centrifuged at 20,000 g for 20 minutes at 4 °C to pellet large 
cellular debris. Supernatant was collected and a 50 μl aliquot used to check 
fragmentation efficiency.  The 50 μl aliquot was diluted with 50 μl cell lysis 
buffer (85 mM KCl, 0.5% NP-40, 5 mM HEPES pH 8.0) and 5 M NaCl at 65 °C 
for 4 hours to reverse the formaldehyde crosslinks and incubated with 1 μl 
RNase A/T1 (Ambion cat no. EN0551) at 37 °C for 30 minutes. Proteinase K 
was added and incubated at 55 °C for 1 hour and samples were analysed by 
gel electrophoresis.  Only samples with DNA fragments between 100-1000 bp 
were used for immunoprecipitation. 
 
The chromatin concentration of sonicated samples was measured at 260 nm 
on a UV-VIS Nanodrop 1000 (Thermo Scientific) and normalised across all 
samples to >200 ng/μl. The samples are then diluted 10 fold in ChIP dilution 
buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH  
7.5, 167 mM NaCl, and protein inhibitor cocktail) and 10% stored as input.  
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50 μl magnetic protein A dynabeads (Invitrogen cat no. #100-02D) per 
immunoprecipitation were preblocked in 5 mg/ml BSA in PBS, before 
antibody incubation in 500 μ l ChIP dilution buffer with proteinase 
inhibitors for 4 hours rotating (15 rpm) at 4 °C. The Dynabeads were then 
washed with BSA 5 mg/ml in PBS, before incubation with samples overnight 
at 4 °C. 
 
Magnets were used isolate the Dynabeads from the solution and washed 
with TSE-I and TSE-II buffers (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 
mM Tris-HCl, 150/500 mM NaCl) for 5 minutes at 4 °C. Samples were further 
washed with LiCl buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM 
EDTA, 10 mM Tris-HCl) and TE buffer for 3 minutes at 4 °C. Chromatin was 
eluted from Dynabeads in 250 μl elution buffer (1% SDS, 0.1 M NaHCO3) for 
1 hour at 65 °C with occasional vortexing, before 5 M NaCl was added to 
each sample (20 μl) and input sample (4 μl) for a further 5 hours at 65 °C. 
The supernatant was then incubated with RNase A/T1 for 30 minutes at 37 
°C. The samples were then treated with proteinase K (2 μl proteinase K, 10 
μl 0.5 M EDTA, 20 μl 1 M Tris-HCl) at 65 °C overnight. The samples were 
then purified using Qiagen PCR MiniElute Kits (Qiagen cat no. 28004) as per 
manufacturer’s instructions. DNA concentrations were then quantified using 
a GE healthcare GeneQuant Pro RNA/DNA Spectrophotmeter (Cat no. 80-




2.3.7 ChIP qPCR 
To quantify the DNA abundance in each ChIP sample, real-time PCR with 
LightCyclerTM SYBR green I Master Mix (Roche cat no. 04707516001) was 
used. 10 μl reactions were analysed for each sample with 0.4 μM of each 
primer in technical triplicates. A lightcycler 480 system was used to perform 
the PCR with 45 cycle amplification reactions as per SYBR green I Master 
Mix manufacture instructions (95 °C for 3 minutes, 45 × 95 °C for 15 s, 58 °C 
for 15 s, and 72 °C for 30 s). Melting curves were observed to ensure single 
annealing steps for each primer, with PCR products checked by 2% agarose 
gel electrophoresis. Ct values were used to determine amplification 
compared to input for each sample and antibody, using the ΔΔCt method.  
 
2.3.8 Sanger sequencing DNA 
Sanger sequencing of plasmids to check sequences were performed by the 
MRC HGU Technical Services using standard methods. BigDye (Thermo 
Fisher cat no. 4337455) was used in terminator sequencing reactions on an 









2.3.9 Nuclei preparation 
To isolate nuclei for downstream experiments, Cereghini and Yaniv's, (1984) 
method was modified. Cells were washed with PBS before Trypsin/EDTA 
(Invitrogen cat no. 59427) was used to detach them for harvest. Trypsin was 
inhibited by adding 10 ml of 10% FCS/PBS to each sample. Samples were 
centrifuged at 1200 rpm for 3 minutes, and the pellet resuspended by pipette 
in 1 ml of NBA buffer (85 mM KCl, 5.5% sucrose, 10 mM Tris-HCl pH 7.6, 0.5  
mM spermidine, 0.2 mM EDTA, and 250 μl PMSF) on ice. A further 4 ml of 
NBA buffer was then added. 5 ml of NBB buffer (NBA + Δ% NP-40) was 
added to each sample on ice for 4 minutes. The nuclei were quickly pelleted 
by centrifugation 2000 rpm for 4 minutes, to prevent lysis of the nuclei. The 
nuclei pellet was resuspended in 10 ml of NBR2 buffer (85 mM KCl, 5.5%  
sucrose, 10 mM Tris-HCl pH 7.6, 1 mM CaCl2, 1 mM MgCl2, and 250μl 
PMSF)  and quickly pelleted again by 2000 rpm for 4 minutes. The nuclei 
pellet was then resuspended in 500 μl NB.R2 buffer.   
 
5 μl aliquot of each sample was then added to 95 μl NBR2 and 1 μl DNaseI 
for 4 minutes at room temperature. 400 μl of 5 M Urea / 2 M NaCl was 
added to each sample and quantified on a GeneQuant Pro 
spectrophotometer at 260 nm. Nuclei samples were normalised to 20 A260 








2.3.10 Southern Blotting 
DNA was transferred from 0.7% agarose TPE gels to Hybond N+ membranes 
(GE Life Sciences cat no. 25005990) as first described by Southern, (1975). 
Agarose gels containing DNA were first exposed to UV light from a 
transilluminator for 3 minutes to cause double strand breaks and trimmed to 
size using a razor blade. Gels were incubated in 250 ml 0.25 M HCl for 20 
minutes shaking at room temperature to depurinate the DNA. The gel was 
washed twice with 250 ml H20 to remove residual HCl and incubated twice 
with 250 ml denaturing buffer (1.5M NaCl, 0.5M NaOH) for 15 minutes at 
room temperature shaking. Once the denaturation buffer was removed and 
the gel rinsed with H2O, gels were twice soaked in 250 ml neutralisation 
buffer (1.5 M NaCl, 0.5 M Tris-HCl). Upward capillary transfer was used to 
transfer DNA from the gel to the Hybond N+ membrane using 20 × SSC 
solution overnight at room temperature. The Hybond N+ membrane was 
rinsed in 2 × SSC solution and exposed to UV on a transilluminator to 
immobilise the DNA. 
 
[α-32P] dCTP radiolabelled probes were then hybridised to the Hybond N+ 
membrane. Each membrane was incubated in 15 ml of hybridisation buffer (6 
× SSC, 10 mM EDTA, 5 × Denhardt’s solution (Thermo Fisher cat no. 750018), 
0.5% SDS, 100 µg/ml salmon sperm DNA) for 30 minutes. Radiolabelled 
probe was then added to the hybridisation solution and incubated at 65°C 
overnight. Membranes were washed twice with 2 × SSC 0.1% SDS for 15 
minutes at 65°C followed by two washes with 0.1 × SSC 0.1% SDS at 65°C for 
15 minutes. Hybridised radiolabelled probes were then detected in 
autoradiography cassettes with phosphorimager screens overnight and 
analysed. 
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2.4 RNA methods 
 
2.4.1 RNA purification 
Total RNA was isolated from mammalian cell cultures using Qiagen’s 
Rneasy Mini Kit (Qiagen cat no. 74104). Cells were washed with PBS, 
harvested by trypsinisation and counted using a Beckman Coulter Counter. 
More than 1 × 107 cells were pelleted per sample. Cell pellets were 
resuspended in 350-600 μl of RLT buffer with 1% β-mercaptoethanol 
depending on cell number. An equal volume of 70% ethanol was then added 
to the samples and mixed by pipetting.  
 
Samples were transferred to Rneasy mini spin column and centrifuged at 
12,000 g for 30 s. 10 μl of DnaseI was mixed with 70 μl of RDD buffer 
(Qiagen  RNase-Free Dnase Set ; Cat no. 79254) and added to each column 
for 15 minutes at room temperature, for on column DNase digestion. RNA 
was eluted from the column in 50 μl of RNase-free water, quantified on a 







2.4.2 cDNA library synthesis 
Complementary DNA to first strand RNA was synthesised using SuperScript 
II Reverse Transcriptase (Invitrogen cat no. 18064-022). 1 μg of purified 
RNA was added to 250 ng of random hexamers, and 10 mM dNTP mix in 
RNase free water. Samples were the incubated at 65 °C for 5 minutes to melt 
secondary RNA conformations and quickly cooled on ice. SuperScript II 
buffer was added to each sample (1 × final conc First Strand Buffer, 0.1M 
DTT). Samples were gently mixed and incubated at 25 °C for 2 minutes. 200 
units of SuperScript II reverse transcriptase was added into each sample and 
incubated at 25 °C for 10 minutes, followed by 42 °C for 50 minutes. 
Reactions were stopped by denaturation at 70 °C for 15 minutes. 
 
2.4.3 Quantitative real time PCR 
To evaluate the relative abundance of complementary DNA sequences 
indicative of relative gene expression, real time PCR was used. Lightcycler 
480 SYBR Green I Master Mix (Roche cat no. 04707516001) was as described 








2.4.4 EU-RNA dot blotting 
Mouse ESCs were incubated with 1 mM ethynyl uridine (EU) overnight at 37 
°C 5% CO2. Cells were rinsed 3 × with CSK buffer (100 mM NaCl, 0.1% Triton 
X-100, 300 mM sucrose, 1 mM MgCl2, 1 mM EGTA, 10 mM PIPES and 100 μ
M PMSF) at room temperature for 5 minutes. Cells were then trypsinised and 
centrifuged at 1200 rpm for 5 minutes. mESC nuclei were isolated using NBA 
and NBbB buffers (Section 2.3.7). RNA was purified using Qiagens Rnasey 
kit (Section 2.4.1).  
 
18 μl of RNA was added to an in vitro click reaction mix (3 μl TEA pH 7, 30  
μl DMSO, 6 μl ascorbic acid, 1.2 μl biotin-azide (Thermo Fisher cat no. 
B10184), 3 μl 10 mM Cu-TBTA, and vortexed to ensure complete mixing. 
Samples were left overnight at room temperature for the click reaction to 
complete. RNA was precipitated using 150 μl of ethanol and 0.3 M sodium 
acetate pH 5.5 and 20 μg of glycogen at -20 °C for 2 hours. Centrifugation at 
12,000 rpm for 30 minutes was used to pellet the RNA and samples were 
washed in 500 μl 70% ethanol. Samples were pelleted again and left to air 
dry to remove residual ethanol at room temperature. Samples were 
resuspended in 20 μl TE and the absorbance measured using a nanodrop 
1000 UV-VIS spectrometer. 
 
Nitrocellulose membranes were hydrated in water for 5 minutes followed by 
20 × SSC for 20 minutes at room temperature. Excess 20 × SSC buffer was 
absorbed using filter paper and 2 × 1 μl of RNA TE was then spotted and 
dried at room temperature. The RNA was crosslinked to the membrane with 
200 mJ of UV radiation and baked at 70 °C for 30 minutes. 
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The crosslinked membranes were then blocked with 50 ml of 3% BSA (w/v) 
in buffer 1 (0.5 M Tris, 0.15 M NaCl) at 60 °C for 30 minutes. For biotin 
detection membranes were incubated with Streptavidin-HRP (Thermo Fisher 
cat no. 89880D) at 1:1000 dilution for 2 hours rotating at room temperature. 
Membranes were washed twice with buffer 1 for 15 minutes with shaking to 
remove any unbound streptavidin-HRP molecules. Membranes were then 
developed with enhanced chemiluminescence detection kit (Pierce cat no. 
32106) for 1 minute at room temperature before exposure to Hyperfilm ECL 




















2.5 Protein analysis 
 
2.5.1 Protein lysate preparation 
Proteins were extracted from mammalian cell cultures by detergent mediated 
cell lysis. Cells were typically grown in T75 flasks or 6 cm dishes to 75% 
(max) density. Cells were washed with PBS and recovered by trypsinisation 
(Invitrogen cat no. 59427C). Non-adherent cells were collected and lysed 
with NuPage LDS sample buffer (Invitrogen cat no. NP0007) with 12.5 mM 
DTT as per manufacturer’s instructions. Samples were incubated at 70 °C for 
10 minutes before being stored at -20 °C. 
 
2.5.2 SDS-PAGE 
Nupage Novex precast gels were used to resolve protein lysates. Nuclear 
lysates were centrifuged at 12,000 g for 1-2 minutes to pellet any large 
cellular fragments. 10-20 μg was loaded per well on 4-12% gradient 
(Invitrogen cat no. NP0322BOX) or 10% (Invitrogen cat no. NP0315BOX) Bis-
Tris gels. 4 μl of SeeBlue Plus2 prestained protein standard (Invitrogen cat 
no. LC5925) was run to determine molecular weights. For low molecular 
weight proteins such as histones, 1 × Nupage MES running buffer 
(Invitrogen cat no. NP0002) was used, while 1 × Nupage MOPS running 
buffer (Invitrogen cat no. NP0001) was used for high molecular weight 
proteins (>80 kDa). Proteins were resolved at 150 V for 50 minutes with MES 
buffer, and 80 minutes with MOPS running buffer. 
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2.5.3 Western blotting 
Nuclear protein lysates resolved by SDS-PAGE electrophoresis were 
transferred to Immobilon-P polyvinylindine flouride (PVDF) membranes 
(Millipore cat no. IPVA00010). ‘Wet’ transfers were performed using the X 
Cell 11 Blot Module (Invitrogen cat no. EI9051). Blotting pads and filter 
paper were submerged in 1 × Nupage transfer solution (Invitrogen cat no. 
NP0006) supplemented with 20% methanol, 1% antioxidant (Invitrogen cat 
no. NP0005) and any air bubbles removed. PVDF membrane was cut to size 
and hydrated in 100% methanol before being soaked in transfer solution. 
Protein transfer was performed at 30 V for 60 minutes. 
 
The protein bound PVDF membrane was incubated in 5% milk powder TBS-
T buffer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20) for 30 
minutes shaking at room temperature. PVDF membranes were washed with 
TBS-T for 10 minutes at room temperature. Membranes were then incubated 
with primary antibodies in 5% milk PBS-T overnight at 4 °C. 
 
Primary antibody was removed and the membrane washed 3 × with TBS-T 
shaking at room temperature for 5-10 minutes. Antibody species specific 
conjugated horseradish peroxidase (HRP) secondary antibodies were diluted 
in 5% milk TBS-T and added to the membranes while shaking at room 
temperature for 1 hour. Membranes were briefly washed in TBS-T and 
incubated with an enhanced chemiluminescence detection kit (Pierce cat no. 
32106) for 1 minute at room temperature. Membranes were place between 
acetate sheets and exposed to Hyperfilm ECL (GE lifesciences cat no. 
28906837) and developed on a Konika SRX-101A processor. Films were 
scanned and densitometry performed on the required bands using ImageJ or 
AIDA image analysis software with background correction. 
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2.6 Cell Culture 
 
2.6.1 Cell lines 
Cell lines used were murine erthroleukeamia cells (Chapter 3), HCT116 cells 
and matched trametinib resistant TRAMR cells (Chapter 4), murine 3T3 
fibroblasts, and mouse embryonic stem cells wild type (WT41) and Suv39h 
double null clones (DN57, DN72) (Chapter 5).  
 
MEL cells with various GFP constructs inserted at the RL5 locus were 
obtained from the Larionov lab. p212 MEL cells lacked any heterochromatic 
sequences within the transgene, while RL5 MEL cells lacked the GFP 
construct entirely. α-MEL cells contained a human alpha satellite domain 
upstream of the GFP enhancers and promoter (Figure 3.1, A). HCT116 cells 
and matched trametinib resistant TRAMR (derived from HCT116) cells were 
obtained from John Dawson, who initially characterised the cellular 








2.6.2 Adherent cell growth and passaging 
HCT116, TRAMR and 3T3 cells were typically cultured in T75 flasks with 15 
ml of Dulbecco’s Modified Eagle Medium F12 (Gibco cat no. 12500-062) 
supplemented with 10% fetal calf serum, 1% penicillin/streptomycin and 1% 
L-glutamine. Cells were grown in 5% CO2 at 37 °C in a humidified cell 
culture incubator. When confluent (> 70% coverage) cells were passaged by 
washing with PBS and treated with trypsin/EDTA (Gibco cat no. 5400054) 
and split 1:7 to 1:10 every 2-3 days. 
 
2.6.3 Suspension cell growth and passage 
MEL cells were also cultured in T75 flasks with 20-30 ml high glucose 
Dulbecco’s modified eagle medium with L-glutamine (Gibco cat no. 
11965084) supplemented with 10% fetal calf serum (FCS) and 1% 
penicillin/streptomycin. Cells were grown at 5% CO2, 37 °C and split 1:10 to 










2.6.4 mESC cell growth and passage 
Mouse embryonic stem cells were only grown with low passage numbers 
(<50). WT41, DN57, and DN72 cell lines were cultured in Glasgow Minimal 
Essential Medium (Gibco cat no. 11710035) supplemented with 10% fetal calf 
serum, 0.1 mM β -mercaptoethanol, 1% penicillin/streptomycin, 1% L-
glutamine, 1 mM sodium pyruvate, non-essential amino acids (Sigma cat no. 
M7145), and 1000 U/ml of human recombinant LIF (prepared in MRC HGU). 
mESC flasks (Corning cat no. 430639) were pre-treated with 0.1% gelatin/PBS 
for 5 minutes. The excess gelatin was removed and 5 ml of mESC media was 
added to prevent the gelatin layer drying out. mESCs suspended in 20 ml of 
media were added to each flask.  
 
2.6.5 Freezing cells 
For cell storage, >80% confluent cell flasks were washed with PBS, incubated 
with typsin/EDTA (Gibco cat no. 5400054) for 5 minutes, collected by 
centrifugation at 1200 rpm for 5 minutes. Cells were resuspended in 1-2ml 
freezing media (50% fetal calf serum, 10% DMSO, 40% ES cell growth 
media). 500 μl aliquots were frozen at -80°C and transferred to liquid 





2.6.6 Thawing cells 
Cell lines retrieved from liquid nitrogen or -80°C storage were kept on dry 
ice before being rapidly thawed at 37 °C in a water bath. Once thawed the 
contents was added to 10 ml of normal growth media pre-warmed to 37 °C 
and centrifuged at 1200 rpm for 5 min. Cell pellets were resuspended in 15 
ml of growth medium in a T75 flask stored at 5% CO2 and 37 °C. After 12-24 
hours flasks were rinsed with PBS and 15 ml fresh growth media added. 
Media was replaced every 1-2 days and cells passaged every 72 hours or 
whenever mESC colonies were enlarged. 
 
2.6.7 Stable mammalian cell transfection 
Mouse embryonic stem cells were seeded at 50,000 cells/ml on 0.1% gelatin 
coated 6-well plates overnight at 37 °C in antibiotic free growth media. 1 μg 
of the vector construct was incubated with 200 μl of Opti-MEM (Gibco cat 
no. 31985070) for 10 minutes, whilst 5 μl lipofectamine 2000 (Invitrogen cat 
no. 11668019) was added to a separate 200 μl Opti-MEM aliquot per 
transfection. The pre-mixed lipofectamine 2000 and DNA constructs were 
mixed by inversion and incubated at room temperature for 30 minutes. This 
mix was then added to 2 ml of fresh antibiotic free media and used to refresh 
the media on a mESC culture. mESC’s were then grown with appropriate 
antibiotic (Zeocin) prior to experiments. 
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2.6.8 Generating drug resistant cell lines 
Cells were initially treated with log dose curves of JQ1 for 5 days and 
viability determined by PrestoBlue reagent (Invitrogen cat no. A13261). Cells 
were seeded at 10,000 cells/ml in 96 well plates with 200 μl of media in each 
well. Cells were left over night to adhere to the well bottom, and the media 
was then aspirated and replaced with JQ1 containing media for 4 days. The 
media was removed and fresh media with 10% PrestoBlue (v/v) was added 
to each well for 90 minutes. 540/590 nm fluorescence was assayed on a 
PerkinElmer Victor3 multilabel reader.  
 
The concentration of JQ1 that inhibited growth by 50% (195 nM) was then 
added to the growth media for two weeks. Cell viability in response to a log 
dose concentration of JQ1 was then reanalysed with PrestoBlue reagent, and 
the JQ1 dose adjusted for the next two-week period. After ~3 months cells 
could tolerate 1 μM JQ1 treatment and were considered resistant. JQ1 was 
then removed from the growth media and viability re-analysed after two 
weeks. Cells presented no loss of resistance to JQ1 demonstrating a 
permanent state of resistance. Cells were periodically retested to check JQ1 







To analyse the cellular distribution of proteins and their modifications cells 
were immunostained with appropriate antibodies. Cells were seeded on 
Superfrost plus slides (Thermo Fisher cat no. J1800AMNZ), pre-coated in 
0.1% gelatin for mESC’s, for 6-8 hours at 37 °C 5% CO2 in chambers with 5 ml 
of growth media.  
 
To observe chromatin bound protein distribution slides were treated with 
CSK buffer (100 mM NaCl, 0.1% Triton X-100, 300 mM sucrose, 1 mM MgCl2, 
1 mM EGTA, 10 mM PIPES and 100 μM PMSF) for 10 minutes on ice.  
 
Slides were carefully washed with PBS to prevent loss of adherent cells and 
fixed with 4% paraformaldehyde (Sigma cat no. 158127) for 10 minutes at 
room temperature. Slides were carefully removed and submerged in PBS 
twice to remove any residual paraformaldehyde and permeabilised in 0.5% 
Triton X-100 (Sigma cat no. T8787) for 10 minutes at room temperature. 
 
Slides were then blocked in 5% donkey serum in PBS for 30 minutes at room 
temperature. Primary antibodies were then added to the slides diluted in 5% 
donkey serum and incubated for 1 hour at room temperature in a dark 
humidified chamber. Slides were washed 3 × in PBS/ 0.02% Tween-20 5 
minutes each at room temperature. Fluorophore conjugated secondary 
antibodies (Jackson Immuno Research) were incubated on the slides for 1 
hour at room temperature in a dark humidified chamber, diluted 1:500 with 
5% donkey serum/PBS. Slides were kept in the dark and washed carefully 3 × 
with PBS 0.02% Tween-20 for 5 minutes at room temperature. For nuclei 
staining the final wash was supplemented with 50 μg/ml of DAPI at room 
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temperature. Slides were mounted in Vector Shield (Vector Laboratories cat 
no. H-1000). Standard and deconvolution epifluorescent microscopes using 
63x or 100x plan-APOCHROMAT (1.4 NA) objectives were used to image 






















2.6.10 Chromatin bound protein distribution analysis 
To determine chromatin bound protein distribution, samples were washed 
with CSK buffer prior to fixation and imaged on a deconvolution 
epifluorescent microscopes as stated above (Section 2.6.8). Image stacks were 
initially deconvolved on iVision software per standard protocols. Image 
stacks were then transferred to ImageJ. A macro in Javascript was written to 
split the channels, identify the single plane for analysis, restack the channels 
for the plane of interest, and save the stack. 
 
A second macro was written to use edge segmentation to make a mask of the 
DAPI channel. The DAPI channel was first applied with a rolling ball 
background subtraction, unsharpen mask to rescale the contrast to the 
original image, and processed with a gaussian blur to smooth the image 
further. The image was then made binary with a black background. The 
classic watershed function was applied to edge segment the image and 
particles under 500 pixels excluded. This created the region of interests (ROI) 
around each nucleus in each image. This mask was then applied to the FITC 
channel, where the area mean integrated intensity for each pixel was 
calculated within the ROI, determining the radial pixel intensity and 
exported to excel.  
 
Each radial pixel number was divided by the max radial pixel number per 
ROI and multiplied by 100 to turn pixel number in percentage distribution. 
This enabled the data of multiple cells to be binned together into radial decile 
pixel intensities, which were then plotted by box plot.     
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2.6.11 Cell cycle analysis with propidium iodide 
Propidium Iodide (PI) is a DNA intercalator that has 20 times the 
fluorescence when bound to DNA (Wilson et al., 1986). As DNA content 
changes as a cell progresses throughout the cell cycle, PI staining was used to 
investigate cell cycle dynamics. Cell cultures were first washed with PBS and 
harvested by trypsinisation. Cells were centrifuged at 1200 rpm for 5 
minutes, resuspended in PBS and counted using a Z2 Coulter counter. Cell 
counts were normalised to 1.5 × 106 cells/ml and 2.5 × volume of 100% 
ethanol was pipetted dropwise while samples were vortexed. Cells were 
incubated on ice for >2 hours to allow fixation, centrifuged at 2000 rpm for 5 
minutes at room temperature and resuspended in PBS. Samples were then 
recentrifuged and cells resuspended in propidium iodide staining solution (1 
μg/ml PI, 4 μg/ml RNase A, PBS) at a count of 2.5 × 106 cells/ml for 2 hours 
at room temperature. 
 
Flow cytometry was used to measure PI staining on a BD LSR Fortessa cell 
analyser. Filters limited fluorescence detection to 695-740 nm. Data analysis 










2.7 Radioactive nucleotide labelling 
 
2.7.1 DNA probe labelling 
25 ng of oligomers or DNA molecular ladders in 11 μl DNase free water 
were boiled for 5 minutes and placed on ice to cool. 4 μl of High Prime Kit 
(Roche cat no. 11585584001) supplemented with 125 mM dATP, dGTP, and 
dTTP was added to each sample as per manufacturer instructions. 5 μl of [
α-32P] dCTP 3000 Ci/mmol was also added and incubated at 37 °C for 30 
minutes. 80 μ l of DNase free water was added to each sample and 
transferred to a G-25 sephadex spin column (Roche cat no. 27532501). 
 
2.7.2 Unincorporated label removal 
Unincorporated free nucleotides dATP, dGTP, dTTP and [α-32P] dCTP were 
removed from DNA probes by passing through sephadex G-25. Columns 
were prepared by vortexing and then the cap loosened ¼ turn and 
centrifuged >700 g for 1 minute. 100 μl of radiolabelled samples were then 
carefully transferred to the column without disturbing the G-25 grade F 
resin. Samples were then centrifuged >700 g for 2 minutes at room 
temperature. The [α-32P] dCTP labelled DNA was recovered in the eluate 






2.7.3 RNA metabolic labelling 
Cells were grown in T75 flasks to 60% confluency and treated with JQ1 1 μ
M for 24 hours. 5 μl/ml of 1 mCi [5-3H] Uridine (Perkin Elmer cat no. 
NET174250UC) was added to the culture media for 30 minutes at 37 °C 5% 
CO2. Media was aspirated from the cells and washed with PBS. Cells were 
trypsinised, collected and washed again with PBS. RNA was extracted from 
the cells using the RNeasy Mini Kit as previously described (Section 2.4.1). 
Samples were quantified on a nanodrop 1000 UV-VIS spectrometer 260 nm 
absorbance and 5 μl of each sample was then added to 4 ml of scintillant. 
Radiation from the tritiated RNA causes the scintillant to fluoresce allowing 
the quantity to be analysed using a Beckman LS 6500 scintillation counter. 
















2.8 Chromatin analysis 
 
2.8.1 Chromatin fibre extraction 
In order to release chromatin fibres from isolated nuclei, chromatin was 
partially digested with micrococcal nuclease (Mnase). Nuclei at 20 A260 in 
NBR2 buffer were incubated with RNase A/T1 (Ambion cat no. EN0551) for 2 
minutes at room temperature. Each sample was then digested with 400 
units/ml of MNase for 8 minutes at room temperature. 125 mM glycine final 
concentration was used to stop the MNase digestion, and samples were 
quickly pelleted at 12,000 g for 1 minute and resuspended in 500 μl TEEP-20 
or TEEP-80 buffer at 4°C overnight. Samples were centrifuged at 12,000 g for 
5 minutes at room temperature to remove nuclear fragments from the 
supernatant.  
 
Samples fixed with 1% formaldehyde for 10 minutes before or after MNase 
digestion, were released into TEEP-20 (+/- 0.5% SDS) and transferred to 
Visking tubing. The samples were then dialysed in 5 litres TEEP-80 or TEEP-






2.8.2 Chromatin purification – Sucrose step Gradients 
Chromatin fibres and chromatin bound proteins can be isolated from nuclear 
components by centrifugation onto a TEEP-80 50% sucrose boundary as 
described in Gilbert, et al, (2007). A 1.5 ml layer of 50% sucrose TEEP-80 was 
added to a SW55 Beckman tube. 10% sucrose TEEP-80 was then slowly 
layered on without mixing, resulting in a boundary between the 10-50% 
sucrose. Chromatin samples released from nuclei were loaded on the 10% 
TEEP-80 and centrifuged 48,000 rpm for 90 minutes. 60% sucrose TEEP-80 
was pumped in the bottom of the centrifuge tubes, using upward 
displacement to fractionate the gradient into 500 μl aliquots. DNA from 
chromatin containing fractions was then purified by phenol chloroform 
extraction. 
 
2.8.3 Isokinetic sucrose gradient fractionation 
Sucrose density centrifugation is a technique used to fractionate 
macromolecules that has been adapted to distinguish between chromatin 
states (Brakke, 1953; Gilbert, Thomson, Boyle, Allan, Ramsahoye and Wendy 
A Bickmore, 2007). Micrococcal nuclease released chromatin fibres were 
resolved in 6-40% isokinetic sucrose TEEP gradient centrifugation in 
Beckmann SW41 tubes. 6% sucrose TEEP ΔNaCl was mixed with 40% 
sucrose TEEP ΔNaCl solution at room temperature in a constant volume 
mixing chamber and loaded bottom up as first described by Noll, (1967). 
Gradients were then left overnight at 4 °C to settle. 0.5 cm was left free at the 
top of each SW41 tube sucrose gradient, and 500 μl of soluble chromatin 
was loaded. Samples were centrifuged in a Beckman ultracentrifuge using a 
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SW41 Ti swinging bucket rotor at 41,000 rpm, 4 °C for 4.5 hours. Gradients 
were fractionated using upward displacement with 50% sucrose TEEP-80 
and samples were passed through an inline UV spectrometer and collected in 
500 μl aliquots. The UV absorbance was used to detect which fractions 
contained chromatin fibres, which were then purified by phenol chloroform. 
DNA samples were fractionated on 0.7% agarose TPE gels.  
 
2.8.4 Micrococcal Nuclease accessibility digestion 
To assess micrococcal nuclease accessibility, isolated nuclei (Section 2.3.7) 
were diluted to 4 A260 (200 μg/ml) in NBR2 buffer. Samples were incubated 
with 1 μl of RNase A/T1 for 2 minutes at room temperature. 800 units/ml of 
micrococcal nuclease was then added to the samples at room temperature. At 
1, 2, 4, 8, and 16 minutes aliquots were added to EDTA to stop the MNase 
digestion. Each time point sample was then added to genomic lysis buffer 1 × 
final concentration and incubated with 1 μl proteinase K at 55 °C overnight. 
Samples were phenol chloroform purified and ethanol precipitated before 











2.9 Reverse phase protein arrays 
 
α-MEL cells were treated with 0.1% DMSO, 1 μM IBET151 for 24 hours in 
normal cell culture conditions. Cells were washed in PBS, trypsinised and 
resuspended in MD anderson buffer (1% Triton X-100, 50 mM HEPES, 150 
mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 199 mM NaF, 10 mM Na 
pyrophosphate, 1 mM Na3VO4, 10% glycerol, phosphatase inhibitor cocktail -
Roche cat no. 04 906 845 001) for 30 minutes at room temperature with 
intermittent vortexing.  
 
Protein concentrations were analysed by Coomassie Plus staining (Pierce cat 
no. 23236). A BSA serial dilution was used as a standard (0, 0.05, 0.1, 0.15, 0.2, 
0.3, 0.4, and 0.6 mg/ml). 2.5 μl of each sample were diluted 1:20 to 50 μl and 
transferred to opaque 96 well plates in addition to 10 μl of standards. 240 μl 
of Coomassie Plus reagent was added to each well for 30 s while shaking and 
further incubated at room temperature for 10 minutes. 595 nm filter 
microplate reader was then used to measure absorbance. Lysates were 
normalised to 1 mg/ml and 150 μl aliquots transferred to fresh tubes.  
 
50 μl of 4x SDS buffer was then added to each sample (40% glycerol v/v, 8% 
SDS v/v, 0.25 M Tris-HCl pH 6.8, 5 mM β-mercaptoethanol). Samples were 
incubated at 80 °C for 5 minutes and rapidly cooled by 15 s max speed 
centrifugation. Samples were then transferred to a 96 well plate in duplicate. 
Samples were half log serial diluted with MD Anderson lysis buffer (1% 
Triton X-100, 50 mM HEPES, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 199 
mM NaF, 10mM Na pyrophosphate, 1 mM Na3VO4, 10% glycerol, 
phosphatase inhibitor cocktail -Roche cat no. 04 906 845 001) supplemented 
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with 1 × SDS buffer (2% SDS, 62.5 mM Tris-HCl pH 6.8, 1.25 mM β-
mercaptoethanol). Samples were spotted onto arrays at 70% humidity using 
an Aushon 2470 microarray printing platform and samples were left at room 
temperature 70% humidity for 2 hours to allow the samples to dry. Once the 
arrays were removed from the printing platform, they were incubated with 
SuperBlock TBS (Pierce cat no. 37535) for 4 hours at room temperature on a 
rocker. 
 
Each array was placed in ArrayIt hybridisation cassettes and rinsed 3 × with 
130 μl TBS-T, followed by incubation with TBS-T at room temperature for 10 
minutes. Primary antibodies diluted in SuperBlock were added to the array 
cassettes and incubated overnight at 4 °C with rocking. The cassettes were 
rinsed 3 × with TBS-T and incubated 3 × with TBS-T for 10 minutes. 
Secondary antibodies and IgG control were incubated in the array cassettes 
for 1 hour at room temperature in the dark. The array cassettes were then 
further rinsed 3 × with TBS-T and submerged in 50 ml of dH2O. The arrays 
were then spun at 200 g for 5 minutes to remove any residual water and left 
overnight in the dark at room temperature. Arrays were imaged on an 










Sample spotting concentrations were quality controlled and normalised for 
analysis using fast green staining. Arrays were first washed in 50 ml dH2O 
for 5 minutes at room temperature before incubation with 0.25 M sodium 
hydroxide for 15 minutes and washed 3 × in dH2O for 10 minutes at room 
temperature. Arrays were then incubated in destain solution (30% methanol, 
7% glacial acetic acid, dH2O) for 15 minutes at room temperature. Arrays 
were incubated with 1x Fast Green destain solution (250 μg Fast Green FCF 
(Sigma cat no. F7252), 30% methanol, 7% glacial acetic acid, dH2O) for 3 
minutes at room temperature with shaking. Arrays were submerged 3 × in 50 
ml dH2O and centrifuged at 200 g for 5 minutes to remove residual water. 



















2.10 Compound screening 
 
2.10.1 FACS screening 
MEL cells were washed with PBS and concentration analysed by a Coulter 
counter. Cell concentrations were normalised to 333,000 cells per ml in fresh 
media and 300 μl added to each well of a 96 well plate resulting in 100,000 
cells per well.  Cells were incubated at 37 °C in 5% CO2 for 6 hours before 
compounds were added. 
 
Compounds were first diluted to 1000 × final concentration in DMSO (1 mM 
unless stated otherwise) in V-bottomed 96 well plates in the required final 
layout. Plates were sealed and kept at 4 °C in the dark for replicate use. 
 
The 1000 × final concentration (1 mM) compounds were then diluted 100 × in 
fresh growth media in an intermediary 96 well plate. 33 μl of the 10 × probe 
compounds were added to 300 μl of MEL cell growth media in each well. 
Cells were incubated for 48 hours at 37 °C in 5% CO2 before being pelleted at 
1200 rpm for 5 minutes and resuspended in 100 μl ice cold PBS. Cells were 
kept on ice and immediately analysed on a BD FACSAria flow cytometer 
analyser. Samples were initially gated on side scatter height and area to 
ensure only single cells were analysed. Forward scatter and side scatter area 
was gated to remove cellular debris. GFP transgene expression was 
determined by 488 nm excitation and 525-550 nm emission filters. RFP 
expression was determined by 561 nm excitation and 610-620 nm emission 
filters. 
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2.10.2 IncuCyte growth screening 
MEL cells with GFP and RFP expression constructs were quantified on a 
coulter counter. Cells were seeded in clear-bottomed 96 well plates at 50,000  
cells/ml in 180 μ l of prewarmed growth media. Each well was 
supplemented with 20 μl of 2 mg/ml of Corning matrigel (Cat no. 354263), 
previously stored at 4 °C was added to each well of 96 well plates. Plates 
were inserted into an IncuCyte Zoom microscope at 37 °C and 5% CO2. 
 
Matrigel is the base components from Engelbreth-Holm-Swarm mouse 
sarcoma extracellular membrane extract (Laminin, Collagen IV, Heparin 
sulfate proteoglycans, entactin/nidogen).  As the matrigel warms to 37 °C it 
solidifies to form a hydrogel preventing the MEL cells from moving between 
focal planes allowing live cell imaging. The IncuCyte Zoom was used to 
image bright field, GFP and RFP every 6 hours for the length of the 
experiment. Four 10 × images were taken per well per time and collated. 
 
Probe compounds were then prepared as 10 × final concentrations in fresh 
growth media as described for FACS screening (Section 2.10.1). After 12 
hours at 37 °C, 22 μl of 10x concentration probe compounds were then 
added to each well. Cells were grown at 37 °C in 5% CO2 and imaged every 6 
hours up to 84 hours. Quantitative data analysis was performed using the 
IncuCyte Zoom analysis software. Brightfield images were used for edge 
segmentation, with the processing definition adjusted manually for each 
experiment. This mask was then applied to the GFP and RFP channels. The 
mean fluorescent pixel intensity for all cells within each image mask were 
then calculated and exported to excel. At each time point samples were 
compared to untreated DMSO controls. 
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2.10.3 Presto Blue viability assays 
Single agent and drug combinations effects on viability were analysed using 
PrestoBlue reagent (Invitrogen cat no. A13261). Adherent HCT116 and 
TRAMR cells were washed with PBS, trypsinised and concentrations 
adjusted to 10,000 cells/ml of growth media. 200 μl aliquots were added to 
each well and incubated at 37 °C overnight. 
 
Single agent log dose concentrations were first prepared 1000 × final 
concentrations in V-bottomed 96 well plates. 10 mM of each compound was 
serial diluted to 100 μM in DMSO. Trametinib was also serial diluted from 
300 μM to 100 nM. Each drug concentration was added in separate wells to 
every concentration of the other drug, reducing the concentration of each 
drug 2-fold. An equal volume of DMSO was therefore added to each single 
agent drug dose range to halve the concentration. 
 
Drug matrix intermediary plates were diluted 50-fold in fresh growth media. 
22 μl was added to each well of a 96 well flat bottomed plate containing cells 
incubated overnight. Cell were then incubated for 48 hours at 37°C in 5% 
CO2.  10% (v/v) PrestoBlue reagent was then prepared in fresh growth media. 
Each well was then aspirated and replaced with 200 μl of 10% PrestoBlue 
growth media, and incubated for 90 minutes. A Victor3 multilabel plate 
reader was then used to detect 540/590 nm fluorescence. 
 
Readings were normalised to DMSO control readings producing relative 
changes to cell growth. 3D plots of relative cell growth across the 
combination and antagonism/synergism analysis was performed using the 
combenefit platform (Di Veroli et al., 2016). Combination matrices were 
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analysed in parallel using Loewe’s model, the Bliss model and the Highest 
Single Agent (HSA) model. Synergy, antagonisms or neutrality modelling 
was similar across all three models, so HSA model was used across all 























2.11 Copper assisted azide-alkyne 
cycloaddition 
 
2.11.1 Single nucleotide HPLC-UV spectrometry 
Cells were washed in PBS, trypsinised and resuspended in genomic lysis 
buffer (150 mM NaCl, 1% SDS, 10 mM EDTA). Samples were then incubated 
with 10 μl/ml proteinase K and incubated at 55 °C overnight shaking at 500  
rpm. An equal volume of phenol chlorofom:IAA was then added to each 
sample and centrifuged at 12,000 rpm for 30 minutes at 4 °C. The aqueous 
phase was then transferred to a fresh tube and retreated with an equal 
volume of chloroform in the same fashion. The aqueous phase was added to 
2.5 × volume of 100% ethanol and 0.3 M sodium acetate pH 5.5 at -20 °C for 2 
hours. Samples were precipitated and collected by 12,000 rpm centrifugation 
for 15 minutes. The supernatant was then removed and the samples air-dried 
at room temperature. Samples were resuspended in 400 μl TE and 6 μl 
RNase A/T1 added at 37 °C overnight. 
 
Samples were again precipitated with 2.5 × volume of 100% ethanol and 0.3 
M sodium acetate pH 5.5 at -20 °C for 2 hours. Samples were pelleted and 
allowed to air dry, before being suspended in 400 μl TE. 6 μl RNase A/T1 
was again added at 37 °C for 6 hours. Samples were re-precipitated by the 
same method described and resuspended in 25 μl of TE. 3 μl of DNaseI and 
10 × reaction buffer were added to each sample and incubated overnight at 
37 °C shaking at 500 rpm. Zinc sulphate and sodium acetate were added to 
each sample at 1 mM and 30 mM final concentrations respectively. 3 μl of 
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nuclease P1 and 48 μl TE was also added and samples were incubated for 6 
hours at 37 °C. Samples were then centrifuged at 12,000 rpm for 5 minutes 
and transferred to fresh tubes before loading onto the HPLC column. Bernie 
Ramsahoye ran samples on the HPLC-UV spectrometer. 
 
2.11.2 Single nucleotide HPLC-MS-MS 
Single nucleotide solution was prepared following the same protocol as 
HPLC-UV analysis (Section 2.11.1). Cells were lysed in genomic lysis buffer, 
and the nucleic acids isolated by phenol chloroform:IAA extraction. RNA 
was then digested by RNase A/T1 and centrifugation used to purify DNA 
molecule from the mono RNA nucleotides. The DNA was digested to 
mononucleotides by sequential digestions with endo- and exonucleases, 
DNaseI and Nuclease P1. Samples were run on a Thermo Q-Exactive 











2.11.3 Click optimisation coumarin assay 
3T3 cells were resuspended at 50,000 cells/ml and 100 μl added to each well 
of a 96 well plate. Media was supplemented with 20 μM of EdU for 24 
hours, allowing for EdU to be incorporated in DNA during replication. 3-
azido-7-hydroxycoumarin [Coumarin-azide] (Baseclick cat no. BCFA-047-5) 
fluorescence was used to determine the rate of azide-alkyne copper assisted 
cycloaddition. 
 
Cells were incubated with 200-250 mM coumarin-azide with a dose curve of 
each click reaction component in turn, across the 96 well plates. EdU treated 
cells were supplemented with 0.25-1 mM Δmetal (copper sulphate, 
ruthenium, magnesium chloride, and copper bromide), 0.01-1 mM Δ
chelating agents (THPTA, TBTA), and 0.1 mM – 1 M sodium ascorbate. 
 
The plates were imaged using the IncuCyte Zoom, with four 10x images per 
well imaged every 30-60 minutes with brightfield and GFP 400 ms channels 
for up to 72 hours. Images were processed with edge segmentation using 
IncuCyte Zoom software as described before (Section 2.10.2). Total 
integrated intensity values for edge-segmented cells was exported to excel 








To determine if cellular membrane disruption enhanced azide-alkyne copper 
assisted cycloaddition kinetics, cells were treated with optimal click 
conditions supplemented with Triton X-100 or lipofectamine. 3T3 cells 
incubated with 20 μM EdU for 24 hours as described above were treated 
with 250 mM coumarin-azide, 250 mM NaAsc, 250 μM THPTA, with 0.001-
1% Triton X-100 for 6 hours. 500 μM CuSO4 was then added to start the click 
reaction.  
 
To investigate the effect of lipofection on click reaction kinetics, optimal click 
reaction final concentration conditions (250 mM NaAsc, 250 mM Coumarin-
azide, 250 μM THPTA) was made at 2 × concentration in opti-MEM for 10 
minutes at room temperature. Lipofectin, Lipofectamine 2000 and 
Lipofectamine 3000 were separately incubated in an equal volume of opti-
MEM for the same time period at room temperature.  Click reaction opti-
MEM was then mixed 1:1 with lipofectin, lipofectamine 2000 or 3000 and 
incubated on 3T3 cells for 6 hours. 500 μM CuSO4 was then added to each 
well to start the click reaction, and cells were imaged on the IncuCyte Zoom 












2.11.4 Naked DNA in vitro click crosslinking reaction  
E. coli transfected with pUC57-Recon2 was grown in 5 ml of Luria-Burtani 
broth (L-broth) overnight in a shaking incubator (250 rpm). Cultures were 
then supplemented with 5 ml of additional L-broth and 20 μM of EdU for 3 
hours in the shaking incubator. EdU incorporated plasmid was isolated and 
an aliquot digested and analysed by HPLC-UV as described above (Sections: 
2.3.3, 2.11.1). pUC57-Recon2 was then digested with XhoI at 37 °C overnight 
with shaking (500rpm). Optimal live cell click conditions (0.5 mM CuSO4, 
0.25 mM THPTA, NaAsc 250 mM) and 100 mM of PEG-bis-azide ~5000 M.W. 
(Sigma cat no. 689580) were then added to the digested plasmid at room 
temperature for 1-8 hours. Samples were then resolve by 1% agarose TBE 
electrophoresis.  
 
2.11.5 Live cell click crosslinking reaction 
Mouse fibroblast 3T3 cells were incubated with 20 μM EdU and 100 mM 
PEG-bis-azide (~5000 M.W) for 24 hours in normal cell culture conditions. 
Optimal live cell click conditions (0.5 mM CuSO4, 0.25 mM THPTA, 250 mM 
NaAsc) was then added to the growth media for 1 hour at 37 °C in 5% CO2, 
Growth media was then aspirated, and cells were washed in PBS, trypsinised 
and resuspended in NBA for nuclei isolation and chromatin released as 
described previously (Sections: 2.3.7, 2.8.1). MNase released chromatin fibres 
were released into TEEP-20 buffer before being dialysed in Visking tubing 
into TEEP-80 or TEEP-1 overnight at 4 °C. Samples were then centrifuged on 
TEEP-80 or TEEP-1 6-40% isokinetic sucrose gradients respectively at 41,000 
rpm for 4.5 hours at 4 °C as described in Section 2.8.3. 
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Mis-regulation of epigenetic mechanisms has been attributed to the aberrant 
phenotypes of numerous conditions, including cancer. The study of altered 
gene regulation has largely focused on gene activation, as this provides an 
obvious mechanism of action, and therefore a validated target for therapeutic 
inhibition, but gene silencing also contributes to disease phenotypes. Within 
a cancer setting, genes that require silencing for oncogenesis to occur are 
termed tumour suppressors. Expression of repetitive DNA elements from 
normally heterochromatic loci are also linked to genomic instability and 
disease phenotypes (Kazazian et al., 1988) whilst loss of pericentric 
heterochromatin and expression of underlying satellite repeats occurs in 
human and mouse tumours across cancer types (Ting et al., 2011). Therefore, 
identifying the fundamental mechanisms of chromatin condensation both at 
constitutive and facultative loci remains an important biological question, 









3.1 A synthetic model of heterochromatic 
silencing 
 
To identify factors affecting heterochromatin formation and gene silencing, 
an artificial P212 construct, developed by Kim et al., (2009), was used to 
screen a library of drugs. This system uses isogenic murine erythroleukaemia 
cells with different elements inserted at the Scl/Map17 (RL5) locus on 
chromosome 4, via the LoxP/Cre system (Feng et al., 2005). The Scl gene 
encodes for a transcription factor, and is expressed in pluripotent 
haemopoietic stem cells, and is required for haemopoietic lineage 
differentiation. Lineage specific DNaseI hypersensitivity sites at the locus 
correlate with Scl expression, and therefore regulated disruption to the 
chromatin fibre have been proposed to modulate local transcription 
(Gottgens et al., 1997; Göttgens et al., 2001). Other studies have identified a 
downstream CTCF site that acts as an insulator from the Cyp gene cluster 
expressed in the liver. While not a tissue specific enhancer, this CTCF site is 
required to separate Scl and Cyp regulation (Follows et al., 2012). As MEL 
cells have a haemopoietic lineage, the local chromatin environment is 
therefore considered to be normally permissive of transcription. 
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Figure 3.1. Organisation and dynamics of an artificial heterochromatic transgene. 
(A) Organisation of an artificial insert at the RL5 locus in a murine erytholeukeamia 
(MEL) cell clone. Construct consists of yeast centromere region from chromosome 6, a 
10 kb array of human alpha satellite, and a GFP transgene with a human β-globin 
promoter and enhancer hypersensitivity sites. (B-C) Histograms showing GFP 
fluorescence of cells on the x-axis. (B) Basal GFP expression level of α-MEL cells (C) 
GFP expression in α-MEL cells after 1 µM TSA treatment for 48 hours. 
 
The inserted P212 cassette encodes an enhanced GFP gene under a human β
-globin promoter and a series of hypersensitivity sites 2, 3, and 4 (HS2, -3, -4) 
from the human β-globin locus control region (LCR) was inserted at the RL5 
locus (Figure 3.1). Activation via HS2 is mediated by the histone 
acetyltransferase CREB binding protein (CBP) (Johnson, Norton and 
Bresnick, 2002) whilst HS3 is the binding site for the required transcription 
factors GATA-1 and Oct1 (Molete et al., 2002). HS4 in contrast acts as a 
terminal differentiation insulator of HS2 from the β-globin promoter, 
mediated by CTCF (Zhao et al., 2006). The β-globin promoter, when 
interacting with HS2, facilitates chromatin remodelling via SWI/SNF 
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complex HLTF, activating globin transcription (Mahajan and Weissman, 
2002). By varying the artificial insert, Feng et al, (2005) demonstrated that 
eGFP with hypersensitivity sites 2 and 3 is permissive of both active and 
silenced states. Kim et al, (2009) showed that the basic eGFP cassette with 
hypersensitive sites, when inserted at the RL5 locus stably expressed eGFP 
for longer than 6 months without selection. This demonstrated a stably 
accessible chromatin environment at the RL5 locus within this cell line.  
 
A modified p212 cassette, with a flanking YAC/BAC centromeric element 
from yeast chromosome 6, Kim (2009), silenced transgene expression (Chen 
et al., 2004; Suzuki, Kasai and Saeki, 2006). This cassette was further modified 
by inserting a 10 kb array of 11 monomer higher order α-satellite repeats 
from the human centromere of chromosome 21 (Figure. 3.1A). This pYB-α 
insert showed the strongest silencing that Kim, (2009) tested and was 
decorated with H3K9me3 and H3K27me3, marks present at repressive 
pericentric heterochromatin (Peters et al., 2003). The expression of eGFP 
within pYB-α MEL cells was therefore considered to be a good system to 
identify compounds, which disrupt heterochromatic silencing and could give 
a clear phenotypic output. 
 
To analyse basal eGFP expression in pYB-α cells, GFP levels were analysed 
by flow cytometry. The cells had a normal distribution, with only a few cells 
with elevated eGFP fluorescence (Figure 3.1B).  To test the effect of changes 
in histone acetylation cells were treated with 1 μM Trichostatin A, an 
inhibitor of histone deacetylases, for 48 hours.  The majority of cells 
maintained an elevated eGFP fluorescence however the distribution was 
biphasic, suggesting some heterogeneity within the cell population, which 
was consistent over time and treatments (Figure 3.1C). Flow cytometry 
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gating for GFP expression was defined by using MEL RL5 cells that lacked 
any eGFP transgene. The level of eGFP fluorescence within this reporter 
system is influenced by the underlying eGFP transgene transcription, and the 
amount of time after treatment that is required to change gene expression. 
Consequently, genes essential for heterochromatin formation after mitosis 
would take longer to activate eGFP transcription and have lower eGFP 
fluorescence. Therefore, for the purpose of this screen, a significant change in 
eGFP fluorescence after drug treatment was considered as a potentially 
relevant compound. 
 
Figure 3.2. Opitmisation of eGFP transgene reactivation in MEL cells. Graph 
showing fold change in GFP expression in α-MEL cells, containing the heterochromatic 
construct after drug treatment measured by flow cytometry. P212 untreated cells (left) 
lack the yeast centromeric sequences and α-satellite repeats, and GFP is constitutively 
expressed. RL5 untransfected loci (right) lack the eGFP construct entirely providing a 
negative control for background fluorescence. Fluorescence was normalised to α-MEL 
cells DMSO treated controls. Six compounds; 5’ Azacytidine, Aspirin, UNC0638, JNK II 
and Akt IV, were tested in α-MEL cells at 1 µM for 72 hours. 
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To investigate the reproducibility of this assay, 6 compounds (1 μM for 48h) 
were screened and compared to the expression level of the p212 cassette 
lacking any centromeric sequences; the RL5 cell line lacking any eGFP 
transgene was used as a negative control (Figure 3.2), and all samples were 
normalised to the 0.01% DMSO control samples. Canonical inhibitors of gene 
silencing, TSA and 5’ azacytidine (5’Aza) altered eGFP expression. 
Expression was more than the p212 eGFP expression suggesting that the 
effect goes beyond the repressive properties of the pYB-α-satellite insert, 
promoting gene activation.  
 
Cells were also treated with 1 μM aspirin and UNC638. Aspirin, while still 
poorly understood, is known to inhibit NF-kB which has been shown to act 
as a transcriptional activator at the β-globin locus in erythroleukaemia cells 
(Moitreyee et al, 1998). As aspirin did not affect eGFP expression this 
suggests that NF-kB does not influence the human β-globin promoter in this 
repressed state, and suggests that the repressed state of this transgene 
prevents transcription factor binding. UNC0638 also did not affect eGFP 
expression. UNC0638 is a highly specific inhibitor of G9a/GLP 
methyltranferases responsible for H3K9 -mono and -dimethylation. G9a/GLP 
function has been associated with selective looping between foetal and adult 
globin genes (Chaturvedi et al., 2009; Deng et al., 2013) and UNC0638 
G9a/GLP inhibition has previously been used to facilitate looping to foetal 
globin promoters reducing β -globin expression (Krivega et al., 2015).  
Therefore, UNC0638 would be expected to inhibit eGFP expression if any 
looping occurred between the LCR hypersensitive sites and the human β-
globin promoter. As UNC0638 had no effect on eGFP expression, chromatin 
looping is unlikely to function within this repressed construct. Investigating 
the signalling pathways associated with β -globin expression is also 
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important; JNK kinase activation regulates haemopoietic transcription factor 
degradation (Lee et al., 2010).  Therefore, JNK2 inhibition should increase TF 
availability for gene activation. Limited re-activation of eGFP after JNK II 
inhibition suggests it is not involved in maintaining the repressive chromatin 
environment at the eGFP transgene. AKT also negatively regulates PLC 
kinase mediated β-globin expression (Follo et al., 2008, 2012). The lack of re-
expression of eGFP after AKT inhibition provides further evidence that this 




Figure 3.3. RFP and heterochromatic eGFP expression dynamics. α-MEL cells with 
a randomly inserted RFP lentiviral construct (Sigma. Cat No. SHC012V). Flow 
cytometry plots showing GFP on the y-axis and RFP fluorescence on the x-axis. (A-B) 
Silenced lentiviral RFP α-MEL clone, treated with (A) DMSO (B) 1µM TSA for 72 hours. 
(C-D) Expressed RFP α-MEL clone, treated with (C) DMSO (D) Chaetocin 1 µM for 72 
hours (E) 10x images of RFP expressing α-MEL cells after 72 hours with DMSO or 
JQ1+/- treatment showing GFP and RFP fluorescence. 
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To control for compounds, which generally affected gene expression, from 
heterochromatic modulators, and to improve this model system, a lentiviral 
system was used to insert an RFP gene under a CMV promoter across the 
genome (Sigma, Cat No. SHC012V). The random integration of this construct 
resulted in MEL clones that varied in eGFP and RFP fluorescence. Clones 
were selected that maintained a silenced eGFP with a silent or expressed RFP 
construct (Figure. 3.3A, C).  When eGFP was re-expressed in the silenced 
RFP clone with TSA (1 μM 24hours) there was no increase in RFP indicating 
that the transgene is silenced (Figure. 3.3B). This effect was also 
demonstrated in RFP expressing clones (Figure. 3.3D). However, RFP 
expressing clones did not see similar levels of eGFP activation but cells with 
higher RFP levels also had higher eGFP levels, limiting the sensitivity of the 
primary reporter. Therefore, for the initial FACS screen MEL clones with the 
silenced RFP construct were used, and validated using the RFP expressing 
clone. Of the compounds that significantly activated eGFP expression in 
Table 3.1 only Cdk inhibitor CR8 and Nicotinamide, which is thought to 
function in DNA methylation, affected RFP expression. When selected hit 
compounds identified using the RFP expressing clone were validated by live 
cell imaging, there was no significant change in RFP pixel intensity 
compared to the increase in eGFP fluorescence (Figure. 3.3E). This suggests 








3.2 Screening for heterochromatic 
modulators 
 
In the primary screen, over 250 compounds were tested with known and 
unknown targets (Appendix 1).  Each compound was tested at 1 μM for 24 
hours and compared to a DMSO control. 30 compounds showed significant 
and consistent eGFP expression (Table 3.1), and can be broadly grouped by 
target; HDAC, histone demethylase, SIRT-HDACs, signalling kinases, cell 
cycle, bromodomain, and unknown. 
 
The most prominent of these was the HDAC group. This was not surprising 
as many HDAC inhibitors exist and are being investigated as therapeutics in 
a range of malignancies (Ceccacci and Minucci, 2016), and were prevalent in 
our library.  Surprisingly, the level of eGFP expression differed significantly 
between the compounds. M344, an HDAC3 inhibitor with an IC50 of 100 nM, 
was less effective than broad HDAC inhibitors (S)-HDAC-42 and CAY10433, 
which are active in the μM range. This could suggest that HDAC3 is less 
important for eGFP reactivation than HDAC1/6.  This is perhaps not 
surprising, as HDAC3 is known to deacetylate H3K27 to enable subsequent 
methylation. H3K27me3 mediated silencing tends to be mutually exclusive 
from constitutive H3K9me3 silencing, as was shown to be enriched over the 
pYB-α construct (Kim et al., 2009). This therefore suggests that inhibtors of  





Table 3.1. α-MEL eGFP reactivation compound screen. eGFP expression 
after α-MEL cells were screened with each compound in turn for 48 hours, and 
fluorescence determine by flow cytometry. Table of compounds that by a 
bonferroni corrected two tailed t-test significantly affected GFP fluorescence 
after treatment for 48 hours at 1 µM (unless stated otherwise). n = >3. 
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The high level of eGFP expression as a result of MS-275, and CAY10603 
treatment is likely due to their high selectivity, and that HDAC1/6 have been 
implicated in haematopoiesis and could have a greater role in regulating 
gene expression in an erythroleukaemia background. Furthermore, HDAC1 
functions in the NuRD complex and inhibition could suppress HP1 
deposition (Huang et al., 2013; Shearstone et al., 2016).  
 
The role of class III HDACS, known as Sirtuins (SIRT), remains unresolved 
(Kozako et al., 2014). In  the MEL system both SIRT inhibitors and activators 
promoted eGFP expression (Table 3.1), although trans-resveratrol is reported 
as a SIRT1 activator, the mechanism is not direct and could function 
differently in this artificial system. The reactivation by SIRT1 
inhibition/activation is significant but is below the basal expression of the 
p212 cassette suggesting a relatively weak effect on heterochromatic 
silencing. SIRT1 canonically functions to deacetylate H4K16 and H3K9 
allowing for H3K9me3 and facilitates linker histone H1 binding and 
heterochromatin formation (Vaquero et al., 2004). 
 
JmjC demethylases have recently been implicated in heterochromatin 
formation and JARID2 can recruit PRC2 complexes although this normally 
occurs in non-cycling cells (Son et al., 2013). JmjC demethylases can remove 
all three methylation states giving them broad functionality, initially 
demonstrated at H3K36. They have subsequently been shown to directly 
demethylate pericentric H3K9me3 (Klose et al., 2006; Whetstine et al., 2006). 
For JmjC domain containing proteins to demethylate substrates they require 
cofactors Fe(II) and α-ketoglutarate (Tsukada et al., 2006). JmjC inhibitors 
such as N-oxalyglycine and IOX1, promote eGFP expression, and could 
function by competitively inhibiting α-ketoglutarate binding to Fe(II) within 
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the domain.  As this catalytic domain is conserved across the family this 
means inhibitors are non-specific. It is therefore surprising that catalytic 
inhibition of a family of demethylases known to directly affect pericentric 
heterochromatin, should cause eGFP expression.  
 
Poly(ADP-ribose) polymerases (PARP) are known to bind at active 
promoters and at heterochromatic regions including α-satellite sequences, 
however this paradoxical function in gene regulation is not understood. At 
promoters, PARP1 binding excludes linker H1 association but PARP1 loss 
only affects a subset of bound genes that are both up- and down-regulated 
(Krishnakumar et al., 2008). Heterochromatic PARP1 interacts with the 
Nucleolus repressor complex (NoRC) (Strohner et al., 2001) and recruitment 
of PARP1-NoRC is facilitated by nascent RNA which acts as a substrate for 
parylation (Mayer et al., 2006). Research has demonstrated that this is a 
transient event after the passage of a replication fork to facilitate 
heterochromatin formation in mid-to-late S phase (Guetg et al., 2012). As 
MEL cells were treated for 48 hours with each compound, this would 
normally allow multiple complete cell cycles to take place so PARP inhibition 










Perturbation to the cell cycle also resulted in eGFP expression. Inhibition of 
cyclins by CR8 and nucleotide analogues such as gemcitabine and 
capecitabine significantly de-repress the RL5 locus. Feng, (2005) 
demonstrated that insertion of p212 cassette with silenced or expressed 
eGFP, replication timing shifts from late-to-early. The relationship of gene 
expression, replication timing and chromatin is unclear, but by altering the 
length of S-phase via Cdk inhibition or nucleotide analogues could affect the 
replication timing of the eGFP transgene which may in turn regulate its 
chromatin environment. 
 
A broad range of kinase inhibitors were found to activate eGFP expression:  
JNK II/III, EGFR, PKC, Polo, and Aurora (Table 3.1). As mentioned above the 
JNK pathway is thought to be antagonistic to β-globin expression (Lee et al., 
2010). JNK II inhibition in Figure. 3.2, did not, however, reactivate the eGFP 
transgene. JNK IX inhibitor of JNK II/III however resulted in an 8-fold 
increase in eGFP fluorescence. JNK III is known to function as a stress 
induced pro-apoptotic pathway independent of JNKI/II transcriptional 
regulation (Yang et al., 1997).  Stress related proteins such as heat shock 
factor 2-β, are regulated by the JNK pathway and are involved in erythroid 
differentiation (Hietakangas et al., 2001). Although exactly how JNK 
functions in differentiation remains undefined, JNK3 is known only to be 
expressed in a tissue specific manner in the brain, heart and testes. The three 
JNK genes are spliced to form 10 JNK isoforms that regulate TF activity 
independently of each other (Gupta et al., 1996). More recently, JNK kinases 
have been shown to directly phosphorylate H3S10 in interphase (Tiwari et al., 
2012) whilst the combined and adjacent marks H3K9me3 and H3S10p have 
been associated with modulating heterochromatin through differentiation 
(Ribeiro-Mason et al., 2012). The effect of JNK IX inhibition on eGFP 
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expression may provide an insight to heterochromatin regulation in the MEL 
background. 
 
During mitosis, H3S10 phosphorylation occurs via Aurora B rather than JNK 
(Hirota et al., 2005). The function of mitotic H3S10p on chromatin 
condensation remains unclear, as its presence causes HP1 proteins to 
dissociate during mitotic compaction. Aurora kinase inhibition by Aurora-A, 
or Phthalazinone pyrazole, caused eGFP expression. When viewed in 
combination with JNK inhibitions effect on eGFP expression, this suggests 
that H3S10p is required for maintaining the transgene silencing, even if the 
mechanism is indirect.  
 
EGFR, PKC and PLC inhibition triggered eGFP expression. EGFR is a 
membrane receptor that can stimulate multiple kinase pathways, including 
PI3K/Akt. Akt inhibition, downstream of EGFR, does not however induce 
expression of the eGFP transgene. This suggests that the PKC/PLC pathway 
of the EGFR response is modulating the transgene expression.  PLC is 
directly activated by EGFR, and results in downstream PKC activation 
(Hofmann et al., 1999). PKC once activated is a potent stimulator of the 
Ras/Raf/MEK/ERK pathway (Schönwasser et al., 1998). ERK activation is 
required to maintain haematopoietic undifferentiated cell states 
demonstrating it as a key regulator within an erythroid setting (Chan, Gu 
and Neel, 2013). How ERK modulates differentiation is not fully understood, 
although it has been shown to regulate key haematopoietic transcription 
factors including c-myc (Chen and Sytkowski, 2001). Additionally, PKC has 
been implicated in heterochromatin modulation directly via interacting with 
transcriptional intermediary factor 1B (TIF1B). TIF1B regulates 
KAP1/TRIM28 chromatin remodelling complex recruitment to chromatin. 
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TIF1B is recruited to heterochromatin by directly binding to HP1 proteins, 
but this is abrogated by its phosphorylation at Ser473 by PKC (Chang et al., 
2008). Inhibiting PKC therefore could directly result in the loss of 
heterochromatin condensation via KAP1/TRIM28. This is most likely the 
mechanism behind eGFP expression, as ERK inhibitors by contrast did not 
result in eGFP activation (Appendix 1). 
 
Intriguingly, bromodomain inhibition by JQ1 also caused eGFP expression; 
the effect was specific as the inactive enantiomer of JQ1 did not change 
expression (Appendix 1). Additionally, the less selective bromosporine 
compound also activated the eGFP transgene. These results were surprising 
as bromo-extra terminal (BET) proteins inhibited by JQ1 are known 
transcription factors found at active enhancers (Chapuy, McKeown and Lin, 
2013). The role of BET proteins in haematological malignancies has been 
widely studied with its function in oncogene activation attributed to 
activation at super enhancers (Lovén et al., 2013). Therefore, the role of BET 













3.3 BET mediated eGFP expression 
 
To better understand the role of BET inhibitors MEL cells were treated with 
bromosporine for 48 hours at 0.05 μM to 1 μM, prior to analysis by FACS in 
the same method as described earlier (Figure. 3.4A). eGFP was upregulated 
after 0.5 μM treatment, and re-expression correlated with increased cell 
death.  This suggests that the function of BET proteins in heterochromatin 
condensation is essential for cell viability.  
 
Figure 3.4. Bromosporine eGFP reactivation and cell cycle arrest. (A) MEL cells 
treated with increasing concentrations of pan BET inhibitor, bromosporine for 48 hours. 
GFP fluorescence and cell death was determined by flow cytometry. (n=3) (B) Stacked 
bar plot showing cell cycle analysis by high content imaging on ScanR platform. MEL 
cells were grown on gelatin coated dishes and treated with bromosporine at various 
doses for 48 hours prior to imaging. Error bars = SEM between biological repilicates. 
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As these cells are non-adherent, plates were coated with 0.1% gelatin, to 
facilitate cell adhesion and access to microscopy techniques. MEL cells were 
treated with 0.1 µM to 5 µM bromosporine for 48 hours, as this covered the 
reactivation of eGFP detected by FACS (Figure. 3.4A). The ScanR analysis 
platform was used to determine cell cycle stage of more than 500 cells per 
treatment. Bromosporine caused a dose dependent increase in G2/S phase 
after treatment (Figure. 3.4 B) which suggests that replication is impaired 
and cells are therefore not allowed to progress through mitosis. 
 
To analyse the relationship between eGFP expression and cellular 
proliferation, cells were treated with a log-dose range of selective BET 
inhibitor I-BET151 (Figure 3.5). MEL cells were treated with I-BET151 for 48 
hours before the addition of cell viability reagent PrestoBlue for 3 hours prior 
to measuring the fluorescence at 590-615 nm. Independent samples were 
normalised to a DMSO 0.01% control. 10-1000 nM I-BET151 gives an 80% 
reduction in cell viability (Figure 3.5 A) and 50-5000 nM I-BET151 affects 
eGFP levels measured by FACS (Figure 3.5 B). This suggests that the effect 




Figure 3.5. Relationship between IBET151 eGFP reactivation and cell viability. α-
MEL cells treated for 48 hours with a log-dose range of I-BET151. (A) Cell viability was 
determined using a Presto BlueTM assay (n=6) (B) Fold change in GFP fluorescence in 






As the previous experiments investigating eGFP involved 48-hour 
treatments, which affect multiple cell cycles, it seemed desirable to 
investigate the kinetics of eGFP expression post treatment. While coating 
wells in gelatin was sufficient for cell attachment before fixation for standard 
microscopy, this method still resulted in cellular detachment over time. This 
led to a change in the depth of field for individual cells preventing tracking 
over time. To reduce this movement, cells were seeded in matrigel (Hughes, 
Postovit and Lajoie, 2010). When incubated post seeding the matrigel 
polymerizes preventing the movement of the non-attached MEL cells and 
enabled imaging of wells at 10x over 84 hours to investigate the kinetics of 
eGFP expression. To investigate kinetics of eGFP expression a MEL clone 
expressing RFP was also used (Figure 3.3 C-E) which allowed a comparison 
of eGFP expression to general gene activation. 
 
To exclude compound specific effects cells were treated with a half-log dose 
range of the three BET inhibitors, previously identified to cause eGFP 
expression: Bromosporine, JQ1+/-, and I-BET151 (Figure 3.6). Cells were also 
treated with dose ranges of 5’Azacytidine and Chaetocin, which inhibit DNA 
methylation and H3K9me3 respectively. DNA methylation, while not 
affecting chromatin condensation, regulates endogenous β -globin 
transcription in MEL cells at the LCR and down-stream of the 3’ end (Yisraeli 







For analysis, the change in RFP expression was subtracted from eGFP 
expression. RFP pixel intensity was however only affected after chaetocin 
treatment. This resulted in a decrease in eGFP/RFP expression ratio after low 
dose chaeotcin (Figure 3.6 B). Intriguingly, the speed of eGFP activation 
differed between 5’Azacytidine and Chaetocin. Re-expression from chaetocin 
was first detected at 12 hours post treatment. 5’Azacytidine by contrast 
required 36 hours post treatment for activation of the eGFP transgene 
(Figure. 3.6 A-B). Also unexpectedly, low dose chaetocin resulted in 
increased silencing. 
 
 All three selective BET inhibitors: I-BET151, JQ1+/-, and Bromosporine caused 
eGFP expression 24 hours after treatment which sits in-between Chaetocin 
and 5’Azacytidine eGFP activation. Additionally, the pan BET inhibitor 
Bromosporine required a higher dose to achieve the same level of eGFP 
expression compared to JQ1+/- and I-BET151 (Figure 3.6 C-E) with JQ1+/- 
having a 2.5 fold greater effect than Bromosporine. I-BET151 was 
approximately 0.6 fold more effective at eGFP reactivation than JQ1+/-; as JQ1 
and I-BET151 are known to be active at inhibiting BET proteins with the 
similar potency, this effect is most likely due to differences in selectivity 





Figure 3.6. Heterochromatic eGFP activation kinetics. α-MEL cells embedded in 
MatrigelTM were imaged over 84 hours using an Incucyte microscope. GFP fluorescence 
is relative to DMSO controls at each time point. Fold change in GFP fluorescence in 
shown for cells treated with compounds 12 hours after seeding. (A) 5’Azacytidine (B) 






To investigate the effect of BET inhibition on epigenetic marks, samples 
treated with BET inhibitors were analysed by reverse phase protein arrays. 
Protein lysates were spotted onto arrays in triplicate serial dilutions (Figure 
3.7), the arrays were clamped into 12 chambers per array and incubated with 
primary and secondary antibodies. The R2 value, used to determine how 
close data fits a line of regression, was measured for signal intensity across 






Figure 3.7. Reverse phase protein arrays. Protein array methodology. Lysates were 
spotted onto arrays in a four series dilution in duplicate. Primary and secondary 
antibodies were sequentially incubated in the chambers and imaged. Antibody 
fluorescence signal was quality controlled by analysing the R2 of the serial dilution. 
Samples 1, 12, and 23 represent the H3K9 acetylation serial dilutions above, indicative 







33 histone modifications or chromatin binding proteins were assayed after 1 
μM I-BET151 treatment for 6 hours and 24 hours. The 6 hour and 24 hour 
treated samples were collated to determine significant changes that were 
sustained over time (Figure. 3.8). The only significant changes after BET 
inhibition were elevated levels of unmodified and dimethylated H3K4. 
Although not significant (p=0.064), H3K4 monomethylation correlated with 
the elevated signals from H3K4me2 and unmodified antibodies. This 
correlation would be expected with loss of H3K4me3, a mark of active 
transcription and is not surprising given the role of BET proteins as 
transcription factors (Kyoo Jang et al., 2005; W. Zhang et al., 2012). As 
expected there were no significant change in global levels of H3K9 
methylation states or BET proteins Brd2, and Brd3, but of interest were a 
near significant loss of H3K27me3 (p=0.059) with elevation of H3K27me2, 
and the general trend for a subtle increase in histone acetylation (H4K16ac, 
H4K12ac, H4K5ac). BET proteins are known to bind to acetylated H4, so a 
compensatory increase in H4 acetylation is possible (Filippakopoulos et al., 
2012) although it remains unknown whether a general increase in histone 
acetylation would affect heterochromatin. 
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Figure 3.8. Global Epigenetic modification changes with IBET151. Boxplots 
showing changes in global epigenetic marks after BET inhibition in α-MEL cells, 
measured by reverse phase protein arrays. Cells treated with 1 µM IBET151 for 24 
hours (n=9) and analyzed by Bonferroni corrected 2-way ANOVA to calculate 
significance. 
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The eGFP transgene is known to be marked with H3K9me3 (Kim et al., 2009). 
Therefore, the levels of H3K4me3, and H3K9me3 at the eGFP transgene were 
evaluated, given the global changes in H3K4 methylation detected by RPPA 
(Figure 3.8). Chromatin immunoprecipitation was used to analyse the effect 
of BET inhibition at the amylase, eGFP, murine β-globin, and major satellite 
(Figure 3.9). Amylase is constitutively repressed throughout normal 
haematological differentiation, whilst a subset of haematological tumours 
have ectopic amylase expression independent of genetic translocations 
(Weiss, Edmondson and Wertman, 1951; Ohtsuki et al., 1989). However, 
amylase is repressed in MEL cells, providing a locus of potential facultative 
heterochromatin (Kim et al., 2009).  The endogenous β-globin gene is in a 
poised state in undifferentiated MEL cells and undergoes chromatin de-
condensation and expression upon differentiation (Smith and Yus, 1984) 
providing a poised silent loci in these MEL cells. Finally, major satellite 
repeats are pericentromeric and are packaged as constitutive 
heterochromatin. 
 
Both JQ1+/- and I-BET151 treatment caused a large reduction in H3K9me3 
over the eGFP transgene (Figure 3.9 B). There was also an enrichment of 
H3K4me3 compared to control. This change in histone modifications 
correlates well with gene activation, although treatment with BET inhibitors 
did not consistently increase Brd4 occupancy at the transgene. Treatment of 
BET inhibitors decreased H3K9me3 and H3K4me3 at the poised β-globin 
gene (Figure 3.9 C) and Brd4 occupancy was also reduced especially after 
IBET151 treatment. 
 
Control facultative and constitutive loci, amylase and major satellite showed 
reductions in H3K9me3 after BET inhibition which was exacerbated after 
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IBET151 treatment (Figure 3.9 A,D). Unlike at the eGFP transgene there was 
no elevation of H3K4me3 at amylase or Major satellite, nor a consistent 
increase in Brd4 after BET inhibition. 
 
 
Figure 3.9. Chromatin immunoprecipitation for H3K9me3, H3K4me3, and Brd4 
after BET inhibition. MEL cells were treated for 24 hours with DMSO, JQ1+/+, or 
IBET151. qPCR’s were performed at four loci and compared to ChIP input samples (A) 
Amylase (B) GFP transgene (C) Murine β-globin and (D) Major Satellite. 
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3.4 BET inhibition affects cell signalling 
 
Cellular epigenetic profiles represent the programmed state, and their 
adaption to the cellular environment (Ravelli et al., 1998; Borengasser et al., 
2013). Inhibiting an epigenetic process such as acetyl-lysine binding is 
therefore likely to alter a cell’s response mechanism. Either compensatory 
changes to signalling pathways could occur to overcome a BET protein 
reduction or cellular adaption to signalling will be altered. To investigate if 
BET inhibitors affected cellular signalling, MEL cells were treated with JQ1+/- 
or I-BET151 1 μM for 24 hours. Cell lysates were prepared and spotted onto 
ZeptozenTM arrays for 87 antibodies. JQ1+/- and I-BET151 samples were 
collated to reduce off target drug specific effects and compared to controls 
(Figure 3.10, Appendix 2). Significant consistent changes with BET inhibition 




Figure 3.10. Signaling kinase changes after BET inhibition. Boxplots of kinase 
proteins and their phosphorylated states after BET inhibition in α-MEL cells. Treatments 
with 1 µM JQ1+/- or IBET151 for 24 hours were collated together to remove off target 

























As one might expect BET inhibition resulted in a decrease in Brd4 protein 
levels, whilst changes in kinases suggest that BET inhibition and loss of Brd4 
adversely affects canonical EGFR signalling.  
 
The canonical EGFR pathway is Ras/Raf/MEK/ERK, which up regulates 
multiple transcription factors including c-myc and Elk-1. Importantly, the 
downstream component ERK1/2 shows a significant loss in phosphorylation 
after BET inhibition (Table 3.2).  MEK is upstream of ERK and shows a 
significant increase in phosphorylation after BET inhibition indicating the 
cell is stimulating ERK signalling. Hyper-phosphorylation of ERK signalling 
is a known resistance mechanism to loss of ERK signalling via receptor 
tyrosine kinase (RTK) or Ras/RAF/MEK inhibition. 
 
BRAF can be alternatively activated by PKA or PKC independently of Ras, 
both of which are phosphorylated after BET inhibition. Both these pathways 
are stimulated by metabolic compounds cAMP and PIP2 respectively. 
Increased cAMP stimulates PKA mediated Rap1 phosphorylation both of 
which are up-regulated by BET inhibition. Rap1 can then directly activate 
BRAF independently of Ras and is known to regulate multiple 
haematological response pathways (Katagiri et al., 2002). PKC can also 
directly activate BRAF. PKC activity is modulated by PLC that requires the 
PIP2 metabolite. PIP2 also acts as the substrate for PI3K signalling, which is 
also stimulated by BET inhibition and activation of the PI3K/Akt pathway, 
and is a well characterised mechanism to mediate loss of ERK signalling 





Table 3.2. Significant kinase changes to BET inhibition. List of two-tailed t-
test significant changes to kinase signaling in α-MEL cells. α-MEL cells were 
treated with 1 µM I-BET151 or JQ1+/-  for 24 hours and the signaling affects 
binned together and normalised from DMSO controls. Bonferoni corrected 







PIP2 is also known to modulate the targeting of Src (Corte, Gettemans and 
Vandekerckhove, 1997; Benesch et al., 2002) which in turn phosphorylates 
Stat3 resulting in increased invasion and poor prognosis in lung cancer 
(Carretero et al., 2010). Src upstream receptor Met has significantly reduced 
phosphorylation after BET inhibition whereas, its downstream effector Stat3 
protein level is up-regulated. LKB1, which normally inhibits Src activation, is 
known to be supressed by elevated cAMP and is reduced by BET inhibition. 
This suggest that normal up-regulation of Src signalling after loss of EGFR is 
also prevented upon BET inhibition (Mueller et al., 2008) and a recent study 
implicated Brd2 as a regulator of Stat signalling hinting at a potential 
mechanism (Liu et al., 2014). 
 
Stress activated MAPK signalling (SAPK/JNK) is also up-regulated after BET 
inhibition (Table 3.2) and the SAPK/JNK downstream partner c-Jun is more 
phosphorylated. SAPK/JNK when activated normally functions to activate 
p53 dependent cell arrest but after oncogenesis is known to mediate 
mesenchymal endothelial transition (MET), and pluripotency (Schramek et 
al., 2011; Neganova et al., 2016). One mechanism functioning in these 
pathways is the stabilisation of c-myc preventing its degradation after 
SAPK/JNK activation (Alarcon-vargas and Ronai, 2004). The modulation of 
ERK/Stat3/PI3K/JNK pathways after BET inhibition suggests that BET 
proteins function in regulating ERK mediated c-myc transcription, for which 









In the compound screens undertaken here multiple targets were identified as 
modulating heterochromatic silencing of an eGFP transgene. This synthetic 
model system generated by the Larionov lab, was previously use to 
investigate the ability of the underlying genetic sequence in modulating 
heterochromatin formation and gene silencing (Ebersole et al., 2005; Kim et 
al., 2009). This system is clearly regulated by the HDAC inhibitor TSA, and 
DNA methylation inhibitor 5’Azacytidine (Figure 3.2). TSA treatment both 
elevates histone acetylation and gene activation and has been shown to 
disrupt heterochromatin formation by mediating loss of H3K9me3 and HP1 
proteins (Taddei et al., 2001). Loss of DNA methylation does not normally 
lead to chromatin de-condensation (Gilbert, Thomson, Boyle, Allan, 
Ramsahoye and Wendy A Bickmore, 2007) but DNA methylation is known, 
however, to regulate β-globin expression, and the eGFP transgene is under a 
human β-globin promoter. Given that MEL cells are of an undifferentiated 
haematological background, the β -globin promoter is normally poised 
(Figure. 3.9 C). Upon differentiation α- and β- globin genes are up-
regulated in these MEL cells (Friend et al., 1971) suggesting that 
differentiation factors may also influence eGFP expression (Figure. 3.9 C).  
 
The positive results in Table. 3.1, further validated this model, as multiple 
inhibitors of heterochromatic factors resulted in eGFP activation (HDAC, 
JmjC demethylases, PARP). An increase in eGFP expression by BET 
inhibition (JQ1+/- and Bromosporine) is surprising as BET proteins are 
universally accepted as transcriptional activators across cell types and 
lineages (Korb et al., 2015; Roe et al., 2015; Najafova et al., 2017). As BET 
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proteins bind to acetylated lysines, this contradicts the role of CBP mediated 
acetylation at HS2 to activate the β-globin promoter (Johnson, Norton and 
Bresnick, 2002).  
 
As demonstrated in figures 3.4 A and 3.5, eGFP activation by BET inhibition 
correlates with cell death. As these cells are stressed and BET protein Brd4 is 
known to stay bound to chromatin throughout mitosis, cell cycle stalling in 
Figure 3.4 B is expected (Zhao et al., 2011), however a correlation with cell 
death is not necessarily causal. 
 
To investigate the kinetics of eGFP activation, MEL cells were embedded in 
Matrigel with the ratio of eGFP to RFP pixel intensity measured by live cell 
imaging (Figure 3.3 E). BET inhibition, resulted in decreased confluence as 
expected from Figure 3.4 B, whilst RFP pixel intensity remained constant. 
5’Azacytidine treatment required multiple cell cycles to give eGFP 
expression (Figure 3.6 A) which is in line with DNA methylation in 
haematopoiesis causing globin gene expression (Lessard et al., 2015). 
Chaetocin, an inhibitor of Suv39 methyltransferases, was used as a drug to 
directly alter heterochromatin (Figure 3.6 B). Chaetocin did promote eGFP 
expression in the primary screen, but was toxic causing high levels of cell 
death. The further suppression of eGFP by low-level chaetocin treatment was 
due to an increase in RFP expression, which affected the GFP/RFP ratio, 
however eGFP activation was detected after 12 hours treatment, indicating 






BET inhibition caused dose dependent eGFP expression 24 hours after 
treatment using a pan inhibitor bromosporine (Figure 3.6 D) and selective 
inhibitors JQ1+/- and I-BET151 (Figure 3.6 C, E). Bromosporine was the least 
effective, followed by I-BET151 and JQ1+/-. As a pan BET inhibitor 
bromosporine binds to proteins including CECR2, CBP and EP300 in 
addition to Brd- proteins (Picaud et al., 2016). As CBP mediated histone 
acetylation at HS2 greatly enhances normal β-globin expression, eGFP 
expression after inhibition of these proteins is intriguing (Johnson, Norton 
and Bresnick, 2002). eGFP expression from selective inhibitors JQ1+/- and I-
BET151 would suggest that eGFP activation is independent of pan BET 
inhibition, and that this process is dominant over CBP-EP300 mediated 
acetylation. As CBP acetylation and GATA-1 recruitment is required for 
differentiation dependent globin expression, this suggests that Brd- protein 
loss directly causes heterochromatin loss (Cho et al., 2008). BET specific 
inhibition, while causing eGFP expression to a greater level than chaetocin 
treatment, was only detected 24 hours post treatment. The loss of 
heterochromatin therefore could require replication. This supports work 
from the Spector lab, where artificial tethering of Brd4 to heterochromatin 
did not cause HP1 loss and gene activation, but accelerates post mitotic de-
compaction (Zhao et al., 2011). 
 
The only histone modifications globally affected by BET inhibition were 
H3K4 unmodified, mono- and di-methylated (Figure 3.8) whilst at the eGFP 
transgene H3K4me3 is enriched (Figure 3.9 B). Together this data infers a 
loss of H3K4 acetylation, which is normally found upstream of active 
promoters (Wang et al., 2008). Promotion of H3K4me2 –me3 over H3K4 
acetylation is mediated via the Set-1 containing complex (COMPASS), 
although the explicit function of H3K4 acetylation is poorly understood 
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(Guillemette et al., 2011). This may be functional however as the tandem 
bromodomains (BD1 and BD2) in Brd- proteins have different specificities 
(Wu and Chiang, 2007). Although highly conserved, the two bromodomains 
only share ~44% homology and have been demonstrated to form 
homodimers (BD1-BD1, BD2-BD2) in solution (Nakamura et al., 2007). This 
has also been inferred in Brd4 where BD1 preferentially binds to the di-
acetylated H4K5acK8ac motif; in contrast Brd4 BD2 preferentially binds to 
H3K4acK9ac over single H3K4 acetylation (Filippakopoulos et al., 2012). This 
indicates that BET protein binding to H3 or H4 is mediated by different 
bromodomains, where H3 needs to be acetylated. If BD2 binding to H3K4 
acetylation is inhibited this would increase the exposure of the modification 
to turnover by COMPASS further preventing Brd- protein binding. 
However, H3K4 acetylation is associated with gene activation and as such 
would not be expected to affect heterochromatic regions. 
 
ChIP-qPCR data shows BET inhibition causes a loss of H3K9me3, and 
enrichment of H3K4me3 at the eGFP transgene (Figure 3.9 B) whilst 
endogenous facultative and constitutive heterochromatin loci, amylase and 
Major satellite, respectively, show moderate loss of H3K9me3 but no 
enrichment of H3K4me3 (Figure 3.9 A, D). This suggests that the BET 
proteins role in heterochromatin maintenance is not limited to the artificial 
transgene, and appears to be a universal property of heterochromatin, even 
without gene activation. At a poised promoter, such as the endogenous β-
globin, there is no significant change in H3K9me3/H3K4me3 ratio suggesting 
that this locus remains poised, although both marks are reduced (Figure 3.9 
C) suggesting that BET inhibition does not induce erythroid differentiation 




Aside from differentiation, BET proteins have been implicated in multiple 
signalling cascades. Brd4 interacts with the activated NF-kB subunit RelA 
and is required for its activation in the inflammation response (Huang et al., 
2009). Brd4 can also act to insulate loci from signalling process such as DNA 
damage processes by recruiting condensin II complexes maintaining 
silencing (Floyd et al., 2013). 
 
c-myc is a master regulator of haematopoiesis and its expression is regulated 
by Brd4. At the murine erythroid developmental stage, Myc is normally 
supressed by GATA-1 (Rylski et al., 2003) but MEL cell proliferation is driven 
by aberrant up-regulation of c-myc that is lost upon differentiation (Lachman 
and Skoultchi, 1984; Coppola and Cole, 1986).  
 
To elucidate the effect of BET inhibitors on kinases, reverse phase protein 
arrays were used to analyse multiple signalling pathways in parallel (Figure 
3.10). BET inhibition leads to increased Brd4 turnover, while Brd2 and Brd3 
were previously shown to be unaffected (Figure 3.8).  This would suggest 








































Figure 3.11 MAPK signaling pathways. Diagram showing signaling pathways affected 
by 1 µM BET inhibition, for 24 hours. Canonical MAPK signaling pathway (right side) 
stabilises c-Myc. Compensatory PI3K/Akt signaling (center) can also lead to ERK 
mediated c-Myc stabilisation, which can also increase c-Myc expression.  JNK/SRC 
signaling (left) associated with loss of cell adhesion factors and EMT-like transitions 
involving c-Myc stabilisation. 
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BET inhibition also caused significant loss of MAPK signalling from 
membrane receptors (Met) to downstream ERK (table 3.2). MEK and PKA, 
components upstream of ERK have increased protein levels but 
phosphorylation levels are not significantly altered. Protein level increase 
would remove their abundance as a factor regulating MAPK signalling, a 
logical response to loss of phosphorylation. Upon BET inhibition, alternative 
signalling pathways I3K and PKC are hyper-phosphorylated. This suggests 
that PIP2 signalling has been up regulated. PKC can act as an alternative 
method for ERK activation, while PI3K pathway is an alternative method of 
stimulating c-myc expression (Chen and Sytkowski, 2001). The stimulation of 
these pathways in addition to STAT and SAPK signalling suggested in figure 
3.11, indicates that BET inhibition leads to a loss of MAPK signalling, for 
which the cell compensates through alternative pathways. Intriguingly, 
inhibitors of these pathways (SAPK/JNK, EGFR/MAPK, PKC) also lead to 














To conclude the MEL eGFP system proved to be a robust synthetic system of 
heterochromatin. Multiple signalling kinases and BET inhibitors, in addition 
to classical heterochromatic mechanisms, were identified as inducing eGFP 
expression. The effect of BET inhibition was not compound specific, 
suggesting it was not due to off-target effects. eGFP activation correlated 
with G2 arrest and cell death. Heterochromatic marks were also lost from 
endogenous facultative and constitutive heterochromatic loci. The loss of 
H3K9me3 at the eGFP transgene was accentuated compared to the 
endogenous loci, likely due to the gene transcription, for which active marks 
were not found at the endogenous loci. There was a global increase in H3K4 
methylation by BET inhibition suggesting a global increase in transcription, 
which suggests an alternative role from transcriptional activation for BET 
proteins.  
 
This is supported by recent work from the Escaffit lab, that recently 
demonstrated Brd2 binding to pericentric heterochromatin (Grézy et al., 
2016). They demonstrated that TIP60 histone acetyltransferase deposits 
H4K12ac that acts as a binding site for Brd2 and depletion of TIP60 or Brd2 
leads to pericentric satellite transcription, conducive to a de-condensed 
chromatin structure. The work presented here in MEL cells suggests that 
Brd4 has a role as it is the only Brd- protein depleted, although this requires 
further investigation to rule out Brd2. Loss of Brd4 has also been shown to 
globally increase accessibility to nucleases indicative of a de-condensed 
chromatin fibre, although not specifically demonstrated at heterochromatin 
loci (Wang et al., 2012a). Together this suggests BET proteins function at 




Chapter 4: Epigenetic factors in tumor 




The previous work in MEL cells identified MAPK signalling as a method of 
modulating heterochromatin structure (Chapter 3) but aberrant MAPK 
signalling is also a hallmark of oncogenesis. Hahn and Weinberg (2002) first 
modelled human cells in vitro proposing six essential steps to oncogenesis: 
independence from proliferative and anti-growth extracellular signals, 
freedom from replication limitation, apoptotic/senescence evasion, and 
gaining invasion and angiogenesis abilities. Through human intervention, 
acquiring drug resistance can also be considered an essential trait of tumour 
development. MAPK signalling cascades have been associated with each of 
these processes, and their mis-regulation is a common occurrence in a 
tumour setting, as suggested by Downward, (2003).  
 
ERKs upstream effectors Ras and Raf have high mutational frequency in 
multiple malignancies, with Ras mutations found in 20-30% of all human 
tumours (Bos, 1989). These are invariably found in protein regions involved 
with GTP hydrolysis, causing constitutive activation. Importantly, this 
information has led to the development of multiple highly specific 
Ras/Raf/MEK inhibitors, to prevent ERK driven tumour survival. These can 
provide a significant benefit to melanoma patients where 45% present with 
BRAF mutations whilst another 20% harbour NRAS mutations (Hocker and 
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Tsao, 2007; Flaherty et al., 2012), but unfortunately, ERK driven tumours 
rapidly develop resistance leading to less than five months increased 
survival. In ~82% of BRAF V600E patients, resistance to BRAF/MEK 
inhibition is linked to reactivation of MAPK, PI3K and ERK signalling (Long 
et al., 2014). Of these V600E BRAF patients amplification only occurs in 20% 
of MEK resistant cases, whereas hyper-phosphorylation induced by V600E 
BRAF overexpression is in 80% of cases (Shi et al., 2012). Therefore the largest 
share of acquired resistance to MEK inhibition is not due to de novo genetic 
mutation, rather it is through an epigenetic response. 
 
Many transcriptional regulators have been implicated in MEK inhibition 
(MEKi) acquired resistance. PTEN, a negative regulator of PI3K signalling is 
lost upon MEKi, while MITF (a PI3K activator) is upregulated (Wee et al., 
2009; Ferguson et al., 2017). Additionally Ras activator ERBB3 is also 
upregulated leading to Ras hyper-phosphorylation (C. Sun et al., 2014).  
 
Recent work has demonstrated that acquired resistance to ERK signalling 
inhibition correlates with large scale alterations in genome regulation similar 
to epithelial mesochymal transition (EMT) (Jakobsen et al., 2016; Byeon et al., 
2017). This leads to a more invasive tumour type and poor patient survival. 
Altered polycomb silencing has been implicated in an EMT-like transition in 
oestrogen receptor positive breast carcinoma background, demonstrating 
epigenetic processes within EMT (Javaid et al., 2013). Understanding how 
MAPK signalling influences genome regulation inducing an EMT-like 
transition is therefore fundamental to understanding how ERK driven 
tumours acquire resistance. 
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4.2 Development of acquired resistance 
MEK inhibition model 
 
Trametinib is a highly selective MEK inhibitor, that prevents ERK 
phosphorylation in a dose dependent manner  <100 nM in HCT116 cells (Abe 
et al., 2011). In order to identify epigenetic mechanisms important for MEKi 
acquired resistance, HCT116 cells were treated with trametinib in increasing 
doses up to 100 nM over three months. HCT116 cells that could survive in 
100 nM trametinib were considered to have overcome MEKi. Invasion assays 
(John Dawson, Neil Carragher lab) demonstrated that trametinib resistant 
cells had altered cellular morphology, decreased cell-to-cell contact, and 
increased motility (Figure 4.1 A). Trametinib treatment in sensitive HCT116 
cells caused a decreased thickness of the cell layer in addition to reduced 
haematoxylin and eosin (H&E) staining, indicative of reduced cell density 
(Figure 4.1, A). HCT116 cells resistant to MEKi (TRAMR) maintain matrix 
invasion and cell layer thickness after trametinib treatment and H&E 
staining was slightly reduced. The decreased cell-to-cell contact and 
increased motility mimics the patient phenotype of MEKi acquired resistance 
due to an EMT-like transition (Byeon et al., 2017). TRAMR cells had increased 
survival at less than 100 nM trametinib treatment but similar cell survival to 
the sensitive HCT116 cells at concentrations about 100 nM (Figure 4.1 B) 
suggesting that resistance is acquired by hyper-activation of the 
Ras/Raf/MEK/ERK pathway. This was sustained even after the removal of 





Figure 4.1. Development of Trametinib resistance. (A) Organotypic invasion assay 
(carried out by John Dawson). HCT116 or TRAMR cells were cultured on fibroblast-
collagen matrices for 7 days with DMSO or 5 nM Trametinib. Images are H&E stained 
cross sections. (B) Cell viability data after trametinib treatment in HCT116 or TRAMR 
cells. Cells were treated with a log-dose of trametinib with viability determined by 




HCT116 and TRAMR cells were treated with 300 nM trametinib for 24 hour. 
Cell extracts were prepared by John Dawson, spotted onto reverse phase 
protein (RPPA) arrays and analysed using 185 antibodies against multiple 
signalling pathways. All the experimental data was collected and analysed 
(Appendix 3). Significant changes between samples are listed in table 4.1. 
The only significant change between DMSO treated HCT116 and TRAMR 
cells was ERK1/2 phosphorylation, which was upregulated in TRAMR cells 
(2.43 fold increase, p = 0.015), an expected result for a resistance mechanism 
linked to ERK hyper-phosphorylation. 
 
Table 4.1. Significant kinase signaling changes in response to trametinib. 
List of bonferroni corrected t-test significant changes in antibody fluorescence 
between either; (1) basal states of HCT116 and its trametinib resistant sister 
cells TRAMR, (2) HCT116 cells treated with 300 nM trametinib for 24 hour 
compared to DMSO controls, or (3) TRAMR cells treated with 300 nM 






Similar to previous studies, trametinib treatment in both cell lines triggered 
upregulation of ERBBs activation (C. Sun et al., 2014). Significant increases in 
phosphorylation after trametinib treatment were also found in HCT116 cells 
for: Met and FLT3 receptors, downstream PLC-gamma and SHP2, and 
SAPK/JNK (table 4.1). Met and FLT3 cell membrane receptors can activate 
PI3K signalling via PLC-gamma and SHP2 and are known to be upregulated 
in resistance to MAPK inhibition increasing cell motility (Usatyuk et al., 2014; 
Nogami et al., 2015). SAPK/JNK stimulation has also been implicated in EMT 
transition by inhibiting EZH2 mediated polycomb gene silencing, and is 
further evidence that trametinib treatment in this in vitro system is a good 
model for trametinib response (Li et al., 2016). While these proteins are also 
upregulated in TRAMR cells after trametinib treatment, only Met 
phosphorylation is significant. Additionally p53 Ser15 phosphorylation is 
also upregulated after trametinib treatment in both cell lines, indicating p53 
mediated transcription (Loughery et al., 2017). Together these data suggest 
that trametinib treatment in HCT116 and TRAMR cells provides a useful 










4.3 Identifying epigenetic components of 
acquired trametinib resistance 
 
To identify mechanisms involved in acquired MEKi resistance, compounds 
were screened in a dose matrix with MEK inhibitor trametinib (Figure 4.2). If 
the compounds are synergistic then the combination of both drugs will 
increase cell death when compared to each compound singularly. Identifying 
differences in responses between HCT116 and TRAMR cells can be used to 
infer that the compound’s target protein is implicated in acquiring trametinib 
resistance. 42 selective inhibitors were screened in a dose matrix across 21 
target classes identified as regulating synthetic heterochromatin in Table 3.1, 
in combination with trametinib. These included selective inhibitors of 
heterochromatin components, BET inhibitors and the kinase inhibitors 
identified in the MEL screen as modulating heterochromatin structure. Eight 
compounds were identified, as having combinatorial effects with trametinib 
or altered effects between HCT116 and TRAMR cells (Figures 4.3, 4.4). Two 
kinase inhibitors demonstrated altered profiles in TRAMR cells compared to 
HCT116. One of them, GW843682X is a selective inhibitor of PLK kinase 
(Lansing et al., 2007). In normal HCT116 cells PLK inhibition demonstrates 
no combinatorial effect with trametinib and limited efficacy singularly 
(Figure 4.3 A). TRAMR cells demonstrate increased sensitivity to PLK 
inhibition singularly (Figure 4.3 B). However, GW843682X has 100-fold 
selectively towards PLK1 and PLK3 (2.2 nM and 9.1 nM) compared to other 
kinases. The increased sensitivity required 500 nM treatment to affect cell 
growth in TRAMR cells and is therefore likely to be due to inhibition of off 
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target kinases. This also applies to the antagonistic affects with low-level 
trametinib treatment and high GW843682X dosage synergism (Figure 4.3 B).  
 
 
Figure 4.2. Drug combination dose matrix. Layout of a dose matrix experiment with 
Aurora kinase inhibitor ZM447439. HCT116 cells or their resistant sister cells were 
treated with a log-dose range of two compounds independently of each other (far left 
column and top row). Other wells were treated with every combination of the two 
compounds dose range. Cells were then incubated for 48 hours and cell viability 
analyzed using PrestoBlueTM. Comparison of concentration combinations were then 
compared to the singular compounds to determine synergistic and antagonistic effects. 
Further comparison between the sister cells identified combinations or targets pertinent 
to MEK inhibition resistance. 
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ZM447439 is a potent inhibitor of Aurora A and B kinases (Ditchfield et al., 
2003) and had an altered combinatorial effect with trametinib treatment 
(Figure 4.3 C, D). In trametinib sensitive HCT116 cells Aurora inhibition had 
little effect on cell viability as a single agent (Figure 4.3 C), while high dose 
ZM447439 (5-10 μM) is synergistic at low trametinib levels; this is lost at 
higher doses. This suggests that trametinib has a dominant effect in this 
combination. In trametinib resistant HCT116 cells (TRAMR) Aurora 
inhibition had a moderate effect as a single agent. The combination with 
trametinib demonstrates combinatorial synergism, limiting cell viability at 
higher concentrations to a similar level to sensitive HCT116 cells (Figure 4.3 
C, D). Together this indicates a minor role for Aurora kinase in acquired 
resistance to trametinib. 
 
UNC642 is a highly selective inhibitor of G9a and GLP methyltransferases 
(IC50 <2.5 nM). It has >2,000 times selectivity toward these H3K9 mono- and 
di- methyltransferases compared with H3K27me3 HMT Ezh2 and H3K9me3 
HMT Suv39h enzymes (F. Liu et al., 2013). High dose treatment of G9a/GLP 
inhibitor UNC642 resulted in low levels of cell viability in both HCT116 and 
TRAMR cells (Figure 4.3 E, F). At low doses UNC642 promotes cell growth 
as a single agent in HCT116 cells (Figure 4.3 E). However, there is no 
significant synergism or antagonism with trametinib treatment. This 
suggests that H3K9me2 does not have a significant role in ERK driven cell 
proliferation. In trametinib resistance cells, UNC642 combination is highly 
antagonistic (Figure 4.3 F) and suggests that H3K9me2 has an altered 
function in cells that have undergone the EMT-like transition to acquire 
trametinib resistance. Proliferation within these conditions is enhanced over 
controls, suggesting that in TRAMR cells this function of H3K9me2 limits cell 
growth when proliferative MAPK signalling is reduced. 
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Figure 4.3. Trametinib 3D HSA dose matrix plots for kinase inhibitors. Fraction 
affected 3D dose combination plots overlaid with the HSA model for synergism with 
MEK inhibitor trametinib. HCT116 or TRAMR cells were treated with a log-dose matrix 
between trametinib and another compound for 48 hours followed by PrestoBlueTM cell 
viability assay. (A-B) Combination plots of for PLK inhibitor GW843682X. (C-D) 
Combination plots for Aurora kinase inhibitor ZM44739. (E-F) Combination plots of G9a, 
GLP inhibitor UNC642. 
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H3K9me2 has been implicated in the formation of facultative 
heterochromatin during differentiation at genic regions in addition to its 
deposition pericentromerically (Wen et al., 2009). Recent work has indicated 
that H3K9me2 functions to allow transcriptionally permissive pericentric 
heterochromatin, maintained by argonaute mediated transcriptional 
silencing (Jih et al., 2017). Maintenance of pericentric heterochromatin in the 
absence of RNAi mechanisms requires the transition to H3K9me3, 
demonstrating an independent role for H3K9me2 in heterochromatin 
formation. The antagonistic effect of G9a/GLP inhibition in TRAMR cells, 
therefore suggests that H3K9me2 has altered function in ERK signalling 
response after acquired resistance, that may indicate altered heterochromatin 
regulation and/or altered heterochromatic transcription. 
 
Polycomb mediated silencing via the formation of facultative 
heterochromatin, is known to also function in differentiation mediated gene 
regulation as an alternative to H3K9me mediated heterochromatin (Gilbert et 
al., 2003). To determine if polycomb functions in trametinib acquired 
resistance, HCT116 and TRAMR cells were treated with selective inhibitors 
of Ezh2 (PRC2 subunit) and L3MBTL (PRC1 subunit), GSK343 and UNC 699 
respectively (Figure 4.4). For both inhibitors in sensitive HCT116 cells, 
inhibition had no effect on proliferation until the highest dose of 10 µ M; 
additionally there was no combinatorial effect with trametinib in HCT116 
cells (Figure 4.4 A, C). However, the trametinib resistant cells, TRAMR, 
showed increased sensitivity to both inhibitors when used as single agents. 
This effect is accentuated in UNC 699 treated TRAMR cells suggesting that 
PRC1 and subsequent PRC2 recruitment may be altered.  
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In combination with trametinib both inhibitors, GSK343 and UNC 699, have 
antagonistic effects at low concentrations (Figure 4.4 B, D). This suggests that 
MAPK signalling interacts with polycomb regulation after developing 
MAPKi resistance.  Canonical PRC1 complexes have a tight association to 
PRC2 and H3K27me3, and the common subunit Cbx7 is known to be 
phosphorylated by MAPK signalling (Kassis and Brown, 2012; Wu et al., 
2013). This would suggest a synergistic relationship with MAPK inhibition. 
However, atypical PRC1 complexes with Cbx6 and L3MBTL2 subunits are 
known to be essential for ES cell differentiation functioning independently of 
PRC2 and repressing MAPK expression (Qin et al., 2012; Santanach et al., 
2017). Together these data suggest that inhibition of PRC1 subunits would 




Figure 4.4. Trametinib 3D HSA dose matrix plots for polycomb inhibitors. Fraction 
affected 3D dose combination plot overlaid with the HSA model for synergism with MEK 
inhibitor trametinib and polycomb subunit inhibitors. HCT116 or TRAMR cells were 
treated with a log-dose matrix of trametinib and another compound for 48 hours 
followed by PrestoBlueTM cell viability assay. (A-B) Combination plots of for EZH2 






PRC2 is also known to have both tumour suppressor and oncogenic 
functions depending on the tumour type. Many tumours overexpress PRC2 
proteins including breast and colon (Bracken et al., 2003), but in contrast 
recurrent somatic loss of function mutations of PRC2 components are 
enriched in diffuse large B cell lymphoma and acute lymphoblastic 
leukaemia (Ernst et al., 2010). Subsequent studies have demonstrated that 
PRC2 loss in solid tumours has cooperative effects with MAPK signalling in 
driving tumour progression (De Raedt et al., 2014; Zhang et al., 2014). Taken 
together this suggests that PRC2 has tumour suppressor functions 
specifically acquired when developing trametinib resistance. 
 
Intriguingly, Thomas De Raedt's (2014) work also suggests that loss of PRC2-
MAPK tumour suppressor functions results is linked to BET protein 
function. To investigate this HCT116 and TRAMR cells were treated with 
multiple BET inhibitors to determine the function of BET proteins in 
trametinib resistance development (Figure 4.5). JQ1, I-BET151, and I-BET762 
are selective inhibitors of Brd2, Brd3, Brd4 and Brdt (Filippakopoulos et al., 
2010; Nicodeme et al., 2010; Mirguet et al., 2013). While selectivity differs 
between compounds, in HCT116 cells, BET inhibition has moderate affect as 
a single compound (Figure 4.5 A, C, E). Low dose of IBET762 and IBET151 
was antagonistic to trametinib, and, although this only occurred at one dose, 
it was reproducible (n=3). This antagonistic effect aside, there was no 
combinatorial effect with trametinib in HCT116 cells. Resistant TRAMR cells 
were more sensitive to all three BET inhibitors as single agents (Figure 4.5 B, 
D, F) while JQ1 was highly antagonistic in combination with trametinib. 
IBET151 and IBET762 by contrast showed moderate antagonism with 
trametinib at higher dosages. Unlike JQ1, which is a pan inhibitor across the 
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BET proteins, IBET151 and IBET762 have differing selectivity across the class. 
IBET151 has decreased selectivity towards Brd2 and further decreased 
selectivity towards Brd3 in vitro. IBET762 is most selective towards Brd2 
followed closely by Brd4, and decreased binding to Brd3 in vitro (Dawson et 
al., 2011). This suggests that the antagonistic properties come either from 
inhibiting all three BET proteins or is specifically linked to Brd2 and Brd3 
rather than canonical Brd4 inhibition.  
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Figure 4.5. Trametinib 3D HSA dose matrix plots with BET inhibition. Fraction 
affected 3D dose combination plot overlaid with the HSA model for synergism with MEK 
inhibitor trametinib and BET inhibitors. HCT116 or TRAMR cells were treated with a log-
dose matrix with trametinib and a BET inhibitor for 48 hours followed by PrestoBlueTM 
cell viability assay. (A-B) combination plots for JQ1+/-. (C-D) combination plots for I-
BET151. (E-F) Combination plots for I-BET762. 
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BET proteins bind to acetylated chromatin via tandem bromodomain 
hydrophilic pockets (Dhalluin et al., 1999). JQ1, IBET151 and IBET762 act as 
competitive inhibitors to acetylated lysines releasing BET proteins from 
chromatin without affecting protein structure. To determine whether 
acetylation changes were affecting BETi sensitivity, HCT116 and TRAMR 
cells were treated with a dose matrix of HDAC inhibitor trichostatin A and 
JQ1 (Figure 4.6). In HCT116 cells TSA and JQ1 are highly synergistic, 
indicative of inhibitors targeting the same pathway (Figure 4.6 A). 
Trametinib resistant cells sensitivity to the TSA single agent treatment was 
similar to that of HCT116 cells. However, JQ1-Trametinib combinations had 
a weak antagonistic effect, suggesting altered BET protein function after 
acquiring trametinib resistance (Figure 4.6 B). As TSA is a pan HDAC 
inhibitor this could be due to altered acetylation of non-chromatin substrates 
or acetylation independent recruitment of BET proteins. Recent work has 
demonstrated that structural chromatin protein CTCF can recruit Brd2 to 
determine transcriptional and architectural boundaries (Hsu et al., 2017). 
Additionally BET proteins Brd2 and Brd4 c-terminal domain interaction with 
viral DNA is known to cause recruitment to heterochromatin (You et al., 




Figure 4.6. Trichostatin 3D HSA dose matrix with BET inhibition. Fraction affected 
3D dose combination plot overlaid with the HSA model for synergism with HDAC 
inhibitor trichostatin A (TSA). HCT116 or TRAMR cells were treated with a log-dose 
matrix with TSA and JQ1+/- for 72 hours followed by PrestoBlueTM cell viability assay. 
(A) combination plot of for HCT116 cells. (B) combination plot of for TRAMR cells 
 
To investigate which BET proteins or bromodomains were implicated in 
trametinib-acquired resistance, further BET inhibitors were compared 
(Figure 4.7). OTX015 is another pan BET inhibitor similar to JQ1 with little 
selectivity between Brd2, Brd3 and Brd4 (Coudé et al., 2015). RVX-208 by 
contrast has 10-100 fold selectivity to BET proteins second bromodomain. 
Additionally RVX-208 has decreased selectivity towards Brd4 when 
compared to Brd3 and Brd2 (Picaud et al., 2013). All BET inhibitors apart 
from RVX-208 demonstrated increased sensitivity in TRAMR cells, indicating 
that both bromodomains are essential to this acquired function. The order of 
sensitivity across the BET inhibitors also correlates with selectivity towards 
Brd3 and Brd2 in contrast to Brd4 suggesting that one or both of these 
proteins may be involved in the acquired resistance to MAPK inhibition. 
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Figure 4.7. BET inhibition and cell viability. Bar charts showing cell viability using a 
PrestoBlueTM assay. HCT116 and TRAMR cells were treated with a half-log dose curve 
of BET inhibitors for 48 hours, independently. Viability was determined by Presto Blue 











4.4 The role of BET proteins in acquired 
resistance to ERK inhibition 
 
In order to further investigate the function of BET proteins, both HCT116 
cells and TRAMR were treated with increasing doses of JQ1 up to 1 µM over 
three months to develop resistance also known to occur in patients 
(Kurimchak et al., 2016). HCT116 and TRAMR cells resistant to JQ1 treatment 
(HJQ1R and TJQ1R) were treated with dose curves of trametinib +/- 1 µM 
JQ1, and JQ1 as a single agent along with their parental cell lines (Figure 4.8). 
With trametinib treatment HCT116 cells were the most sensitive. 
Intriguingly, both JQ1 resistant cell lines had similar tolerance of trametinib, 
beyond that of TRAMR cells (Figure 4.8 A). When treated with a log dose 
range of JQ1, both JQ1 resistant cell lines demonstrated negligible reduction. 
Reaffirming the drug combination matrix results TRAMR cells were more 












1 µM JQ1 combined with a log dose range of trametinib was however 
synergistic in both JQ1 and trametinib resistant cells (Figure 4.8 C) which 
suggests that BET inhibition is able to overcome MEK inhibition, reverting 
resistant cells to a sensitive state. Additionally, the synergism of JQ1 and 
trametinib in JQ1 resistant cells suggest that these act as a switch between 
molecular states, and not just as an upregulated multidrug resistance 
pathway. Together these results suggest that BET/MEK inhibition would be a 
viable drug combination, as they prevent acquired resistance to each other. 
This hypothesis has been further established by recent studies demonstrating 
that a Tip60/Brd4/Twist complex is required for nuclear reorganisation in an 
endothelial mesenchymal like transition (Shi, Cao and Zhou, 2015).  
 
The antagonistic combination shown previously in figure 4.5 B was not 
observed here at these comparatively higher dosages. Hyperphosphorylation 
at multiple protein residues is known to reduce the affinity of trametinib to 
MEK1, decreasing its efficacy, resulting in the stabilisation of phosphorylated 
c-myc, preventing its ubiquitination (Gilmartin et al., 2011; Tsai et al., 2012). 
Subsequent studies have demonstrated that c-myc, known to be regulated by 
BET proteins, contributes ERBB2/3 suppression, thus acting as a negative 
feedback loop (C. Sun et al., 2014). As such, BET inhibition and downstream 
reduction of c-myc will partially compensate for trametinib MEK1 inhibition. 
Further studies demonstrated that more extensive RTK inhibition was, 
however, able to overcome this myc driven feedback loop, demonstrated by 
higher doses used in figure 4.8 C (Lito et al., 2012).  
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Figure 4.8. Development of JQ1 resistance in combination with trametinib. 
Comparison of HCT116 cells and their sister cells with trametinib or JQ1+/- acquired 
resistance cells. Cell viability was assayed by PrestoBlueTM incubation and measured at 
540/590 nm.  (A) Cells treated with a log-dose range of trametinib for 24 hours. (B) 
Cells treated with a log-dose range of JQ1+/- for 24 hours. (C) Cells were treated with a 
singular dose of 1 µM JQ1+/- and a log-dose range of trametinib for 24 hours. 
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BET proteins have multiple functions modulating cell cycle progression. 
Brd4 stays bound to chromatin through mitosis, and is known to interact 
with condensin II and insulate chromatin from the DNA damage response. 
Loss of this function induces relaxed chromatin compaction and rapid cell-
cycle checkpoint recovery (Floyd et al., 2013). Brd2 was first identified as a 
regulator of cyclin A transcription and subsequent cell cycle progression 
(Sinha, Faller and Denis, 2005). To determine whether cell cycle alterations 
occur when HCT116 cells develop resistance to trametinib and JQ1 that could 
alter BET inhibition efficacy, propidium iodide cell cycle flow cytometry 
analysis was performed (Figure 4.9). HCT116, TRAMR, and HJQ1R cells 
were tested with 1 µM JQ1 for 48 hours. Untreated TRAMR cells had a 
similar cell cycle profile to untreated HCT116 cells, suggesting that the 
development of resistance to trametinib had no effect on cell cycle 
progression. Untreated HJQ1R cells however had elevated levels of cells in S 
phase and G2 indicating that the development of JQ1 resistance alters cell 
cycle progression. In all cell lines however JQ1 treatment resulted in an 
increase of cells in G1 (Figure 4.9 G) and suggests that development of 
resistance to JQ1 is an inherent property of “resistant” cells and not just an 
altered response to JQ1 treatment. 
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Figure 4.9. BET inhibition and the cell cycle. Frequency distributions for propidium 
iodide (PI) stained cells analyzed by flow cytometry. Treated cells were ethanol fixed 
and stained with 1 µg/ml of PI for 2 hours at room temperature. PI fluorescence was 
detected at 695-740 nm by flow cytometry (A-B) HCT116 cells treated with DMSO or 1 
µM JQ1+/- for 48 hours  (C-D) TRAMR cells  treated with DMSO or 1 µM JQ1+/- for 48 
hours  (E-F) HJQ1R cells treated with DMSO or 1 µM JQ1+/- for 48 hours. (G) Cell cycle 
stage ratios from A-F. 
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To determine if there was a change to the spatial distribution of Brd4, Brd4 
was analysed by immunofluorescence after 1 µM JQ1 treatment for 24 hours 
(Figure 4.10). In untreated HCT116 and TRAMR cells Brd4 had a diffuse 
staining pattern but HJQ1R cells by contrast had a diffuse staining pattern in 
addition to some punctate spots. The appearance of punctate Brd4 also 
occurred in each cell line after JQ1 treatment. To determine if Brd4 was 
redistributed from a central to more peripheral position, DAPI images were 
used in conjunction with edge segmentation to determine nuclear 
boundaries for each nucleus. These were then applied to the linked Brd4 
image and the average radial pixel intensity was calculated and binned into 
deciles for each cell. At least 20 cells were analysed for each treatment and 
cell line and plotted (Figure 4.10 B-G). Both HCT116 and TRAMR untreated 
cells had Brd4 radial distributions weighted to more central positions, in line 
with canonical functions of Brd4 within euchromatin, and JQ1 treatment in 
HCT116 cells did not significantly alter Brd4’s distribution (Figure 4.10 B-C). 
TRAMR cells by contrast saw a significant shift in Brd4 signal towards the 
periphery, which could be indicative of Brd4 being recruited to 
heterochromatic regions (Figure 4.10 D-E). HJQ1R cells differed from 
HCT116 and TRAMR cells as untreated Brd4 was evenly distributed from the 
centre to the periphery. JQ1 treatment of HJQ1R cells also did not 
significantly alter this distribution despite the signal being more variable 
(Figure 4.10 F-G) which might suggest that a Brd4 distribution associated 
with the nuclear periphery is not dependent on bromodomain function. 
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Figure 4.10. Brd4 distribution in nucleus after BET inhibition. HCT116, TRAMR and 
HJQ1R cells were treated with DMSO or 1 µM JQ1+/- for 24 hours. Cells were washed 
before fixation to remove unbound proteins, and stained with DAPI and Brd4 antibodies. 
(A) DAPI and Brd4 images of cell nuclei. (B-G) Radial distribution of Brd4 pixel signal 
intensity binned into deciles from more central positioning to the nuclear periphery. (B-
C) HCT116 cells treated with DMSO or JQ1+/- (D-E) TRAMR cells treated with DMSO or 
JQ1+/- (F-G) HJQ1R cells treated with DMSO or JQ1+/- 
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To determine if the increased sensitivity to JQ1 in TRAMR cells was directly 
due to BET protein transcription, RT-qPCR normalised to MRIP was used to 
analyse RNA levels (Figure 4.11). In HCT116 cells, JQ1 1 µM treatment for 6 
hours resulted in no significant changes in Brd3 and Brd4 transcription, with 
a minor decrease in Brd2. C-myc, the canonical downstream effector of Brd2 
and Brd4, also showed no significant increase in transcription after JQ1 
treatment. Untreated TRAMR cells by comparison had a 4-fold increase in c-
myc transcription. This could implicate c-myc as a driver of resistance within 
TRAMR cells. Importantly, this increase in c-myc transcripts is lost upon JQ1 
treatment, directly implicating BET proteins in regulating MEK inhibition 
resistance. Untreated TRAMR cells also had a 2-fold increase in Brd2 
transcription. JQ1 treatment did not affect Brd3 and Brd4 transcription but 
Brd2 decreased 4-fold. This suggests that the only immediate change in 
transcription post JQ1 treatment is a reduction in Brd2.  
Figure 4.11. Transcriptional response to BET inhibition. HCT116 and TRAMR cells 
were treated with DMSO or 1 µM JQ1+/- for 24 hours. Transcription of c-Myc, Brd4, 
Brd3, and Brd2 was quantified by qPCR. Amplification was normalized to the house-
keeping gene MRIP. 
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RT-qPCR was also used to determine if these transcriptional changes were 
sustained out to 24 hours and determine the effect on HJQ1R cells (Figure 
4.12). HCT116 and TRAMR BET protein transcription broadly mirrored the 
changes at 6 hours, except a two-fold reduction in Brd2 after JQ1 treatment in 
HCT116 cells. Untreated HJQ1R cells had no significant changes in all BET 
proteins when compared to HCT116 cells. JQ1 treatment however resulted in 
decreased transcription (30-70%) across the BET proteins. Intriguingly, 7sk 
RNA levels were also elevated in TRAMR cells. 7sk functions in a complex to 
sequester P-TEFb, regulating its binding to Brd4 and its function in 
transcriptional elongation (Prasanth et al., 2010). Together this suggests that 
BET proteins have altered post-transcriptional regulation in TRAMR cells. 
 
The radial distribution of Brd4 in TRAMR cells after JQ1 treatment and 
HJQ1R distribution suggests a role at the nuclear periphery (Figure 4.10). 
HP1 proteins play an important role in the maintenance and propagation of 
heterochromatin (Nakayama, Klar and Grewal, 2000; Hall et al., 2002). 
Therefore RT-qPCR was used to determine if BET proteins regulate 
heterochromatin via HP1 proteins (Figure 4.12). Upon JQ1 treatment 
HCT116 cells showed no significant change to HP1α transcripts, while HP1β 
and HP1γ are elevated by 48% and 68%, respectively. Untreated TRAMR 
cells however showed no major change in any HP1 isoform transcripts after 
JQ1 treatment or to HCT116 cells. Untreated HJQ1R by contrast had 
decreased levels of HP1α accentuated by JQ1 treatment. HP1β was also 
reduced after JQ1 treatment in HJQ1R cells suggesting that acquiring 





Figure 4.12. HP1 α/β/γ protein expression in response to BET inhibition. HCT116, 
TRAMR, and HJQ1R cells were treated with 1 µM inactive JQ1-/- or active JQ1+/- for 24 
hours. Transcription of 7SK, BET proteins and HP1 proteins were quantified by qPCR. 












Western blotting was used to assess whether JQ1 treatment and acquired 
resistance affected protein levels (Figure 4.13) and densitometry was 
performed to quantify protein levels in HCT116, TRAMR and HJQ1R cells. 
Brd4 total protein levels were only elevated in HJQ1R cells upon JQ1 
treatment. This indicates that HJQ1R cells may overcome JQ1 treatment by 
preventing Brd4 degradation, as transcription is not supressed (Figure 4.12). 
Brd3 nuclear protein levels were stable across all three cell lines and 
treatment conditions, suggesting that it is not involved in acquired resistance 
to BET or MEK inhibition but Brd2 nuclear protein levels by comparison 
were altered in the resistant cell lines. Although HCT116 cells showed no 
major changes in Brd2 levels after JQ1 treatment, TRAMR cells presented 
with a significant reduction. Untreated HJQ1R cells also had significantly 
lower Brd2 levels when compared to TRAMR and HCT116 cells. Upon JQ1 
treatment however Brd2 levels are restored to levels similar to HCT116 and 
TRAMR cells. Taken together this implicates Brd2 in the phenotypic switch 
between JQ1 and trametinib resistance implicated in figure 4.8.  
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Figure 4.13. Nuclear protein levels after BET inhibition. (A) Westerns of HCT116, 
TRAMR, and HJQ1R nuclear lysates after 48 hour treatment with DMSO or JQ1+/- 1uM. 
(B) Bands were quantified by 2D densitometry and normalised to total histone H3. 
Relative protein levels determined by comparison to HCT116 DMSO controls. 
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HP1 nuclear protein levels were also analysed by western blotting (Figure 
4.13). JQ1 treatment in HCT116 cells had no effect on any HP1 isoform 
nuclear concentration. Untreated TRAMR cells presented elevated levels of 
HP1α and HP1γ  when compared to HCT116 cells and this effect was 
partially negated by JQ1 treatment. Untreated HJQ1R cells also had 
increased HP1α nuclear levels, but no significant changes to HP1β or HP1γ 
levels. In contrast, JQ1 treatment in TRAMR cells resulted in a further 
increase in HP1α levels. This suggests that HP1α may function in acquiring 
resistance to JQ1 and trametinib in addition to Brd2. Intriguingly, H3K9me3 
levels appear to be severely depleted in HJQ1R cells. As H3K9me3 and HP1α 
are hallmarks of pericentric heterochromatin, this also suggests an altered 
chromatin state at the nuclear periphery in response to developing 
resistance. 
 
Figure 4.14. Transcriptional response to trametinib resistance. Global transcription 
levels determined by the incorporation of 5 µl per ml of [5-3H]-uridine within 30 minutes. 
HCT116, TRAMR, and HJQ1R were treated with DMSO or 1 µM JQ1+/- for 24 hours 
prior to [5-3H]-uridine exposure (n = 3 technical replicates). RNA was purified and 
incorporation determined via scintillation counting (n = 2). 
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HP1 proteins have been associated with RNA at pericentric heterochromatin, 
and are known to have a non-specific RNA binding site. To determine if 
global transcription levels were affected by JQ1 or resistance the 
incorporation of tritiated thymidine was assayed. 5 µ l [3H]-Thymidine was 
added per ml of media for each sample for 30 min to allow incorporation into 
RNA polymerase transcripts. Purified RNA was added to scintillant and 
measured on a scintillation counter (Figure 4.14). While biological replicates 
showed some variation, there was no consistent effect of JQ1 on global 
transcription in any cell type, for this short period of time. Untreated HJQ1R 
cells showed a minor increase (30%) in global transcription levels compared 
to HCT116 cells, however given the variation in untreated HCT116, this was 
not likely to be significant. Untreated TRAMR cells in contrast have a 2-fold 
increase in global transcription levels. This suggests that in addition to 
elevated Brd2 and 7sk levels (Figure 4.12), there is a significant but subtle 











Epithelial to mesenchymal transitions (EMT) are driven by specific 
transcription factors SNAIL and TWIST, and typified by the loss of E-
cadherin (Cano et al., 2000; Yang et al., 2004). Rapid development of acquired 
resistance to MAPK inhibitors is associated with an EMT-like transition 
across tumour types (Byeon et al., 2017; Kitai and Ebi, 2017) and EMT tumour 
progression is known to result in genome wide chromatin reorganisation. 
This chromatin reprogramming encompasses distinct alterations of H3K9 
methylation and HP1 binding to heterochromatin (McDonald et al., 2011; 
Millanes-Romero et al., 2013). Therefore, the inhibitors identified as 
modulating synthetic heterochromatic domains (Table 3.1), were 
investigated within a MAPK inhibitor resistant model system. 
 
The initial studies characterising the altered phenotype to prolonged MEK 
inhibition (Figure 4.1) demonstrated that this in vitro cell line model mirrored 
the patient phenotype for overexpression/hyperphosphorylation of the 
Raf/Ras/MEK/ERK pathway (Montagut et al., 2008; Long et al., 2014). 
Trametinib resistance resulted in more invasive cells and basal levels of ERK 
phosphorylation were upregulated, whilst the adaptive signalling response 







To determine if drugs could modulate pathways associated with an EMT-
like transition to a drug resistant state, they were screened in a dose-matrix 
combination with MEK inhibitor trametinib (Figure 4.2). Two specific kinase 
inhibitors of PLK and Aurora B (Figure 4.3) were identified as having an 
altered phenotypic effect in MEKi resistant cells. PLK, a known regulator of 
chromosome segregation correlates with tumour grade and invasiveness 
across Ras driven tumours (X. G. Zhang et al., 2012; W. Sun et al., 2014) and 
the elevated sensitivity towards PLK inhibition suggests increased 
dependence on PLK in MEKi resistant cells. PLK is also a downstream 
effector of Akt driven EMT, while hyperphosphorylation of Ras has been 
linked to Akt crossover activation (Carracedo and Pandolfi, 2008; Cai et al., 
2016; Ferrarotto et al., 2017).  The antagonism between GW843682X and 
trametinib however suggests that trametinib promotion of EMT and 
acquired MEKi resistance is not dependent on PLK phosphorylation.  
 
Aurora kinases also plays a key role in chromosome segregation during 
mitosis, with Aurora A being implicated in activating EMT (D’Assoro et al., 
2014). Increased sensitivity to Aurora A/B inhibition by ZM447439 as a single 
agent in TRAMR cells is therefore expected. Additionally the weak 
synergism with trametinib treatment is likely due to the direct activation of 
Aurora A by MAPK signalling previously reported, further demonstrating 
the dependence of EMT and heterochromatin regulation in acquired drug 






Three epigenetic target classes (EZH2, L3MBTL, and BET) from the inhibitor 
panel (Table 3.1) also had altered sensitivity in TRAMR cells. UNC642, a 
potent inhibitor of G9a/GLP methyltransferases was more sensitive as a 
single agent in resistant cells, but had significant antagonism with MEK 
inhibition (Figure 4.3). G9a/GLP are responsible for H3K9 mono- and di-
methylation. These histone modifications are thought to regulate the 
formation of facultative heterochromatin and gene silencing via HP1 
recruitment (Ogawa et al., 2002; Lyons et al., 2014). G9a has previously been 
associated with EMT-like phenotype by interacting with SNAIL in MAPK 
driven tumours (Dong et al., 2012). This suggests that G9a/GLP inhibition 
would be synergistic with trametinib. However, G9a has been identified as a 
direct regulator of Sprouty4 which in turn negatively regulates MAPK 
signalling and the mesenchymal phenotype (Taniguchi et al., 2009; Hua et al., 
2014). This regulation is likely to contribute to large antagonistic effect with 
G9a/GLP-MEK combinations. 
 
The EZH2 inhibitor, GSK343, demonstrated a weak increase in response to 
treatment in TRAMR at high concentrations only (Figure 4.4 B). Equally, in 
combination with trametinib it showed a weak antagonistic effect. UNC699, 
an inhibitor of the PRC1 subunit, L3MBTL, showed a large increase in 
response to treatment as a single agent at low dosage, by contrast. However, 
UNC 699 was also antagonistic in combination with trametinib (Figure 4.4 
D). As discussed previously, canonical and atypical PRC1 complexes have 
been linked with driving EMT and repressing MAPK signalling, 
demonstrating its dual role and subsequently antagonism with MEK 
inhibition (Kassis and Brown, 2012; Santanach et al., 2017). 
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BET protein inhibitors were also identified as having increased sensitivity in 
TRAMR cells (Figure 4.5) and were antagonistic in combination with 
trametinib. Recent studies have demonstrated that RTK-driven cancers’ 
resistance mechanism converge on MYC activation supporting this result 
(Ma et al., 2017; Singleton et al., 2017; Zawistowski et al., 2017). These studies 
also present evidence that MEK inhibition is enhanced with the addition of 
JQ1, however they did not comprehensively analyse the synergism of the 
combinations. While BET-MEK combination therapy may not be synergistic, 
the additive effects presented in these studies and ability to resensitise MEKi 
resistance was demonstrated at higher trametinib concentrations (Figure 4.8). 
Singleton, et al (2017) and Zawistowski, et al (2017) studies were also 
performed on in vivo models over prolonged treatment which would 
accentuate any cytostatic effects of the combination. This was not be 
identified with the combination matrixes analysed in figure 4.5 or figure 4.8 
which were performed over 24-48 hours treatment but these studies do, 
however, validate findings that BET inhibition has altered effects in cells that 
have adaptive resistance to MAPK inhibition. 
 
Variations in sensitivity towards different BET inhibitors gave an indication 
of which BET proteins had the dominant effect on acquired resistance 
(Figure 4.5 and 4.7). The results shown here suggest that selectivity towards 
Brd2 influenced cell survival. However Brd4 nuclear distribution was 
significantly altered after JQ1 treatment in TRAMR cells, with increased 
association with distinct loci at the periphery (Figure 4.10). No clear change 
in Brd2 pattern was observed (data not shown), suggesting that the change in 
Brd4 distribution occurs with general loss of Brd2.  This interplay between 
Brd2 and Brd4 supports the current studies indicating a partial overlap in 
function (Cheung et al., 2017). Recent studies have also indicated that isoform 
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switching between Brd2 and Brd4 drives lineage specific differentiation 
(Fernandez‐Alonso et al., 2017). Cell cycle analysis showed no difference 
between HCT116 and TRAMR cells suggesting that the atypical Brd4 
distribution was not due to mitotic defects (Figure 4.9).  The potential role of 
Brd2 was further linked to this response, attributable to its elevated 
transcription in TRAMR cells. Supporting the recent studies indicating MYC-
driven resistance to MAPK inhibition, c-myc was also elevated in TRAMR 
cells; elevated levels of c-myc and Brd2 are both lost upon JQ1 treatment. 
Brd3 and Brd4 levels remained unchanged further implicating Brd2 as the 
driver of JQ1 sensitivity. Consistently, loss of Brd2 transcripts also translates 
to protein levels (Figure 4.13).  
 
Intriguingly, HP1 isoform levels were significantly altered by acquiring 
trametinib resistance and JQ1 treatment. Untreated TRAMR cells had 
significantly increased abundance of nuclear HP1α and HP1γ (Figure 4.13) 
but JQ1 treatment caused significant reductions in all HP1 isoforms. This 
suggests that BET proteins play a significant role in regulating HP1 
transcription and consistently in cells resistant to JQ1 treatment these 
changes to BET and HP1 proteins were broadly reversed, providing further 
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evidence of BET protein regulation in switching of phenotypic states.  
 
  
Figure 4.15. BET proteins distribution at HP1 promoters. Brd4 ChIP-seq tracts from 
Asangani (2014), W. Liu (2013), and Knoechel (2014) on epithelial cell lines HEK292 
and HeLa compared to mesenchymal drug resistant prostrate cell line VCaP and T-ALL 













Comparison of publically available Brd4 ChIP-seq data sets further supports 
this position. Epithelial cell lines HEK293 and HeLa (W. Liu et al., 2013)  lack 
Brd4 binding at HP1 promoters while mesenchymal and drug resistant 
DND-41 and vCaP cells (Asangani et al., 2014; Knoechel et al., 2014) have 
distinct Brd4 peaks over HP1 promoters (Figure 4.15). JQ1 treatment of the 
castration resistant VCAP cells resulted in a significant decrease in Brd2 
occupancy over HP1 promoters when compared to Brd3 and Brd4, further 
suggesting a Brd2 specific role in acquired MAPK resistance (Figure 4.16). 
 
 
Figure 4.16. BET chromatin binding at HP1 promoters with JQ1 treatment. ChIP-
seq tracts from Asangani (2014), depicting Castration resistant mesenchymal prostate 
cancer cells VCaP. VCaP cells were treated with DMSO or 0.5 µM JQ1+/- and immune-
precipitated for Brd2, Brd3, and Brd4. HP1β gene CBX1 shows reduced BET protein 
occupancy after JQ1+/- treatment, representative of the HP1 family. Black bar 




Together the results shown here further support the concept that relates 
EMT-like phenotypes with acquired MAPK inhibitor resistance, and the 
identification of BET proteins as a potential therapeutic agent to resistant cell 
types. Additionally, this work suggests that BET proteins are associated with 
heterochromatin regulation in acquired MAPKi resistance. There is evidence 
suggesting that Brd2 drives BET proteins function at heterochromatin. This 
could be indirect via regulating HP1 transcription or direct by TIP60 
mediated recruitment to pericentric repeats (Grézy et al., 2016). Although the 
regulation of pericentric heterochromatin, is not well understood, TIP60 is 
known to acetylate H4K12 at satellite repeats, recruiting Brd2 to maintain 
chromatin compaction and suppress transcription, while loss of Brd2 
association via BET inhibition leads to aberrant satellite expression that could 
explain the Brd4 punctate recruitment to the nuclear periphery (Figure 4.10). 
Investigations of heterochromatin compaction and its impact on cellular 


















A well-defined model of constitutive heterochromatin is mouse embryonic 
stem cells (mESCs). Mouse centric and pericentric heterochromatin is easily 
visualised by DNA staining, as it co-locates to form chromocenters unlike 
most primate cells. Pericentromeric regions are comprised of A-T rich 
repetitive elements such as minor and major satellites in mouse cells; major 
satellites form large arrays of a 234 bp core monomer (Vissel and Choo, 
1989), whilst minor satellite forms a 120 bp repeat. Due to the role of 
centromeric chromatin in correct kinetochore assembly, chromatin 
abnormalities in constitutive heterochromatin can lead to mitotic defects 
(Ekwall et al., 1997). In Drosophila and mammalian cells constitutive 
heterochromatin also spreads to adjacent euchromatic regions mediating 
transcriptional suppression (Muller, H, 1930) and position effect variegation. 
The constitutive heterochromatin at these suppressive regions of variegation 
are characterised by DNA methylation, general hypoacetylation, H3K9 
methylation and association of HP1 proteins (James and Elgin, 1986; 





The interplay between HP1 proteins, H3K9me3, and Suv39h1/2 
methyltransferases has been extensively studied at constitutive 
heterochromatic regions. HP1 isoforms are highly conserved across species 
from Swi6 in S. pombe to HP1α/β/γ in mammalian cells (Singh et al., 1991). 
HP1 proteins are regulators of gene expression by position-effect variegation 
(Eissenberg et al., 1990). Although they do present some variation in their 
distribution (Minc, Courvalin and Buendia, 2000; Nielsen et al., 2001), the 
differential functions of the HP1 isoforms have yet to be fully elucidated. The 
HP1 protein encodes a chromo domain that facilitates its binding to 
H3K9me3 (Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002) in a process 
that requires dimerisation of HP1 proteins via its chromoshadow domain 
(Cowieson et al., 2000; Sadaie et al., 2008).  Subsequent studies on the S.pombe 
HP1 homologue Swi6 suggest that proximity of two H3K9me3 enables two 
HP1 proteins to tetramerise on a nucleosome which, in addition to the 
formation of homodimers, enables oligomerisation of HP1 across large 













The disordered hinge region of HP1 proteins is the least conserved and has 
been shown to interact with both RNA and DNA (Meehan, Kao and 
Pennings, 2003; Keller et al., 2012). As RNase treatment triggers the 
dissociation of HP1 from heterochromatin (Maison, Bailly, Peters, J.-P. 
Quivy, et al., 2002) it suggests an RNA component to HP1 recruitment or 
stabilisation. In S.pombe DICER mediated RNAi produces short transcripts 
from pericentric regions that stabilise the recruitment of HP1 proteins, while 
in humans lncRNA TERRA has been implicated in HP1 recruitment to 
telomeric constitutive heterochromatin, however a similar mechanism at 
pericentric heterochromatin has yet to be found (Arnoult, Van Beneden and 
Decottignies, 2012; Keller et al., 2013). 
 
HP1 canonical recruitment to heterochromatin is driven by Suv39 histone 
methyltransferase through the deposition of H3K9me3. This was proposed 
when Suv39h double null knockout fibroblast cells showed a loss of 
H3K9me3 and HP1 from heterochromatin (Lachner et al., 2001). However, 
HP1 affinity for trimethylated H3K9 is particularly low suggesting that 
additional factors are directly involved in its recruitment (Jacobs and 
Khorasanizadeh, 2002). This is further supported by studies on the X-
chromosome where inactivation leads to H3K9me3 deposition but not HP1 
recruitment (Chadwick and Willard, 2003), but to complicate the picture  
Suv39h1 and Suv39h2 have also been implicated in directly recruiting HP1 
proteins (Hall et al., 2002). Due to the cooperativity between H3K9me3 
deposition, HP1 and Suv39h recruitment, recent studies have focused on 




Suv39h methyltransferases contain an N-terminal chromodomain and a C-
terminal SET domain (Horita et al., 2001; Min et al., 2002) which are highly 
conserved across species and protein classes. SET domains are catalytic sites 
for S-adenyl-methionine (SAM) mediated methylation (Trievel et al., 2002). 
whereas chromodomains were identified as a consensus motif between 
polycomb and HP1 proteins in drosophila (Paro and Hogness, 1991). Site 
directed mutagenesis experiments showed that these chromodomains 
functioned in gene repression (Messmer, Franke and Paro, 1992). This was 
confirmed by in vitro studies demonstrating their reactivity towards di- and 
tri-methylated lysines (Hughes et al., 2007). Suv39h chromodomains however 
are more specific towards trimethylated states (Schalch et al., 2009).  This 
specificity however suggests that Suv39h chromodomain is not involved in 
its recruitment for de novo heterochromatin formation. 
 
Given that RNase treatment leads to loss of the H3K9me3/HP1/Suv39h 
complex from heterochromatin, back to back studies in eLife suggested that 
recruitment of Suv39h enzymes can be mediated by RNA (Johnson et al., 
2017; Shirai et al., 2017; Velazquez Camacho et al., 2017). However, these 
studies do not completely validate each others’ findings. They present 
conflicting data around the specificity of Suv39h binding to specific RNA 
transcripts and general RNA/DNA binding affinity. Despite the controversial 
claims of these studies, they do provide strong evidence for a direct 
interaction between Suv39h and nucleic acids, and that pericentric 
transcripts can associate with local chromatin and concentrations correlate 




In addition to RNA and H3K9me3, HP1 SUMOylation has been implicated in 
regulating RNA associated de novo heterochromatin formation and 
maintenance (Shin et al., 2005). Maison et al. (2011) demonstrated that HP1 
proteins are only associated with major satellite RNA transcripts when 
SUMOylated at the hinge region, and that this only occurs at low levels 
(>1%) in vivo. In Suv39h double null mouse cells, constitutively SUMOylated 
HP1α, HP1 was weakly associated with the pericentromere despite the lack 
of its binding partners H3K9me3 and Suv39h. However the exact method of 
de novo chromatin recruitment remains elusive, with recent evidence 
implicating Suv39h as recruiting Ubc9 to SUMOylate HP1 proteins (Maison 
et al., 2016). While SUMOylated HP1 proteins are chromatin associated at de 
novo heterochromatin sites, the SUMO protease SENP7 is required to 
maintain HP1 enrichment across established heterochromatin domains by 
reducing its mobility (Maison et al., 2012). SENP7 has two HP1 binding 
motifs that have been suggested to recruit SENP7 to sites of oligomeric HP1 
in contrast to de novo HP1 recruitment, demonstrating how SUMOylation is 
removed from established heterochromatin (Romeo et al., 2015). 
 
The interplay between H3K9me3, Suv39h, and HP1 in their binding of 
chromatin is complex; Suv39h double null cells also lose H4K20me3 and 
DNA methylation while presenting chromosome instability with increased 
tumour risk in mice (Peters et al., 2001). Knock out of DNA methylation 
enzymes by contrast does not result in the loss of Suv39h mediated 
H3K9me3 or chromatin compaction, implying that Suv39h is the master 
determinant of hertochromatin modifications (Martens et al., 2005; Gilbert, 
Thomson, Boyle, Allan, Ramsahoye and Wendy A Bickmore, 2007). Despite 
an absence of extensive epigenetic marks Suv39-/-mice cells still form 
cytological chromocenters, questioning the perceived role of histone 
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modifications and their binding partners in being able to regulate the 
compaction state of the underlying chromatin. Therefore, before 
investigating the role of histone modifiers such as BET inhibitors on HP1 
proteins and chromatin compaction, the regulators of chromatin compaction 























5.2 Characterising the chromatin state of 
Suv39h double null mESC’s 
 
To maintain mouse embryonic stem cells in an undifferentiated state, 
different growing conditions were first analysed (Figure 5.1). mESCs were 
grown on gelatin coated Corning orange capped flasks and yellow capped 
Sarstedt cell+flasks for sensitive adherent cell types . 10X magnification 
bright field images show that growth in yellow capped flasks resulted in 
more round distinct colonies, similar to the morphology of ES cells grown in 
2i medium (information from Richard Meehan lab). This was regardless of 
Suv39h phenotype (Figure 5.1, A). Transcription of key pluripotency factors 
Nanog and Oct4 were then analysed by qPCR. Nanog and Oct4 levels were 
elevated in the orange capped Corning flasks indicative of increased stem 
cell characteristics (Chambers et al., 2003; Niwa, Miyazaki and Smith, 2016) 
(Figure 5.1, B). Therefore cells were grown on gelatinised corning flasks for 
cell line maintenance.  
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Figure 5.1. Mouse embryonic stem cell phenotype. (A) 10X bright field images of 
mouse ESC colonies from wild type [WT41] and Suv39h1/2 double knockout cells 
[DN57]. “Orange Caps” are Corning CellStar flasks manually coated in 0.1% gelatin for 
5 minutes, “Yellow Caps” are Sarsted Cell+ pre-coated flasks. (B) RNA from mESC’s 
was harvested using an RNeasy kit and cDNA libraries prepared.  QPCR for stem cell 
factors Nanog and Oct4, normalized to actin for cells grown on Corning orange capped 
flasks coated in gelatin and Sarstedt Cell+ yellow capped pre-coated flasks. Error bars 
= SEM of biological replicates (n=3). 
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To analyse the effect of Suv39h1 and Suv39h2 double knock out (DN57) on 
heterochromatic makers in ES cells, nuclei were isolated and analysed by 
western blotting compared to wild-type cells (WT41) (Figure 5.2). Double 
null cells (DN57) showed a 20% decrease in H4K20me3 and a significant 
increase in mono-methylation. This supports evidence linking Suv39h 
regulation of H4K20me3 at the pericentromere (Peters et al., 2001; Yang et al., 
2008). H3K27me3 was also elevated in the knockout cells at the expense of 
H3K27me2. This suggests that polycomb activity is increased in the absence 
of Suv39h. Intriguingly, repressive H3K9 di- and tri-methylation were not 
completely lost. This suggests some redundancy with other 
methyltransferases at least on a global scale. HP1α and HP1β levels, were 
also reduced, possibly as a feedback from their disassociation from 
chromatin. Together these data suggest that Suv39 double knockout mESCs 
mimic phenotypes described previously (Peters et al., 2001). 
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Figure 5.2. Heterochromatic histone modifications response to Suv39h1/2 loss. 
(A) Nuclei were isolated and protein lysates prepared from WT41 and DN57 mouse ES 
cells. Samples were run on a 4-12% Bis-Tris Nupage gel and western blots performed 
for multiple heterochromatin components. (B) Densitometry quantification of the blots. 
Results show the relative levels of DN57 to WT41 samples. 
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As global levels of H3K9me3 and H4K20me3 were not completely lost in the 
double knockout cell lines, immune-fluorescence was used to determine their 
nuclear distribution (Figure 5.3). Both H3K9me3 and H4K20me3 signal in 
wild type cells were concentrated at chromocentres as visualised by DAPI 
staining and this was lost in the knock out cell lines.   
 
To investigate changes in chromatin compaction at the level of the 30-nm 
chromatin fibre after loss of Suv39h, chromatin was analysed by sucrose 
gradient sedimentation and Southern blotting (Figure 5.4). This technique 
was used previously to measure compaction in a Dnmt3a/b null background 
(Gilbert et al, 2007). Nuclei were first isolated from the cells and digested 
with RNase A/T1 and micrococcal nuclease, in order to release soluble 
chromatin fibres from the nucleus under physiological salt conditions. In this 
approach RNase digestion is used to stop nuclear RNAs competing for 
binding of H1 to chromatin, which would otherwise affect the structure. 
However, this does have the disadvantage of degrading potential nuclear 
RNAs that might otherwise affect chromatin structure. In addition, 
micrococcal nuclease also attacks the 5’phosphodiester backbone of RNA so 
even in the absence of RNase the enzyme will digest potential chromatin 
associated RNAs and this might affect conclusions that have been drawn in 
studies implicating RNA in Suv39h recruitment (Cunningham, 1959; 
Velazquez Camacho et al., 2017). After soluble chromatin is released from the 




Figure 5.3. Distribution of histone modifications in SUV-/- cells. Wild type (WT41) 
and Suv39h1/2 knockout (DN57) mouse ES cells imaged for the methylation 
modifications attributed to Suv39h and Suv420h enzymes (H3K9me3, and H4K20me3). 
(A) images of DAPI and H3K9me3 immunofluorescence (B) Images of DAPI and 




The sedimentation rate of chromatin is determined by the fragment size 
(mass) and its structure. More disrupted chromatin fibres sediment at a 
slower rate than a more regular compact fibre of the same DNA length due 
to differences in friction. After sedimentation the gradient is fractionated by 
upwards displacement while measuring the DNA content via an inline UV 
spectrometer. Chromatin fibres of the same size (mass) but different 
compaction states will therefore be in different sucrose gradient fractions. 
Proteinase K treatment and phenol:chloroform extraction is then used to 
purify the DNA in each fraction before fractionating the DNA on a 0.7% Tris-
phosphate gel at a low voltage to improve resolution (Figure 5.4, B).  
 
In order to detect specific DNA regions the gel is Southern blotted onto a 
membrane and probed with radioactive DNA fragments described in Section 
2.8. Essentially the agarose gel is UV nicked on a transilluminator and 
depurinated using HCl. NaOH treatment is used to induce DNA strand 
separation to single stranded DNA. Neutral Southern blotting is used to 
transfer single stranded DNA fragments to a nitrocellulose membrane, and 
complementary radiolabelled oligonucleotide fragments are used to analyse 






Figure 5.4. Sucrose gradient chromatin analysis methodology. Process of isolating 
chromatin fibers and performing compaction analyses. (A) Nuclei are prepared from 
cells under physiological conditions. Micrococcal nuclease partial digest allows 
chromatin fragments to be released from the nuclei. This chromatin solution is then 
spun through an isokinetic sucrose gradient. (B) The sucrose gradient is fractionated 
and passed through a UV spectrometer to determine the DNA content of each fraction. 
Each fraction undergoes a phenol/chloroform extraction to purify the DNA and run on a 
0.7% TPE gel. The maxima intensity for each fraction is used to determine the DNA 
fragment size for each fraction and plotted to compare samples. (C) The DNA gel is 
treated with UV and HCl to fragment the DNA. Afterwards the gel is treated with NaOH 
to separate the DNA strands and single stranded DNA is transferred to a nylon 
membrane by Southern blotting. This membrane is then hybridized to radio labeled 
DNA probes for heterochromatic repeats and compared to the total DNA fragment 




















Gradient fractions containing chromatin fibres ranging from 2.5 kb to 12 kb 
were compared between wild type (WT41) and Suv39h double null (DN57) 
mESCs (Figure 5.5). As chromatin fibres get longer the number of possible 
disruptions increases, therefore, increasing the differences in sedimentation 
between the chromatin fibres. To facilitate a comparison in chromatin 
structure the sedimentation rate of chromatin fibres at 9 kb were contrasted. 
By reading across from 9 kb it is apparent that DN57 chromatin is 
sedimenting more slowly that WT41 chromatin (Figure 5.5, B). Reading the 
graph the other way, the bulk chromatin fragment size at Fraction 17 from 
WT41 cells was 8588 bp compared to 9328 bp in DN57 cells. This 8.6% 
discrepancy is a very surprising result that indicates that chromatin fibres in 
DN57 cells are on average more disrupted across the entire genome.  
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Figure 5.5. Effects of Suv39h1/2 loss of global large scale chromatin structure. 
Chromatin fibers were prepared from WT41 and DN57 nuclei preps in physiological 
NaCl conditions (80 mM) and resolved by sucrose sedimentation  (A) DNA from 
sucrose gradient fractions were phenol chloroform purified and resolved on a 0.7% TPE 
gel at 25V for 16 hours. Left image – WT41 cells, Right image – DN57 cells. (B) Lane 
2D densitometry was used to determine the position of the fraction intensity maxima. 
Maxima across fractions was plotted and compared between WT41 and DN57 
chromatin. 
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The distribution of signal intensity throughout each lane represents the 
variation of compaction states in each fraction. The fragment size 
measurements are determined by the intensity maxima in each lane. In order 
to determine the effect of Suv39h1/2 knock out on pericentric and centric 
heterochromatin, fractions from the sucrose gradient were blotted and 
probed for major and minor satellite (Figure 5.6). Regions of constitutive 
heterochromatin are more compact than bulk chromatin as previously 
reported (Gilbert and Allan, 2001). This results in similar fragment sizes 
appearing in different fractions in bulk chromatin compared to 
heterochromatic regions. Major satellite DNA from WT41 and DN57 cells 
sediments into fraction 19 with 9624 bp and 10965 bp respectively. Bulk 
WT41 and DN57 chromatin fragments sedimented into fraction 18 with 9511 
bp and 10266 bp sizes by comparison. The change in bulk chromatin 
sedimentation in DN57 was at similar levels to the previous experiments (7-
9%) demonstrating that this change in compaction state is relatively stable. 
Major Satellite chromatin of similar fragment size (WT41: 9642 bp, DN57: 
10965 bp) presents more disrupted sedimentation (13.7% change in 9 kb 
fragment size) in the Suv39h knockout system, than in bulk chromatin. This 
could be due to either a global de-compaction to a similar state, therefore 
accentuated in more compact chromatin regions; or that de-compaction is 





Figure 5.6. Effect of Suv39h1/2 loss on interphase centromere chromatin 
structure. Chromatin fibers were isolated from WT41 and DN57 nuclei and resolved by 
sucrose sedimentation. DNA from sucrose gradient fractions were phenol chloroform 
purified and fractions run on 0.7% TPE gels. Gels were then southern blotted and 
probed for Major and Minor satellite repeats. (A)  Images of TPE gels with chromatin 
fractions from WT41 and DN57 cells. Left – all (Bulk) chromatin. Right – Minor satellite 
chromatin from southern blot. (B) Fraction peak intensity maxima from WT41 and DN57 
cells, of total (bulk) chromatin (C) Fraction peak intensity maxima from WT41 and DN57 























To investigate if this was limited to major satellite heterochromatin, 
chromatin fraction for minor satellite DNA was also radiolabelled (Figure 
5.6). Again bulk chromatin DNA fragment sizes in DN57 cells was 8.5% 
larger in fraction 17 (WT41: 8769 bp, DN57: 9523 bp). Minor satellite DNA, 
similar to major satellite was significantly more de-compacted than bulk in 
DN57 cells. WT41 cells fraction 18 DNA size was 9222 bp compared to 10353 
bp in DN57 cells. This represents a 12.3% shift in DNA fragment size 
sedimentation of 9 kb chromatin fibres, similar to the 13.7% in major satellite 
DNA. This suggests that chromatin de-compaction is not limited to specific 
satellite repeats. Seminal studies by Kit, (1961, 1962) used CsCl gradients to 
quantify the satellite composition of mouse cells (10%) which has now been 
validated by sequencing techniques (Komissarov et al., 2011). Given the 10% 
nuclear abundance of satellite chromatin, if the chromatin de-compaction 
was limited to satellite repeats in DN57 cells, and then the global effect 
should be a 10th of major and minor satellite de-compaction. As this is not 
the evident (Bulk: 7-9%, Major: 13.7%, Minor: 12.3%) this suggests significant 













5.3 Investigating Suv39h double null cells 
global chromatin compaction 
 
Sedimentation rate would be expected to alter if the mass of the chromatin 
fibre between WT41 and DN57 was different. In order to determine if the 
histone composition along the chromatin fibres was altered in DN57 cells, a 
step gradient was utilised to separate chromatin associated proteins (Figure 
5.7). Chromatin fibres released after micrococcal nuclease treatment were 
loaded on a 50-10% sucrose step gradient described in Section 2.8.2. This 
forms a boundary between the two different sucrose concentrations and 
results in an accumulation of chromatin fibres of all sizes at the sucrose 
phase boundary. As unbound proteins will not sediment during 
centrifugation, this allows the separation of proteins bound to chromatin 
fibres from their soluble nuclear counterparts. Chromatin bound histone 
proteins were not consistently altered in the DN57 cells compared to wild 
type (Figure 5.7 C). This suggests that histone protein levels are not altered 
in DN57 chromatin fibres compared to WT41 cells.  
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Figure 5.7. Chromatin incorporated histone levels after Suv39h1/2 loss. Chromatin 
fibers released from WT41 and DN57 were purified by sucrose step gradient 
sedimentation. (A) 10-50% sucrose SW55 step gradient preparation and centrifugation 
of chromatin fibers. (B) UV absorbance traces during the step gradient fractionation 
process. (C) Protein lysates from chromatin containing fractions were resolved on a 
10% Bis-Tris Nupage and coomassie stained to visualise histone proteins. Relative 2D 
densitometry was used to compare chromatin bound histone levels from WT41 and 
DN57 mES cells. 
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Chromatin accessibility to nucleases has long been used as a method used to 
distinguish between chromatin structures (Huebner et al., 1981). A 
micrococcal nuclease (MNase) timecourse digest was used to determine 
whether DN57 cells have altered accessibility to their DNA compared to 
WT41 (Figure 5.8). High molecular weight material is digested over time 
with MNase; DNA is cut between nucleosomes to form shorter nucleosomal 
fragments. DN57 cells high molecular weight material has accentuated 
digestion of high molecular weight DNA. Two minutes of MNase treatment 
reduces high molecular weight material by 18% and four minute treatment 
resulted in a 19% decrease compared to controls. This suggests that 
chromatin fibres in DN57 are more accessible to micrococcal nuclease, 
supporting the sucrose sedimentation experiments indicating that chromatin 




























Figure 5.8. Chromatin accessibility with Suv39h1/2 loss. Nuclei were isolated from 
WT41 and DN57 cells, and a partial MNase digestion time course performed. Digestion 
was resolved on a 1% acrylamide gel. (A) Micrococcal Nuclease digest timecourse of 
WT41 and DN57 nuclei. 1-16 minutes. (B) Percentage of lane total pixel intensity above 
4 kb for WT41 and DN57 cells, across 1-16 minutes micrococcal nuclease digest. 
 
However as these mESCs were derived from a single clone, it was important 
to determine if this change in global compaction was restricted to this 
specific clone. Therefore, the chromatin compaction of another Suv39h 
double null clone was analysed. DN72 cells also presented a global change in 
chromatin compaction (Figure 5.9). In fraction 18, DN72 chromatin had an 
average DNA size of 9390 bp compared with WT41 chromatin DNA size of 
8809 bp. This represents a 6.5% shift in DNA fragment size sedimentation in 
line with similar levels in the DN57 clone (Figure 5.5). 
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Figure 5.9. Bulk large scale chromatin compaction states of DN72 Suv39h1/2 
clone. Chromatin fibers were purified from WT41 and DN72 nuclei and resolved by 
sucrose sedimentation (A) DNA from sucrose gradient fractions was phenol chloroform 
purified and run on 0.7% TPE gels at 25V for 16 hours. Left – DN72 cells, Right – WT41 
cells. (B) Comparison of fraction peak maxima determined by 2D densitometry in WT41 
and DN72 total (bulk) chromatin. 
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To determine if the relationship between Suv39h loss and chromatin de-
compaction was direct, human Suv39h1 was reinserted into DN72 cells. 
Suv39h1 was cloned into the pPyCAGASIZ cassette and transfected into 
DN72 cells for stable expression under internal ribosome entry site (IRES) 
controlled zeocin resistance. To determine if Suv39h1 was stably expressed 
after transfections, western blots were used to quantify protein levels (Figure 
5.10, A). In each DN72 clone selected, Suv39h1 was stably expressed. While 
exogenous human Suv39h1 was stable in these cells, expression levels were 
clearly below that of wild type mESCs. Despite the lower re-expression levels 
of Suv39h1, this was sufficient to recover H3K9me3 at chromocenters (Figure 
5.10, B) and indicates that exogenous human Suv39h1 was properly recruited 
to chromocenters and maintained its catalytic activity.  
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Figure 5.10. Exogenous Suv39h1 expression and restoration of H3K9me3 at 
constitutive heterochromatin. (A) Western of nuclei protein lysates of Suv39h1 
rescue clones from DN72 knock out cells compared to wild type and the DN72 parental 
cells. (B) DAPI and H3K9me3 Immunofluorescence of wild type, Suv39h1/2 knockout 




In addition to H3K9me3 deposition, it was important to determine if HP1 is 
also recruited to chromocenters. Immunofluorescence was used to determine 
recruitment of HP1α to chromocenters in wild type (WT41), Suv39h double 
null (DN72) and exogenous Suv39h1 rescued DN72 cells (Figure 5.11). HP1α 
demonstrated distinct recruitment to chromocenters in the majority of 
Suv39h1 rescued cells. The lack of recruitment in every cell may be indicative 
of some cells losing the exogenous Suv39h1 construct, or its expression being 
slightly lower. However, the correct recruitment of HP1α in the majority of 
Suv39h1 rescued cells, suggest that this is sufficient for correct establishment 









Figure 5.11. Recruitment of HP1α with exogenous Suv39h1 expression. 
Immunofluorescence of DAPI and HP1 alpha distribution in mES cells. Wild type 
(WT41), parental Suv39h1/2 knockout cells (DN72) and a daughter Suv39h1 rescue 









Chromatin fibre sucrose sedimentation was used to determine if the Suv39h1 
re-expression in the DN72 background was sufficient to ablate the global 
chromatin de-compaction phenotype (Figure 5.12). At larger chromatin 
fragment sizes, DN72R chromatin was more compacted when compared to 
WT41, completely reversing the original phenotype.  At fraction 17, DN72R 
chromatin was 9067 bp compared while WT41 chromatin was 9487 bp in 
size. This suggests that DN72R chromatin is 4.4% more compact at this 
fragment size. This result was repeated (N=2) to validate the altered global 
compaction state of Suv39h1 rescued mESCs. 
 235 
 
Figure 5.12. Reversal of global decompaction with exogenous Suv39h1 
expression. Chromatin fibers were isolated from WT41 and DN72R nuclei and resolved 
by sucrose sedimentation. (A) DNA from sucrose fractions of WT41 and Suv39h1 
rescue cells from DN72 parental cells run on a 0.7% TPE gel (B) Comparison of 
fragment intensity maxima from sucrose fractions of WT41 and DN72R chromatin 
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Given the growing evidence of an RNA component in heterochromatin 
formation (Maison, Bailly, Peters, J.-P. Quivy, et al., 2002; Maison et al., 2012; 
Keller et al., 2013), RNA distribution was analysed by EU incorporation 
(Figure 5.13).  Cells were treated with 1 mM EU so that the majority of EU 
transcripts would have EU incorporation. Cells were then washed with CSK 
buffer in order to remove free non-chromatin associated RNA and proteins 
from the nucleus and fixed with 4% PFA. A click reaction was used to 
covalently attach a biotin-azide to EU overnight before immunofluorescence 
was used to determine chromatin RNA distribution. Neither WT41, DN72, of 
DN72Rescue cells presented any distinct pattern to their chromatin 
associated RNA. However, DN72 cells did appear to have an increased 
intensity of EU-biotin signal. 
 
In order to quantify chromatin bound RNAs, RNA was isolated from each 
cell line and analysed by dotblot (Figure 5.14).  Similar to EU 
immunofluorescence experiments; each cell line was incubated with 1 mM 
EU overnight to incorporate EU into RNA. Cells were washed to remove 
non-chromatin bound RNA, before being trypsinised and the nuclei isolated, 
before further NB.B buffer incubation to remove the nuclear membrane. The 
Biotin-azide was then clicked onto the RNA overnight at room temperature 
before samples were normalised to the DNA concentration and spotted onto 
a nitrocellulose membrane. Avidin-HRP incubation was then used to 
quantify EU-RNA concentration. DN72 cells showed a 25% increase in 
chromatin associated RNA when compared to WT41. Additionally, the 
Suv39h1 rescue cell line had a further 10% reduction in chromatin associated 
RNA. These results correlate with the chromatin compaction states between 
the cell lines and suggest that Suv39h/HP1/H3K9me3 heterochromatin 
recruitment directly affects the global levels of chromatin associated RNA 
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and chromatin compaction states. While this data demonstrates an altered 
level of chromatin associated RNA, this does not explain the full de-
compaction of chromatin fibres after sucrose sedimentation, as these fibres 
have be prepared in the presence of RNase and MNase. However, this 
provides further evidence towards to a regulatory role of chromatin 
associated RNA in heterochromatin formation and beyond in the genome. 
 
Figure 5.13. Suv39h1/2 loss/rescue and chromatin associated RNA. mES cells 
treated with 1 mM EU O.N, then washed in CSK buffer and fixed in 4% PFA for 10 
minutes, further washed in 0.5% Triton-X for 10 minutes, before click reaction with an 
azide flourophore and DAPI stained for 3 minutes at room temperature. Chromatin 
associated RNA was imaged from wild type (WT41), Suv39h1/2 double null (DN72) and 
human suv39h1 rescue (Clone 4, 5) mouse ES cells. 100X magnification. 
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Figure 5.14. Effect of Suv39h methyltransferase expression on global chromatin 
associated RNA levels. (A) mES cells treated with 1 mM EU O.N before 3 x CSK 
washes for 5 minutes and nuclei isolation. RNA was prepared using Qiagen RNeasy kit 
instructions, and a biotinylated azide added via click chemistry. Samples were spotted 
on nitrocellulose membranes and incubated with avidin-HRP for detection. (B) 2D 
densitometry of chromatin bound RNA dotblot for wild type, Suv39h1/2 knockout DN72 








5.4 Click chemistry DNA fixation: method 
optimisation 
 
While the chromatin compaction studies, such as sucrose gradient 
sedimentation, are able to distinguish between chromatin fibres with 
different structures, but whether these are representative of in vivo chromatin 
is still not clear. As previously mentioned, the inevitable digestion of 
potential chromatin-associated RNAs by MNase could alter chromatin 
compaction (Maison, Bailly, Peters, J.-P. Quivy, et al., 2002), and as the 
chromatin fibres released are not fixed, any torsional forces (such as DNA 
supercoiling) within the chromatin fibre will be lost.  Finally, the process of 
releasing soluble chromatin fibres may directly alter their structure, despite 
physiological salt conditions being used, as this environment cannot 
compensate for the local hydrophobicity of the surrounding liquid state that 
is caused by protein and RNA concentrations in the nucleus (Larson et al., 
2017).  
 
By comparison, altered salt conditions affect the ionic interactions between 
nucleosomes, and therefore can significantly affect chromatin compaction 
(Figure 5.15). Release of 3T3 chromatin into 1 mM NaCl compared to 80 mM 
NaCl (physiological levels) and subsequent characterisation of chromatin 
structure by sucrose gradient sedimentation shows that chromatin in low salt 




Figure 5.15. Decompaction of unfixed chromatin in low NaCl conditions. Chromatin 
fibers were isolated from mouse 3T3 cells and resolved by sucrose sedimentation in 
physiological (80 mM) and low (1 mM) NaCl conditions. (A) purified 3T3 cell DNA from 
80 mM and 1 mM sucrose gradient fractions resolved by 0.7% TPE gel electrophoresis. 
(B) Comparison of fraction fragment intensity maxima identified by 2D densitometry of 
chromatin in physiological and low NaCl conditions. 
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Although formaldhyde is a commonly used and fast fixation method it is 
very indiscriminate and after cross-linking MNase can no longer efficiently 
digest chromatin and soluble fibres cannot be released (Figure 5.16, A-B). 
Treatment of 1% formaldhyde prevents any MNase digestion within 16 
minutes, while 1% FA treatment after MNase digestion requires SDS 
addition to release chromatin fibres. Unfortunately, detergent treatment also 
disrupts chromatin fibre compaction and chromatin no longer sediments 
well in sucrose gradients indicative of heterogeneous and disorganised 
fibres. This could suggest that chromatin fibres have dramatically more 
diverse structures within the genome, or more likely that 1% FA treatment 
crosslinks between chromatin fibres of different sizes. This would result in 
shorter chromatin fibres ‘piggybacking’ on the larger chromatin fibres 




Figure 5.16. Difficulties of fixed chromatin preparation and click chemistry. 
Chromatin fibre release under formaldhyde (FA) fixed conditions. (A) Micrococcal digest 
of nuclei FA 1% fixed for 10 minutes RT. (B) DNA from sucrose gradient fractions with 
nuclei FA 1% fixation after micrococcal digest, treated with 0.5% SDS to release 
chromatin fibers. (C) DNA analogue EdU incorporation and alkyne click reaction (D) 
PEG-Bis-azide (E) Picolyl-bis-azide linker (F) 3-azido-7-hydroxycoumarin 
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Instead of using formaldehyde as an indiscriminate cross-linker we 
investigated the idea of specifically crosslinking DNA as it might still allow 
MNase accessibility and maintain chromatin fibres’ flexibility in order to be 
released from the nucleus (Figure 5.16, C). Click chemistry could be used as a 
method to cross-link DNA-DNA due to its highly specific reaction 
conditions. In a click reaction an alkyne group is covalently attached to an 
azide group forming a triazole (Jiang et al., 2014). A copper ion initially 
attacks the alkyne group weakening the triple bond. This allows another 
copper ion to associate with the alkyne group. The positive charge of the 
second copper ion then attacks the base nitrogen atom of a nearby azide 
group. Through electron pushing this causes the electron pair in the alkyne 
initially interacting with the second copper ion to switch to third nitrogen in 
the azide group resulting in the covalent bonding between the two groups 
(Figure 5.17). This click reaction has already been extensively used in vitro to 
covalently attach molecules to nucleic acids (Kumar et al., 2007; Gramlich et 
al., 2008).  
 
Additionally this click reaction has been used to crosslink fluorophores to 
cellular membranes in vivo but has not been presented within the nucleus of 
live cells (Uttamapinant et al., 2012; Jiang et al., 2014). As free metals are toxic 
in cells, the free copper ion cellular availability inside cells must be highly 
regulated. Copper ions are therefore added to cells in the form of CuSO4 to 
reduce initial toxicity. In order to release copper ions, sodium ascorbate is 
used as a weak reduction catalyst. To further reduce free copper ion toxicity 
a sequestering partner such as THPTA or TBTA is added and this enabled 




Figure 5.17. Click Chemistry azide-alkyne reaction. Mechanistic rational for copper 
assisted akyne-azide cycloaddition (CuAAC). Diagram adapted from Jiang, et al. (2014) 
 
 
However, in order to fix chromatin fibre structure in cells the density of 
cross-links must be high and the reaction speed fast enough to prevent the 
likelihood of trans-fibre crosslinking. In order to determine if nucleotide 
analogues conjugated to an alkyne could be incorporated at a high enough 
density to facilitate chromatin fixation, cells were treated with EdU and EdC 
at 20 µM for up to 72 hours (Figure 5.18, A).  The DNA was purified, 
digested to mononucleotides, analysed by HPLC and quantified using UV 
spectroscopy. The retention times and absorption profiles of the uridine 
analogues were determined via input standards. Under these conditions both 
EdC and EdU were detectable as being incorporated into the genome. In our 
hands the EdU derivative F-ara-EdU incorporation was barely detectable 
(data not shown) despite being sufficient for click based immunofluorescence 
(Neef and Luedtke, 2011). F-ara-EdU has been proposed as a less toxic tool 
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than EdU and BrdU however this may be due to significantly reduced 
incorporation rates during replication. F-ara-EdU was therefore rejected as a 
potential analogue for click-mediated chromatin fixation.  
 
EdU and EdC had similar incorporation rates to each other with over 15% of 
all nucleotide incorporated after 72 hours. EdC incorporation plateaued 
between 24 and 48 hours, suggesting that replication rate after EdC 
incorporation was affected (Figure 5.18, A). To determine how stable 
analogue incorporation was and if they were excised by the repair process, 
cells were treated with 20 µM EdC or EdU for 72 hours, washed out and then 
a further 48 hours without analogue incorporation (Figure 5.18, B). Both EdU 
and EdC presented a partial decrease in analogue incorporation after free 
analogue nucleotides were removed. This would be expected, as future 
replication cycles would dilute the analogue nuclear concentration. The 
relatively stable incorporation of EdU and EdC analogues suggest that both 
would be suitable candidates for a click-based fixation method.  
 
To determine if nucleotide analogue incorporation affected the ratio of 
endogenous nucleotide (A-T, C-G), Nucleotide ratios to dG were compared 
over dose ranges of EdU and EdC (Figure 5.18, C-D). Given that EdU and 
EdC are thymidine and cytidine analogues respectively, the levels of adenine 
and guanine should not be affected by analogue incorporation. With both 
EdU and EdC treatment: dG, dA, and methyl dC levels were not affected. 
Both EdU and EdC incorporation levels were inversely correlated with 
thymidine levels, suggesting that both are incorporated in place of 
thymidine. The fact that adenine and guanine ratios were unaffected by EdC 
treatment also implies that when EdC is incorporated instead of a thymidine, 
it is still paired correctly with an adenine nucleotide. 
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Figure 5.18. Alkyne nucleotide analogue incorporation. 3T3 cells incubated with 
DNA analogues and their DNA digested to mononucleotides for HPLC-UV analysis. (A) 
Percentage of DNA analogues [EdU and EdC] incorporation into mESc DNA at 20 µM 
over time. (B) DNA analogue incorporation density at 20 µM for 72 hours and after an 
additional 48 hours without DNA analogue treatment. (C) Individual mononucleotide 
ratios to dG after EdU dose range exposure (D) Individual nucleotide ratios to dG after 
EdC dose range exposure. 
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To determine if EdC was incorporated after being modified, the 
spectrometry profiles of incorporated EdC was compared to EdU and EdC 
standards. Incorporated nucleotides will always have a slightly altered 
spectrometry profile however due to the attached phosphate group required 
for incorporation into the DNA backbone. Despite this the EdC profile 
absorption peaks were more aligned with EdU than EdC standards (Figure 
5.19, A). To further understand how EdC is modified when it is incorporated, 
EdC and EdU treated cells’ nucleotides were analysed by HPLC-MS-MS 
(Figure 5.19, B-C).  Peaks for the predicted EdU-monophosphate mass were 
detected in both EdU and EdC treated cells. The MS/MS fragmentation of 
these peaks revealed identical profiles for EdU and EdC. Together these data 
demonstrate that EdC is deaminated to an EdU molecule before its 
incorporation into DNA. This is an important finding as many studies 
(Petryk et al., 2016) use EdC instead of EdU to control for sequence bias.  
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Figure 5.19. DNA analogues EdU and EdC UV spectra and MS fragmentation 
profiles. 3T3 cells were incubated with 20 µM DNA analogues for 24 hours before their 
DNA was digested to mononucleosomes. Samples were analysed by HPLC-UV or Mass 
spectrometry and compared to purified standards. A) DNA analogue UV spectrometer 
intensity profiles resolved by HPLC retention time. Comparison between incorporated 
EdC and the purified standards for EdU and EdC. B) Retention time profiles of 
incorporated DNA analogues of predicted EdUMP m/z by HPLC-MS C) MS/MS 






Figure 5.20. Azide-alkyne in vitro plasmid click reaction and clicked coumarin-
azide fluorescence. A) In vitro click reaction of EdU incorporated Recon2 plasmid 
digested with Xho1. E.coli with Recon2 plasmid were incubated with 20µM EdU for 3 
hours at 37°C. Plasmid was purified using the Qiagen mini prep protocol and digested 
O.N with Xho1 at 37°C. Click reaction was then added at RT: CuSO4 0.5mM, THPTA 
0.25mM, NaAsc 250mM, 100mM PEG-bis-azide (5000) B) 10X 400ms 488nm of mouse 
3T3 cells incubated with 20µM EdU O.N before click reaction added for 60 minutes: 












As the incorporation of exotic nucleotides into DNA is normally unwanted 
during replication, the effect of EdU/EdC incorporation on the cell cycle was 
investigated (Figure 5.21). Propidium Iodide staining and FACS analysis 
showed that both a 24 hour 20 µ M EdU and EdC treatment increased the 
number of cells in S-phase. Significantly though, cell numbers in G2 that 
have exited S-phase was elevated in EdC but not EdU treated cells. This 
suggests that the deamination process required for EdC incorporation 
resulted in replication stress causing cellular arrest. By contrast, EdU 
treatment increased the time in S-phase but did not result in stalling of cells 
in G2, nor a significant increase in polyploidy. Together this evidence 
indicates that EdU is the analogue of choice for incorporating an alkyne tag 
into genomic DNA for click chemistry based cross-linking. 
 
In order to optimise the click chemistry reaction in vivo a 3-azido-7-
hydroxycoumarin compound was used (Figure 5.16 D-F). 7-
hydroxycoumarin is a blue wavelength fluorophore between 404 and 480 nm 
and its fluorescence is quenched in the presence of the 3-azido sidechain. 
This quenching by the side group is however lost when the azide reacts with 
an alkyne to form a triazole (Gierlich et al., 2006) and results in an order of 
magnitude (15x) increase in fluorescence in the clicked coumarin form (Li et 
al., 2010). The use of a coumarin-azide fluorophore therefore allows the 




Figure 5.21. Effect of nucleotide analogue incorporation on the cell cycle. 3T3 
cells treated with 20 µM of DNA analogues for 24 hours, ethanol fixed and propidium 
iodide (PI) stained for flow cytometry. (A) PI stain cell cycle analysis after EdU or EdC 
20 µM treatment of mES cells for 24 hours and controls. Histogram plots of PI 
fluorescent intensity. (B) Gated cell cycle stages ratios from flow cytometry PI plots, 
analysed by FlowJo. 
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In order to determine if the coumarin-azide was detectable in cells, 3T3 cells 
were treated with EdU for 24 hours and were fixed with 1% 
paraformaldehyde. After fixation cells were with incubated with coumarin-
azide in a click reaction (Figure 5.22) and a dose dependent incorporation 
was observed. In live 3T3 cells however an increase in coumarin fluorescence 
was only detectable at 500 µM CuSO4. This suggests that live cells actively 
inhibit the click reaction mechanism, which is possibly due to native cellular 
copper chelators evicting free copper ions efflux transporters (Petris, 2004). 
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Figure 5.22. Coumarin-azide click reaction kinetics in live cells. 3T3 cells were 
incubated with 20 µM EdU for 24 hours. (A) Intensity of coumarin-azide fluorescence in 
3T3 cells 1% formaldehyde fixed before click reaction. 3T3 cells were washed with CSK 
buffer prior to fixation. Click reaction: ΔµM CuSO4, 10 mM NaAsc, 200 mM coumarin-
azide added to PBS. (B) Intensity of coumarin-azide fluorescence in 3T3 cells after click 




For click reactions to be conducive to fixing chromatin structure it must be 
efficient, fast, accurate, and non-toxic to the host cell. To achieve this the 
metal, chelating agent, and catalyst need to be optimised. Different metals 
and concentrations were first tested on 3T3 cells incubated with 20 µ M EdU 
for 24 hours (Figure 5.23). In addition to CuSO4; Ruthenium, MgCl2 and 
CuBr2 have previously been used as metal agents in click reactions and their 
efficacy was analysed (Pérez-Balderas et al., 2003; Boren et al., 2008). Cells 
were incubated with 250 mM coumarin-azide, 10 mM sodium ascorbate in 
the presence of each metal salt. Both ruthenium and magnesium chloride had 
delayed onset of coumarin fluorescence and did not present the expected 
sigmoidal reaction kinetics. Contrastingly CuSO4 and CuBr2 demonstrated 
dose dependent increases in fluorescence kinetics. At lower concentrations 
this dose dependent effect was more sensitive in CuSO4 suggesting that it 
may be the optimal click reaction catalyst within this setting. 
 
To determine if a chelating agent would accelerate or slow the reaction rate, a 
dose range of THPTA was added to 200 µM CuSO4, 200 mM Coumarin-
azide, and 10 mM sodium ascorbate  (Figure 5.24). Increasing the THPTA 
concentration increased the reaction speed up to 100 µM, after which higher 
concentrations resulted in decreased reaction kinetics. This suggests that the 
chelating agent’s ability to prevent free copper ion excretion increases the 
reaction speed up to a 1:2 ratio with CuSO4. As the chelating agent’s 
concentration increases above this ratio, the increased kinetics from 
preventing excretion is offset by the sequestering of the free copper ions from 
catalysing the click reaction. While other chelating agents were tested (TBTA, 




Figure 5.23. Live cell click chemistry metal catalyst optimisation. Comparison of 
different metals as click reaction catalyst. 3T3 cells were incubated with 20 µM EdU for 
24 hours prior to click reaction. Click reaction conditions: Δ µM Metal, 250 mM 
Coumarin-azide, 10 mM NaAsc. And normal mESc growth media. Metals tested were; 
















Figure 5.24. Live cell click chemistry metal chelator optimisation: chelating agent. 
Optimization of chelating agent THPTA concentration. 3T3 cells were incubated with 20 
µM EdU for 24 hours prior to click reaction. Click reaction conditions: 200 µM CuSO4, Δ 













For free copper to be chelated by THPTA and used in a click reaction, it must 
first be reduced from the CuSO4 source. Sodium ascorbate (NaAsc) and 
ascorbic acid have traditionally been used as the reducing agent for free 
copper ions (Himo et al., 2005). As NaAsc is less toxic than ascorbic acid a 
dose range of NaAsc was added to 500 µM CuSO4, 200 mM coumarin-azide, 
250 µM THPTA (Figure 5.25). NaAsc increased the click reaction kinetics in a 
dose dependent manner up to 250 mM. Concentrations above 250 mM of 
NaAsc did not present any increase in reaction speed. This implies that after 
a NaAsc:CuSO4 ratio of 500:1, the reduction of CuSO4 to free copper ions is 
not the limiting factor to the reaction speed. However, under these 
conditions the click reaction was complete in 5 hours. To try and increase the 
reaction speed further, lipofectin or Triton-X100 was used to disrupt the cell 
membrane to prevent copper ion excretion. However, Triton-X100 and 
lipofectin conditions had no benefit to click reaction kinetics (Figure 5.26). 
 
Figure 5.25. Live cell click chemistry reducing agent optimisation: reduction 
agent. Optimization of catalyst NaAsc concentration. 3T3 cells were incubated with 20 
µM EdU for 24 hours prior to click reaction. Click reaction conditions: 500 µM CuSO4, Δ 
mM NaAsc, 200 mM coumarin-azide, 250 µM THPTA. 
 259 
 
Figure 5.26. Live cell click chemistry, cell membrane disruption optimisation. A) 
Optimization of click reagent transfection. 3T3 cells incubated with 20µM EdU for 24 
hours before the addition of  250mM coumarin-azide, 250mM NaAsc, and 250µM 
THPTA. 500µM CuSO4 addition after 6 hours to start the click reaction. B) Optimisation 
of detergent addition to EdU click reaction.  Δ% Triton-X added to click reaction mix: 
250mM Coumarin-azide, 250mM NaAsc, 250µM THPTA, and 500µM CuSO4. 
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This timeframe for reaction completion (5 hours) is biologically relevant due 
to the incorporation levels of EdU (Figure 5.18, A). As each nucleosome is 
wrapped around 147 bp of DNA, and mouse cells have a GC content of 
51.24%, there should be ~70 AT nucleotide pairs on each nucleosome 
(Romiguier et al., 2010). With 20 µ M EdU treatment for 24 hours, 7% of all 
nucleotides are EdU molecules, representing 14.35% of all thymidines. 
Together these data indicate that each nucleosome will have 7-14 alkyne tags. 
To maintain chromatin structure, crosslinking each nucleosome to its 
adjacent neighbours once should be sufficient to maintain fibre structure. 
Therefore only 20% of the total reaction potential (1 hour) should be needed 
to fix chromatin structure. This reaction time can theoretically be reduced 
further by the use of a picoyl-azide crosslinker (Figure 5.16, E) which should 
decrease the reaction time by an order of magnitude (Uttamapinant et al., 
2012; Jiang et al., 2014). 
 
Having optimised the click reaction conditions, the use of a bis-azide 
crosslinker to covalently bond two DNA fragment was investigated in vitro 
(Figure 5.20). E.coli cells transformed with a pUC57-Recon2 plasmid were 
grown overnight. 20 µM EdU was added for 3 hours before cells were lysed 
and plasmids extracted and purified. 3 hour 20 µM EdU treatment was 
previously determined to be sufficient for >10% EdU incorporation by 
HPLC-UV spectrometry (data not shown). Two DNA fragments were 
prepared by digesting the EdU containing pUC57-Recon2 plasmid with XhoI 
restriction endonuclease. Optimised click reaction conditions (24 hours of 20 
µM EdU incubation, 250 mM NaAsc, 250 µM THPTA, and 500 µM CuSO4) 
with an bis-azide PEG-linker (average M.W 5000 Da) were added to the 
digested Recon2 plasmid for 1 – 8 hours. Within 1 hour interstrand 
crosslinking had occurred resulting in two additional DNA bands and after 4 
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hours intrastrand crosslinking resulted in smearing of the DNA bands. This 
suggests that a click reaction can crosslink between naked DNA strands in 
vitro. 
 
To establish if these click reaction conditions would be sufficient to fix 
chromatin fibre structures in live cells, sedimentation rates of clicked 
chromatin fibres were compared in sucrose gradients with 1 mM or 80 mM 
salt (Figure 5.27). 3T3 cells were incubated with 20 µ M EdU and 100 mM 
PEG-bis-azide for 24 hours. Cells were then crosslinked via a click reaction 
with 500 µ M CuSO4, 250 µ M THPTA, and 250 mM NaAsc for 1 hour. 
Chromatin fibres were digested with MNase and then released as presented 
in figure 5.4. The clicked chromatin fibres were loaded onto isokinetic 
sucrose gradients in TEEP buffer with either 80 mM NaCl or 1 mM NaCl 
buffer. As 1 mM NaCl causes 3T3 chromatin fibres to de-compact 
substantially (Figure 5.15), if click crosslinking had fixed the chromatin 
structure the sedimentation rate should have been the same in 80 mM or 1 
mM NaCl gradients. 
 
Unfortunately, 3T3 click fixed chromatin unfolded in 1 mM NaCl, suggesting 
that cross-linking was not sufficient to stabilise the chromatin structure 
(Figure 5.27). In fraction 13, 80mM salt conditions had an average DNA 
fragment size of 5213 bp compared to 6728 bp in 1 mM NaCl conditions. This 
represents a 29% shift in DNA fragment size sedimenting in fraction 13. This 
suggests a significantly slower sedimentation rate in 1mM NaCl conditions. 
However, unfixed 3T3 chromatin sedimenting in fraction 12 in 80 mM NaCl 
buffer had an average fragment size of 5176 bp whilst in 1 mM NaCl the 
chromatin sedimenting in fraction 12 was 9595 bp (Figure 5.15). Therefore 
unfixed chromatin of similar fragment sizes to fixed chromatin presents an 
 262 
85% shift in DNA fragment size. This suggests that a click-based cross-
linking approach can fix chromatin fibres to an extent but cannot prevent 
other physiological properties from partially altering the chromatin 
compaction state.  
Figure 5.27. Azide-alkyne click reaction link chromatin stability in low NaCl 
conditions. Azide-alkyne clicked chromatin fibers were released from 3T3 nuclei into 
physiological (80 mM) and low (1 mM) NaCl conditions and resolved by sucrose 
sedimentation. 3T3 mouse fibroblast cells incubated with EdU 20 µM EdU and 100 mM 
PEG-Bis-azide (5000 MW) for 24 hours prior to click reaction. Click conditions: CuSO4 
0.5 mM, THPTA 0.25 mM, 250 mM NaAsc for 1 hour (A) DNA from 3T3 cell clicked 
chromatin sucrose fractions, at 80 mM or 1 mM NaCl buffer conditions. Fractions 10-18 
run on a 0.7% TPE gel. (B) Comparison of fragment intensity maxima from fractions in 




5.5.1 H3K9me3 and chromatin compaction 
 
Suv39h1 and Suv39h2 are the main methyltransferases responsible for 
H3K9me3 (Hall et al., 2002). H3K9me3 is specifically limited to regions of 
constitutive heterochromatin including pericentric chromatin, telomeres and 
retrotransposons across the genome (Arnoult, Van Beneden and 
Decottignies, 2012; Bulut-Karslioglu et al., 2014).  This has led to a long-
standing hypothesis that H3K9me3 has an important functional role in 
heterochromatin formation. Loss of Suv39h enzymes results in the loss of 
Suv39h, H3K9me3, H4K20me3, DNA methylation and HP1 proteins from 
constitutive heterochromatin regions (Peters et al., 2001). However DNA 
methylation levels at heterochromatin have been shown to have no 
functional role in regulating heterochromatin compaction (Gilbert, Thomson, 
Boyle, Allan, Ramsahoye and Wendy A Bickmore, 2007). Given that Suv39h 
double null mice are viable, still form nuclear chromocenters, and only have 
a mild genome instability phenotype, the function of H3K9me3 in having a 
causal role in chromatin compaction remains unclear (Peters et al., 2001). 
Furthermore, no epigenetic modifications have been directly demonstrated 






Initial experiments shown here were focused on confirming that Suv39h 
double null mESC cell line presented the same profile of epigenetic marks as 
previously reported. H3K9me3, H4K20me3 and HP1α were all shown to be 
lost from chromocenters in Suv39h double null ES cells (Figure 5.3, 5.10). 
This supports the current view that Suv39h HMTs’ specificity to H3K9me3 
deposition results in the recruitment of Suv420 HMTs and HP1 proteins to 
constitutive heterochromatic domains (Schotta et al., 2004).  
 
In addition to H3K9me3 nuclear distribution, total levels of H3K9me2 and 
H3K9me3 were significantly reduced along with its pericentric 
heterochromatin recognition partners HP1α and HP1β (Figure 5.2). HP1γ 
levels were increased in the double null cells. However HP1γ is thought to 
function exclusively in euchromatin and therefore does not function at the 
pericentromere outside of S-phase (Minc, Courvalin and Buendia, 2000). 
Interestingly, H3K27me3 levels were significantly elevated suggesting an 
expanded regulatory role for polycomb silencing in Suv39h double null cells. 
Recent studies have begun to implicate PRC2 function with DNA 
methylation and HP1 chromatin stabilisation.  Reddington et al., (2013) 
demonstrated that a loss of DNA hypomethylation led to a global 
redistribution of DNA methylation, while comprehensive studies by Manzo 
et al., (2017) described the detailed function of H3K27me3 and H3K4me3 in 
excluding DNMT3 isoforms from their bivalent chromatin domains but 







While H3K27me3 is not found at pericentric regions, the principle of mutual 
exclusivity with H3K9me3 has been demonstrated to be false.  Mass 
spectrometry of H3K27me2 and H3K27me3 containing nucleosomes from 
HeLa, mESC, and MEF cells consistently had H3K9me2/me3 and H4K20me2 
marks (Voigt et al., 2012). Additionally, chromatin immunoprecipitation 
experiments have found co-occupation of H3K9me3 and H3K27me3 at 
repetitive elements, telomeres, and bivalent promoters (Zeng et al., 2009; 
Hawkins et al., 2010; Arnoult, Van Beneden and Decottignies, 2012). Further 
studies have demonstrated that PRC2 subunits Ezh2 and Suz12 are required 
for HP1α recruitment to heterochromatin but not H3K9me3 deposition 
(Boros et al., 2014). In the absence of H3K9me3, DNA methylation and HP1 
heterochromatin recruitment, a compensatory increase in PRC2 mediated 
H3K27me3 deposition would not be unexpected and may cause the 
relatively mild mouse model phenotype (Peters et al., 2001). 
 
Having demonstrated that DN57 cells lacked H3K9me3, HP1α, and 
H4K20me3 at chromocenters, the effect of this altered epigenetic state on 
chromatin compaction was investigated. Unlike DNA methylation (Gilbert, 
Thomson, Boyle, Allan, Ramsahoye and Wendy A Bickmore, 2007), loss of 
the H3K9me3/HP1/Suv39h complex from heterochromatin results in the de-
compaction of pericentric (major satellite) and centromeric (minor satellite) 
chromatin (Figure 5.6). However, this chromatin de-compaction was not 
limited to pericentric and centromeric domains, as Suv39h double null cells 
presented global de-compaction of chromatin fibres when compared to wild 
type (Figure 5.5). This altered the sedimentation rate by 7-9% for 9 kb DNA 
fragments compared to 13.7% for Major satellite and 12.3% for minor satellite 
chromatin fibres of similar size.  
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As <10% of the mouse genome is made up of major and minor repetitive 
elements, if chromocenter de-compaction was solely responsible for the 
global effect, the de-compaction effect would be expected at a 10th of the 
effect at pericentric regions (Kit, 1962; Komissarov et al., 2011). This therefore 
suggests changes in chromatin compaction beyond the normally H3K9me3 
marked chromocenters. A possible mechanism for the global de-compaction 
may come from interspersed repetitive elements. Around 38% of the mouse 
genome is composed of interspersed repetitive elements, with 19% of the 
genome being LINEs, 8% SINEs, and 10% LTR elements (Waterston et al., 
2002). Recent studies have demonstrated Suv39h mediated H3K9me3 at ~5% 
of repetitive elements in mESCs (Bulut-Karslioglu et al., 2014). However, in 
order for repetitive elements to result in the global chromatin de-compaction, 
every element would need to be regulated by Suv39h, which has not been 
demonstrated. Together this suggests that at least some of the global 
chromatin de-compaction is likely due to changes in chromatin structure at 













To determine if this effect was due to clonal variation, the chromatin 
compaction state of an additional Suv39h double null clone (DN72) was 
investigated (Figure 5.9). DN72 also demonstrated a slower sedimentation 
rate (6.5% change in DNA fragment size at 9 kb) indicative global de-
compaction of chromatin fibres albeit slightly lower than DN57 cells (7-9%). 
To determine if this was directly linked to Suv39h activity, exogenous human 
Suv39h1 was transfected via a pPyGAGASIZ cassette. This resulted in stable 
expression of human Suv39h1 with the Suv39h double null mESC 
background, although at lower levels than endogenous Suv39h1/2 in wild 
type cells (Figure 5.10). The expression of human Suv39h1 was subsequently 
sufficient to restore H3K9me3 deposition at chromocenters and HP1α 
recruitment (Figure 5.11). Together this suggests that human Suv39h1 
expression was sufficient to ablate the endogenous Suv39h double null 
phenotype.  
 
When chromatin fibres from DN72R cells (expressing exogenous human 
Suv39h1) were compared to wild type chromatin, the original chromatin de-
compaction phenotype was completely reversed. DN72R chromatin fibres 
were comparatively 4.4% smaller than WT41 suggesting a more compact 
chromatin fragment for a 9 kb DNA fragment size (Figure 5.12). This 
demonstrates for the first time a direct relationship between a histone 
modification deposition and chromatin fibre compaction.  The increased 
compaction beyond wild type could be due to slightly differing functionality 
of human Suv39h1 compared to mouse Suv39h1. Alternatively, regulatory 
changes induced by Suv39h1/2 KO results are not completely reversed by 
human Suv39h1 expression and in combination with exogenous Suv39h1 
expression contribute to chromatin compaction. 
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Given the growing body of evidence suggesting an RNA component to 
heterochromatin regulation (Arnoult, Van Beneden and Decottignies, 2012; 
Maison et al., 2016; Shirai et al., 2017), the levels and distribution of chromatin 
associated RNA was investigated (Figures 5.13, 5.14). Loss of Suv39h HMTs 
in DN72 clearly led to an increase in chromatin associated RNAs that was 
reversed with exogenous human Suv39h1 expression. The major question 
from this result is whether Suv39h/H3K9me3/HP1α recruitment mediates the 
RNA’s chromatin association, or whether Suv39/H3K9me3/HP1 supresses 
the transcription of ncRNAs from the underlying DNA. This remains a 
pertinent question yet to be answered in understanding heterochromatin 
regulation. While Suv39h and HP1 proteins clearly interact with RNAs, the 
global chromatin de-compaction cannot be completely attributed to altered 
Suv39h-HP1 recruitment (Meehan, Kao and Pennings, 2003; Bulut-Karslioglu 
et al., 2014; Maison et al., 2016). Therefore the regulation of underlying 
ncRNAs by Suv39h H3K9me3 deposition would project changes in 
chromatin associated RNAs beyond regions bound by Suv39h-HP1 
complexes. This would be more representative of the global chromatin de-









5.5.2 Sucrose sedimentation and click-fixation 
 
The validity of analysing unfixed chromatin fibres remains a debated 
question, particularly in relating the sedimentation properties of chromatin 
in vitro to an in vivo structure. Formaldhyde fixation is known to induce 
aggregate formation that can result in large biases in chromatin 
immunoprecipitation (ChIP) experiments (Baranello et al., 2016). This 
aggregate formation prevents MNase catalytic activity and chromatin fibre 
release (Figure 5.16, A). Furthermore, in the same way as GFP can be 
artificially recruited by formaldhyde in ChIP experiments, the dynamic 
properties of the chromatin fibre could result in artificial formaldhyde 
induced chromatin compaction.  
 
However, if the chromatin fibre is unfixed the process of micrococcal 
nuclease digestion will release the torsional stress in the fibre. Additionally 
the process of releasing chromatin fibres into solution could alter the 
chromatin state.  Whether formaldhyde fixation or native methods are 
representative of the true physiological chromatin state in vivo remains 
debated and has led to the development of native ChIP and native 
conformation capture methods (i4C) (Dorbic and Wittig, 1986; Thorne, Myers 
and Hebbes, 2004; Brant et al., 2016). 
 
While formaldhyde fixation is possible after MNase treatment, the nuclei 
must be treated with SDS in order to extract the fixed chromatin fibres 
(Figure 5.16, B). This suggests that a degree of fibre flexibility in the 
chromatin fibre is required for chromatin release. However, the use of 
detergents to disrupt ionic bonding and denaturing proteins could alter 
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chromatin compaction to a greater extent than no fixation. Additionally, the 
smearing in SDS formaldehyde fixed fractions is indicative of interstrand 
crosslinks from a large chromatin fragment to a small fragment. This 
significantly disrupts the resolution of the experiment and induces an 
additional bias (Figure 5.16, B). 
 
To try and circumvent the negative drawbacks of formaldhyde fixation and 
native chromatin fibre sucrose sedimentation, the use of copper assisted 
cycloaddition chemistry to covalently crosslink only DNA was investigated. 
By only creating DNA:DNA crosslinks this should maintain some fibre 
flexibility while preventing aggregation. Additionally this method will allow 
fixation before MNase digestion and therefore before chromatin RNAs are 
affected (Huebner et al., 1981; Maison, Bailly, Peters, J.-P. Quivy, et al., 2002). 
 
Preliminary studies demonstrated that thymidine-alkyne tags could be 
incorporated into DNA at high density without inducing cell cycle arrest 
(Figures 5.18, 5.21).  The discovery that EdC is deaminated before DNA 
incorporation demonstrates a bias in DNA incorporation (Figures 5.18, D, 
5.20). At a 10 nm chromatin fibre scale, linker regions are enriched for 
adenine-thymidine nucleotides, suggesting that more alkyne tags will be 
between nucleosomes (Trifonov and Sussman, 1980; Cui and Zhurkin, 2009). 
This may affect the accessibility of the alkyne tag while affecting its ability to 
fix the chromatin conformation. Furthermore, at large scale chromatin 
structure, euchromatic regions are enriched for AT sequences compared to 
heterochromatin (Dekker, 2007). This suggests that the distribution of alkyne 
tags will be skewed to euchromatic regions. Therefore the use of EdC as a 
single agent or in combination with EdU will not increase coverage at 
heterochromatin domains when compared to euchromatin. 
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A high incorporation rate is therefore required to assure genome coverage 
with multiple alkyne tags per histone. A nucleosome has ~147 bp of DNA 
wrapped around it, of which 58.76% on average (SD: 7.85%) in mice would 
be A-T base pairs (Romiguier et al., 2010). Therefore, each mouse nucleosome 
will have between 49 and 95 thymidine nucleotides across both DNA 
strands. With 20 µ M EdU treatment, EdU makes up 7% of all incorporated 
nucleotides, corresponding to 7-14 EdU molecules per nucleosome (Figure 
5.18, A). As copper assisted cycloaddition results in a triazole mediated 
bond, one crosslink with each adjacent nucleosome should be sufficient to 
maintain the chromatin fibre structure.  
 
Although nuclei are porous, allowing small molecules to enter by diffusion, 
cell membranes contain multiple efflux transporters to remove metals and 
toxins (Petris, 2004). These cellular processes limit the click reaction speed, 
requiring optimisation for fast and efficient reactions (Figure 5.22). Once 
optimised completion of cellular click reactions of incorporated EdU 
occurred within 5 hours (Figures 5.25, 5.26). This would allow between 1-3 
click reactions per nucleosome per hour with a standard azide.  
 
Further chemical studies have indicated that this reaction speed can be 
further enhanced from the addition of a picoyl group inside the azide group. 
Azide picoyl groups chelate with the first copper ion that attacks the alkyne 
group reducing the partial molar free energy needed 25 fold for the click 
reaction (Uttamapinant et al., 2012). The can be further reduced by reversing 
the amide group on the opposite side of the picoyl group from the azide 
(Figure 5.16, E). This makes the amide electron donating and further 
increases the reaction speed 2-3 fold.  The subsequent 50 fold reduction of 
reaction time via a picoyl-azide would allow reaction completion in 10-12 
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minutes in live cells. Although a bis-picoyl-PEG crosslinker was designed, 
this was not synthesised within the timeframe of this study.  
 
Instead, a PEG linker (MW, 5 kDa) with two azide groups was used to 
crosslink DNA fragments (Figure 5.16, D). Using in vitro naked DNA, 
interstrand crosslinks were visible after 1 hour (Figure 5.20).  Following these 
positive results the ability of a 1-hour click reaction to fix EdU containing 
chromatin fibres was investigated and analysed by sucrose sedimentation 
(Figure 5.27). The ionic conditions of the chromatin solution, has previously 
been shown to dramatically alter the chromatin compaction state with low 
NaCl concentrations associated with de-compaction (Thoma, et al, 1979). To 
determine if a 1-hour click reaction could fix chromatin structure in live cells, 
Click-fixed chromatin was analysed in physiological (80 mM) and low (1 
mM) NaCl conditions (Figure 5.27). Unfortunately, in 1 mM NaCl click-fixed 
chromatin demonstrated significant de-compaction compared to 80 mM 
NaCl conditions. However, when compared to unfixed chromatin in these 
conditions, click-fixation did partially reduce chromatin de-compaction 
(Figures 5.15, 5.27) and suggests that a click-based approach could fix 
chromatin fibre structure. The lack of complete fixation could be due to not 
producing enough DNA click crosslinks within a 1-hour reaction. While a 
longer reaction time could increase the number of crosslinks, this might also 
induce a bias similar to the long fixation times in formaldhyde (Baranello et 
al., 2016). Moreover, analysis in 1 mM NaCl treatment may be too excessive 
an alteration compared to physiological conditions. As DNA crosslinks 
would not prevent proteins dissociating from the chromatin fibre, the loss of 
linker histones or the production of heminucleosomes in 1 mM NaCl could 
be responsible for partial chromatin de-compaction. 
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Chapter 6: Discussion 
 
6.1 Heterochromatin regulators 
 
The cytological restriction of centromeric DNA during metaphase identifies 
the centromere as having a distinct chromatin structure. In some organisms 
centromeres remain cytologically compact throughout the cell cycle leading 
to their label as constitutively compact (or heterochromatic) DNA regions. 
This provides a good distinction from which to investigate chromatin 
structure and function, leading initial studies to focus on effectors of 
heterochromatin formation and maintenance (Muller, H, 1930). Using the 
position-effect variegation (PEV), determined by an eye pigment gene 
translocation to centromeric regions, gave a phenotypic output to identifying 
factors regulating heterochromatin formation and regulation. 
 
Since the development of sequencing based ‘omics’ approaches, our 
understanding of euchromatin organisation has advanced significantly.  
However the repetitive nature of centromeric DNA sequences has prevented 
chromatin conformation and modification distributions to be resolved at 
these regions. Therefore identifying factors and regulators of 






Model systems, such as artificial chromosomes, have often been used to 
investigate heterochromatin structure (Grimes, Rhoades and Willard, 2002; 
Ohzeki et al., 2002). However, measuring the stability of artificial 
chromosomes to identify centromeric components is difficult, and it has 
limitations for identifying heterochromatin components. This approach also 
lacks scalability, and is limited to essential components of faithful 
chromosome segregation rather than heterochromatin structure directly. The 
artificial heterochromatin system developed by the Larionov lab enables 
large scale screening of heterochromatin factors, while its artificial nature 
should limit cell type specific regulation. This artificial system uses a 
centromeric sequence from yeast chromosome 6 and a 10 kb array of human 
alpha satellite, and mimics the epigenetic profiles of constitutive and 
facultative heterochromatin resulting in transcriptional silencing (Figure 3.9) 
(Ebersole et al., 2005). A GFP reporter can then be used to provide a fast and 
efficient output of gene expression. 
 
5’azacyctidine and trichostatin A, well characterised inhibitors of DNA 
methyltransferases and HDACs respectively, triggered GFP expression. This 
demonstrates that inhibition of canonical heterochromatin components 
results in GFP expression within this system and helps to validate it as a 
screening tool (Figure 3.2). Additionally many specific HDAC inhibitors 
gave GFP expression with this screen (Table 3.1).  
 
The identification of kinase signalling pathways in modulating 
heterochromatin is not surprising given that cells utilise kinase signalling to 
adapt to their environments and alter transcription. As transcriptional 
changes require chromatin remodelling it is also not surprising that some 
kinase pathways are involved in heterochromatin maintenance. Indeed 
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aurora kinase has well characterised roles in regulating cohesin loading and 
proper chromatin compaction (Nishiyama et al., 2010; Tedeschi et al., 2013). 
 
The surprising result from the work presented here was the identification of 
BET proteins in maintaining heterochromatic gene repression. Both pan-BET 
inhibitor bromosporine and selective inhibitor JQ1 de-repressed GFP 
expression and caused G1 cell cycle arrest demonstrating the effect is not 
compound specific (Figure 3.4, 3.5). BET proteins canonically function as 
transcriptional activators (Chapuy, McKeown and Lin, 2013) where they 
bind to acetylated histones and are therefore often associated with 
euchromatin (Najafova et al., 2017). Additionally Wang et al., (2012) 
demonstrated that full length Brd4 protein was required to maintain 
chromatin structure and prevent abnormal heterochromatinisation.  
 
However some recent studies suggest that histone acetylation and BET 
proteins can also be associated with pericentric heterochromatin 
maintenance (Grézy et al., 2016). This study  demonstrated that when 
H3K9me3/Suv39h/HP1 heterochromatin association is disrupted, that TIP60 
acetylation recruits BET proteins to maintain heterochromatin compaction. 
 
Further studies have demonstrated specific recruitment of BET proteins to 
heterochromatin due to multiple stress responses (Floyd et al., 2013). This 
study demonstrated that Brd4 can recruit condensin II preventing DNA 
damage response pathways, while Col et al., (2017) demonstrated BET 
proteins were essential for pericentric transcription after heat shock. 
Together these studies support the idea that BET proteins can function at 
heterochromatin in certain situations. 
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The synthetic GFP cassette in the MEL cells is marked by H3K9me3 
enrichment suggesting Suv39h/HP1 mediates its heterochromatinisation.  
This therefore implicates BET proteins function beyond abnormal 
heterochromatin organisation and stress responses. 
 
When global histone modifications were analysed by protein arrays, H3K4 
methylation was elevated (Figure 3.10). This could be due to inhibition of 
BET proteins binding to acetylated lysines, which exposes histone acetylation 
to increased de-acetylation. H3K4 acetylation is associated with pericentric 
heterochromatin in yeast, and has an attributed function in recruiting the 
HP1 homologue Swi6 (Xhemalce and Kouzarides, 2010). If BET proteins bind 
to H3K4ac at pericentric regions this could provide a potential mechanism of 
action for heterochromatin maintenance.  
 
Additionally BET inhibitors resulted in significant decreases in MAPK 
signalling, and compensatory up regulation of PI3K/Akt and JNK signalling 
(Table 3.2) (Chen and Sytkowski, 2001; Mirzoeva et al., 2009). BET proteins 
have a key function in regulating c-Myc transcription, which is downstream 
of MAPK signalling. In turn, c-Myc is stabilised by MEK1 phosphorylation, 
but acts as a negative feedback loop for MAPK signalling by supressing 
ERBB-kinases (Tsai et al., 2012; C. Sun et al., 2014). This provides a 
mechanism for BET protein mediated activation of MAPK signalling 
pathways. As aberrant MAPK signalling is associated with driving EMT-like 






6.2 The relationship between BET proteins 
and EMT driven drug resistance 
 
Epithelial mesenchymal transitions (EMT) is a natural developmental 
process first observed in the heart (Markwald, Fitzharris and Smith, 1975). 
The process was initially described as the invasion of the cardiac matrix 
between E8.5 and E12, when cells morphologically change and aggregate 
into fibroblastic cushions. However this pathway is often hijacked by cancer 
cells to promote invasion and tumour metastasis (Yang et al., 2004; S. H. 
Wang et al., 2017). 
 
The EMT phenotype is the loss of cellular adhesion and membrane 
polarisation via reduced levels of E-cadherin and claudin proteins. 
Additionally N-cadherin, fibronectin, and extracellular matrix proteases are 
up regulated. Snail or Twist regulates this phenotypic switch and is strongly 
associated with metastasis (Rosivatz et al., 2002; Yang et al., 2004). Cells that 
have undergone an EMT-like transition often require the hyper activation of 
the Ras/Raf/MEK/ERK signalling pathway (Oft et al., 1996; Seton-Rogers et 
al., 2004; Xie et al., 2004). In addition, compensatory kinase pathways (Pi3K 
and Src) that are known to have crossover with the Ras/Raf pathway have 
also been implicated as drivers of EMT and metastasis (Bakin et al., 2000; 






EMT-like transitions occur with a high frequency in cutaneous melanomas, 
leading to aggressive metastasis and poor patient prognosis (Dissanayake et 
al., 2007; Fenouille et al., 2012).  As 45% of patients present with BRAF 
mutations and 20% present with NRAS mutations, MAPK inhibition has 
been explored as a therapeutic avenue (Hocker and Tsao, 2007; Flaherty et al., 
2012). Unfortunately, melanomas rapidly develop resistance and metastasise 
by hyper activating the MAPK pathway and only 20% present with new 
genetic abnormalities (Shi et al., 2012; Long et al., 2014). This suggests that 
acquired drug resistance occurs on a genome regulation level, rather than by 
aberrant genetic instability. Additional studies indicate that EMT-like status 
was completely independent of MAPK mutational status and is reversible 
(Hoek et al., 2006; Fallahi‐Sichani et al., 2017). This further suggests that 
MAPK acquired drug resistance linked EMT-like transitions may be 
epigenetically regulated. 
 
BET inhibition and loss of artificial heterochromatin silencing in the α-MEL 
system (Table 3.2) resulted in hyper phosphorylation of MAPK signalling, in 
addition to up regulation of EMT biomarkers including JNK signalling, 
FAK1, and STAT signalling. This suggested that BET proteins might function 
during EMT. 
 
An HCT116 cell line, developed by John Dawson, has n-Ras driven MAPK 
signalling that when exposed to MEK inhibitor trametinib, developed 
resistance with a mesenchymal phenotype (Figure 4.1). This provided a 
useful model to utilise epigenetic inhibitors to determine EMT-like pathway 
epigenetic components in relation to patient phenotype. 
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As one might expect, crossover kinase inhibitors (PLK/Akt) were more 
sensitive in resistant cells with hyper phosphorylation of MAPK signalling 
(Figure 4.3). Additionally identifying polycomb as functioning in acquired 
drug resistance is supported by recent evidence implicating PRC2 as a 
regulator of EMT and poor patient prognosis (Jene-Sanz et al., 2013; Tiwari et 
al., 2013; Cardenas et al., 2016). 
 
BET inhibition sensitivity increased further in mesenchymal-like cells and 
correlates with the kinase signalling response identified in α-MEL cells 
(Figure 4.8). The use of multiple BET inhibitors enabled off-target effects to 
be ruled out, and were used to investigate the role of specific BET proteins 
based on inhibitor selectivity. This demonstrated that selectivity toward Brd2 
correlated with cell survival (Figure 4.7). This specificity towards Brd2 has 
recently been supported by studies suggesting that Brd2 and Brd4 function 
as opposite drivers of EMT and MET respectively.  Andrieu and Denis, 
(2018) demonstrated that EMT-like transitions in triple negative breast cancer 
are induced by an up regulation of Brd2 expression, a process repressed by 
Brd4. This is also supported in non-disease cellular environments. Brd4 to 
Brd2 occupancy switching at enhancers, including Nodal, results in 
mesodermal differentiation of mES cells (Fernandez‐Alonso et al., 2017).  
This would explain the antagonistic effect observed in low concentrations in 
combination with trametinib (Figure 4.5). 
 
Furthermore, c-Myc, the downstream effector protein for Ras/Raf/MEK/ERK 
signalling is up regulated by acquired MAPK inhibitor resistance (Singleton 
et al., 2017; Zawistowski et al., 2017). BET proteins are known to have an 
essential function in regulating c-Myc expression, presenting another 
dependency of EMT-like acquired drug resistance on Brd2/4 (Lovén et al., 
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2013). There is growing evidence that cells having gone through an EMT-like 
transition, can overcome the loss of EMT drivers such as Notch/TGF-β 
signalling via enhancer BET protein occupancy (Yashiro-Ohtani et al., 2014). 
Together this evidence supports the data presented here that BET proteins, 
and specifically Brd2, have a key regulatory role in EMT-like transitions and 
resistance to MEK inhibition. 
 
When BET protein levels were observed in endothelial like (HCT116) and 
mesenchymal like (TRAMR) cells, Brd2 transcription and nuclear protein 
levels were elevated in the trametinib resistant mesenchymal like cells. 
Additionally Brd2 protein and transcript levels were both reduced upon BET 
inhibition in TRAMR cells indicative of a specific function on TRAMR cells 
(Figures 4.12, 4.13). Intriguingly this correlated with HP1α and HP1γ protein 
levels. Given HP1 proteins key role in chromatin compaction, this suggests 
that BET proteins may function to modulate chromatin organisational 
changes in mesenchymal like cells. Comparison of multiple endothelial and 
mesenchymal cell types demonstrated that BET protein occupancy at HP1 
promoters only occurred in mesenchymal cells and that bromodomain 
inhibition reduced Brd2 occupancy (Figures 4.15, 4.16) (W. Liu et al., 2013; 
Asangani et al., 2014; Knoechel et al., 2014). 
 
HP1 proteins and large scale conformation changes in chromatin 
organisation are associated with EMT (McDonald et al., 2011). Maybe, this is 
not surprising given the stark and relatively stable phenotypes of endothelial 
and mesenchymal cells. TGF-β induced EMT causes initial repression of 
pericentric transcription mediated by Snail1 recruitment and HP1α release 
(Millanes-Romero et al., 2013). This demonstrates the potential for MAPK 
signalling to regulate the large scale chromatin reorganisation during EMT. 
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Furthermore BRCA1 functions to supress EMT with mutations associated 
with poor patient prognosis (Bai et al., 2014). Loss of BRCA1 elevates major 
satellite transcription in mice while it also associates with HP1γ to form 
facultative heterochromatin mediated silencing of interspersed 
retrotransposons (Zhu et al., 2011; Filipponi et al., 2013). 
 
To determine BET protein distribution immunofluorescence across the 
nucleus was used in endothelial and mesenchymal like cells (Figure 4.10). 
While no discernible distribution pattern was observed for Brd2 or Brd3, JQ1 
treatment resulted in the formation of Brd4 foci that were associated with the 
nuclear periphery in mesenchymal like cells. This suggests a direct function 
for BET proteins at heterochromatin, supported by the recent study 
demonstrating TIP60 mediated BET protein recruitment to heterochromatin 
(Grézy et al., 2016). Together these data support the current opinion that BET 
proteins have a function in EMT-like transitions, while also suggesting that 














6.3 H3K9me3 and chromatin compaction 
 
Our understanding of heterochromatin structure and regulation currently 
remains limited. A key model system for investigation of HP1 proteins role 
at pericentric heterochromatin, are mouse embryonic stem cells and their 
Suv39h1 and Suv39h2 double null sister cells (Peters et al., 2001).   
 
Unlike human cells mouse constitutive heterochromatin is readily visible by 
microscopy and DAPI staining (Figures 1.4, 5.13). Despite the classical 
studies identifying Suv39h methyltransferases and HP1 proteins as 
suppressors of variegation, the cytologically distinct aggregates of 
constitutive heterochromatin are not lost upon Suv39h/H3K9me3/HP1 loss 
from these domains (Figures 5.3, 5.11). These domains in Suv39h knockouts 
also lack DNA methylation, H4K20me3, and increased histone acetylation 
(Peters et al., 2001). Given these large-scale changes to the heterochromatin 
epigenetic profile, the maintained presence of chromocenters, questions the 
relevance of histone modifications and their binding partners having a causal 
role in chromatin structure regulation. Indeed studies have directly 
demonstrated that loss of DNA methylation from heterochromatin had no 
effect on chromatin structure (Gilbert, Thomson, Boyle, Allan, Ramsahoye 
and Wendy A. Bickmore, 2007). 
 
To determine if H3K9me3 and HP1 proteins had a functional structural role 
at heterochromatin, the chromatin compaction state of wild type (WT41) and 
Suv39h1 and Suv39h2 double null (DN57)) mouse ES cells was analysed 
(Figures 5.5, 5.6). It was demonstrated that there was a resolvable loss in 
chromatin compaction in DN57 cells. This chromatin de-compaction was not 
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however limited to pericentric heterochromatin and suggested a global effect 
on chromatin compaction. Although H3K9me3 and HP1 is also found at 
facultative heterochromatin and interspersed retrotransposons, de-
compaction of these additional regions would still not account for the global 
change in chromatin compaction. This suggests that the effects of correct 
heterochromatin formation and H3K9me3/HP1 association extend beyond 
heterochromatin, effecting euchromatic regions. This affect was abrogated by 
the reestablishment of H3K9me3 by exogenous human Suv39h1 expression 
(Figure 5.12). This is the first evidence that alterations in histone 
modifications can affect chromatin structure.  
 
There is a growing body of evidence for an RNA component in chromatin 
compaction (Maison, Bailly, Peters, J. P. Quivy, et al., 2002; Arnoult, Van 
Beneden and Decottignies, 2012). Both Suv39h and HP1 protein families have 
RNA binding domains, but the exact function of RNA is hotly debated 
(Maison et al., 2011; Johnson et al., 2017; Shirai et al., 2017; Velazquez 
Camacho et al., 2017). Chromatin associated RNA in DN57 cells was analysed 
and preliminary results indicated that H3K9me3 loss correlated with a global 
elevation in chromatin associated RNA (Figures 5.13, 5.14). 
 
As previously stated, transitions to a mesenchymal-like phenotype require 
elevated levels of pericentric transcription and chromatin reorganisation 
(Zhu et al., 2011). The expression of heterochromatic repetitive elements is 
inversely correlated with H3K9me3 and HP1 association in a mesnchymal 
setting (Filipponi et al., 2013). This suggests that while RNA functions in 
heterochromatin formation, transcription of heterochromatic elements 
requires its absence (Casanova et al., 2013; Velazquez Camacho et al., 2017). 
Loss of H3K9me3 from constitutive heterochromatin is therefore likely to 
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increase satellite transcription. These repeat transcripts are non-coding and 
have been observed up to 8 kb in length in mouse cells (Quivy et al., 2004). 
 
Chromatin associated RNA has long been identified as a major chromatin 
component in vivo (Holmes et al., 1972; Berezney and Coffey, 1974). Recent 
work by Nozawa et al., (2017) demonstrated that chromatin associated RNA 
interacts with scaffold attachment factor A (SAF-A) to de-compact 
chromatin. This mechanism, coupled with increased satellite transcripts in 
the absence of H3K9me3 presents a potential mechanism for global 





















Regulation of chromatin structure is a complex multifaceted system utilising 
many biochemical and spatial components. These include; the transcriptional 
status, radial nuclear distribution, histone modifications, RNA containing 
nuclear scaffolds, cohesin and condensin mediated TAD formation, and most 
recently phase separation based on hydrophillicity (Wiblin et al., 2005; Larson 
et al., 2017; Nozawa et al., 2017; Rao et al., 2017).  The interplay between these 
components has yet to reveal a causal driver of large-scale chromatin 
regulation.  
 
However one can think of chromatin fibre structure regulation as a similar 
process to protein folding. Multiple orders of protein folding are required, 
and the local environment and physical forces must be tightly regulated to 
ensure a correct structure.  In this manner, recent work understanding 
chromatin organisation into phase separated states with different 
hydrophilic forces suggests that chromatin regulators can alter the chromatin 
local environment to affect its structure (Larson et al., 2017). This is consistent 
with protein folding where hydrophilicity is the greatest force effecting 
folding across the sequence (Dyson, Wright and Scheraga, 2006) and in 
proteins this results in the aggregation of hydrophobic residues to form 
secondary and tertiary structures (Camilloni et al., 2016). 
 
As such it is important to re-evaluate chromatin structure regulatory 
processes within a similar context. Histone acetylation or phosphorylation 
states for instance alters histone hydrophilicity (Lindner et al., 1996). 
Additionally the disordered hydrophobic C-terminal domain of linker 
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histone H1 is required for chromatin compaction (Allan et al., 1986). This 
suggests that H1 proteins alter the hydophilicity of the chromatin 
supramolecule to facilitate compaction. In this same way, H3K9me3 
recruited HP1 proteins have an essential unstructured hinge region, that 
interacts with RNA (Meehan, Kao and Pennings, 2003). The oligomierisation 
of HP1 into large arrays in the supramolecule are therefore likely to change 
the fibres hydrophilictiy facilitating conformational changes or sequestration 
into liquid droplets (Strom et al., 2017). 
 
The large RNA component of chromatin, suggests that it would also have a 
significant effect on the chromatin fibre supramolecules hydrophilicity. The 
base pairs of nucleic acids are naturally hydrophobic while the polar 
phosphate backbone is hydrophilic. In physiological conditions DNA 
generally forms B-form helices with charges distributed throughout. RNA, in 
contrast, forms A-form helices where the base pairs are more exposed. RNA 
secondary structures can therefore dramatically alter their hydrophilicity 
profile dependent on conformation (Suga et al., 2012). This switching 
between hydrophobic and hydrophilic states could therefore be regulatory 
by sequestering chromatin into liquid phase states. Altered RNA 
conformation by methylation or protein binding may also affect the physical 
properties of the underlying complex or molecule, providing a mechanism of 
action for RNA mediated tethering or aggregation.  
 
While the studies presented here demonstrate that histone modifications can 
directly alter chromatin fibre compaction, it is possibly indirect via altering 
non-coding RNA transcription. Pericentric non-coding RNA transcription 
has been presented as a driver of chromatin reorganisation in EMT/MET-like 
processes (Millanes-Romero et al., 2013). This supports observations herein of 
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Brd4 foci formation at the nuclear periphery once global Brd2 levels were 
reduced.  
 
This work suggests that a Brd2/Brd4 switch functions in altering chromatin 
organisation and is supported by recent publications (Cheung et al., 2017; 
Fernandez‐Alonso et al., 2017). It also suggests that Brd2 is a key regulator 
of EMT-like acquired drug resistance, but understanding mechanistically 
how Brd2 modulates this process would be the next step. These studies 
investigating the fundamental components of heterochromatin provide 
further evidence that RNA can modulate chromatin structure; the 




















Appendix 1. α-MEL eGFP reactivation compound screen. eGFP expression 
after α-MEL cells were screened with each compound in turn for 48 hours, and 
fluorescence determine by flow cytometry. Table of init ially screened 
compounds (n = 1) GFP fluorescence after treatment for 48 hours at 1 µM 










Appendix 2. Significant kinase changes to BET inhibition in α-MEL cells. 
α-MEL cells were treated with I-BET151 or JQ1+/-  1 µM for 24 hours. Protein 
lysates were spotted onto arrays and changes in kinase signaling after JQ1 
treatment when compared to DMSO controls. JQ1 and IBET151 treated α-MEL 
cells were treated as replicates and binned together before compared to DMSO 





Appendix 3. Kinase signaling changes in response to trametinib. Cells 
were treated with DMSO or 300 nM Trametinib for 24 hours before protein 
lysates were prepared and spotted onto arrays. List of all changes to kinase 
antibody fluorescence between either; (1) basal states of HCT116 and its 
trametinib resistant sister cells TRAMR, (2) HCT116 cells trametinib 300nM 24 
hour treatment to DMSO controls, or (3) TRAMR cells trametinib 300 nM 24 
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